BOC Sciences (Page 108) @ ChemBuyersGuide.com, Inc.

C-1311 DIHYDROCHLORIDE
CAS:138154-55-9
Formula: C20H26Cl2N4O3
98%
138154-55-9
Imidacrine; XLS-002; C-1311 dihydrochloride; XLS 002; C 1311 dihydrochloride; XLS002; C1311 dihydrochloride; Symadex; Imidazoacridinone; CHEMBL3545337;5-(2-(diethylamino)ethylamino)--8-hydroxy-6H-imidazo(4,5,1-de)acridin-6-one

C-6 NBD
CAS:88235-25-0
Formula: C12H14N4O5
GëÑ96%
88235-25-0
C6-NBD; NBD Hexanoic Acid; NBD-X; GÇï6-(7-Nitrobenzofurazan-4-ylamino)hexanoic Acid; 6-[(7-nitro-2,1,3-benzoxadiazol-4-yl)amino]-hexanoic acid

C-Cys-Mel
BAT-017009
Gly-Ile-Gly-Ala-Val-Leu-Lys-Val-Leu-Thr-Thr-Gly-Leu-Pro-Ala-Leu-Ile-Ser-Trp-Ile-Lys-Arg-Lys-Arg-Gln-Gln-Cys

C-DI-2'-D-2''-O-ME-AMP
Formula: C21H26N10O11P2 (free acid)
GëÑ 95% by HPLC
2'- Deoxy- 2''- O- methyl- cyclic diadenosine monophosphate, sodium salt

C-DI-2'-DAMP
Formula: C20H24N10O11P2 (free acid)
GëÑ 95% by HPLC
2'- Deoxy- cyclic diadenosine monophosphate, sodium salt

C-DI-2'-DGMP
CAS:132182-18-4
Formula: C20H24N10O13P2 (free acid)
GëÑ 95% by HPLC
132182-18-4
2'- Deoxy- cyclic diguanosine monophosphate, sodium salt

C-DI-AMP
CAS:54447-84-6
Formula: C20H24N10O12P2
GëÑ95%
54447-84-6
Cyclic diadenylate monophosphate; Cyclic diadenylate; Adenylic acid, cyclic ester; 3',5'-Cyclic diadenylic acid; Cyclic di-3',5'-adenylate; Cyclic di-AMP; Cyclic-di-AMP; Cyclic diadenosine monophosphate; (2R,3R,3aS,7aR,9R,10R,10aS,14aR)-2,9

c-di-AMP diammonium
Formula: C20H30N12O12P2
GëÑ95%
Cyclic diadenylate diammonium; Cyclic-di-AMP diammonium; 3'-Adenylic acid, adenylyl-(3'GåÆ5')-, cyclic nucleotide, diammonium; Adenylic acid, cyclic ester diammonium; 3',5'-Cyclic diadenylic acid diammonium; Cyclic di-3',5'-adenylate diammoni

c-di-AMP disodium
CAS:2734909-87-4
Formula: C20H22N10Na2O12P2
2734909-87-4
3',5'-Cyclic diadenylic acid sodium salt; Cyclic diadenylate disodium; Cyclic-di-AMP disodium; 3'-Adenylic acid, adenylyl-(3'GåÆ5')-, cyclic nucleotide, disodium; Adenylic acid, cyclic ester disodium; 3',5'-Cyclic diadenylic acid disodium; Cy

C-DI-AMP SODIUM
Formula: C20H24N10O12P2.xNa
GëÑ95%
Cyclic diadenylate sodium; Cyclic-di-AMP sodium; 3'-Adenylic acid, adenylyl-(3'GåÆ5')-, cyclic nucleotide, sodium; Adenylic acid, cyclic ester sodium; 3',5'-Cyclic diadenylic acid sodium; Cyclic di-3',5'-adenylate sodium; Cyclic diadenylate m

C-DI-GMP
CAS:61093-23-0
Formula: C20H24N10O14P2
GëÑ95%
B2001-006107
3'-Guanylic acid, guanylyl-(3'GåÆ5')-, cyclic nucleotide; 5GP-5GP; Cyclic di-3',5'-guanylate; Cyclic diguanylate; Cyclic diguanylate monophosphate; Cyclic-di-GMP; cGpGp; Cyclic diguanylic acid; cdiGMP; 3',5'-Cyclic diguanylic acid; c-(Gpgp);

C-DI-GMP FLUORINATED
CAS:1334145-18-4
Formula: C20H20F2N10O12P2 .2Na
1334145-18-4

C-DI-IMP
CAS:79940-41-3
Formula: C20H22N8O14P2
GëÑ95% by HPLC
79940-41-3
Cyclic diinosine monophosphate; 3'-Inosinic acid, inosinylyl-(3'GåÆ5')-, cyclic nucleotide; Cyclic-di-IMP; 3',3'-Cdimp; 9,9'-((2R,3R,3aS,7aR,9R,10R,10aS,14aR)-3,5,10,12-tetrahydroxy-5,12-dioxidooctahydro-2H,7H-difuro[3,2-d:3',2'-j][1,3,7,9]te

C-DI-UMP
CAS:73120-97-5
Formula: C18H20N4O16P2 .2Na
73120-97-5
Cyclic di-uridine monophosphate, c-di-UMP sodium salt

C-DIM12
CAS:178946-89-9
Formula: C23H17ClN2
98%
178946-89-9
C-DIM 12; C-DIM-12

C-FMS INHIBITOR
CAS:885704-21-2
Formula: C23H30N6O
>98%
885704-21-2
1H-Pyrrole-2-carboxamide, 4-cyano-N-[4-(4-methyl-1-piperazinyl)-2-(4-methyl-1-piperidinyl)phenyl]-

C-FMS-IN-1
CAS:885703-64-0
Formula: C22H27N5O2
GëÑ95%
885703-64-0
5-Cyano-N-[4-(4-methyl-1-piperazinyl)-2-(1-piperidinyl)phenyl]-2-furamide; 2-Furancarboxamide, 5-cyano-N-[4-(4-methyl-1-piperazinyl)-2-(1-piperidinyl)phenyl]-; 5-Cyano-furan-2-carboxylic acid [4-(4-methyl-piperazin-1-yl)-2-piperidin-1-yl-ph

C-FMS-IN-10
CAS:1527517-50-5
Formula: C22H19N7OS
GëÑ95%
1527517-50-5
4-Amino-N-{3-methyl-1-[(6-methyl-2-pyridinyl)methyl]-1H-indazol-4-yl}thieno[3,2-d]pyrimidine-7-carboxamide; Thieno[3,2-d]pyrimidine-7-carboxamide, 4-amino-N-[3-methyl-1-[(6-methyl-2-pyridinyl)methyl]-1H-indazol-4-yl]-

C-FMS-IN-2
CAS:791587-67-2
Formula: C19H21N3O3
GëÑ95%
791587-67-2
5-Cyanofuran-2-carboxylic Acid N-[5-hydroxymethyl-2-(4-methylpiperidin-1-yl)phenyl]amide; c-Fms inhibitor 2; 2-Furancarboxamide, 5-cyano-N-[5-(hydroxymethyl)-2-(4-methyl-1-piperidinyl)phenyl]-; 5-Cyano-N-[5-(hydroxymethyl)-2-(4-methyl-1-pip

C-FMS-IN-6
CAS:1628574-81-1
Formula: C22H25N7O2
GëÑ95%
1628574-81-1
2-(5-{[2-(1-Ethyl-1H-pyrazol-4-yl)-4-pyridinyl]oxy}-6-methyl-2-pyridinyl)-5-(2-methyl-2-propanyl)-2,4-dihydro-3H-1,2,4-triazol-3-one; 3H-1,2,4-Triazol-3-one, 5-(1,1-dimethylethyl)-2-[5-[[2-(1-ethyl-1H-pyrazol-4-yl)-4-pyridinyl]oxy]-6-methyl

C-FMS-IN-7
CAS:1313408-89-7
Formula: C26H24N6OS
GëÑ95%
1313408-89-7
N-(3-cyclopropyl-1-((6-methylpyridin-2-yl)methyl)-1H-indazol-4-yl)-7-(methylthio)imidazo[1,2-a]pyridine-3-carboxamide; N-{3-Cyclopropyl-1-[(6-methyl-2-pyridinyl)methyl]-1H-indazol-4-yl}-7-(methylsulfanyl)imidazo[1,2-a]pyridine-3-carboxamide

C-FMS-IN-8
CAS:1255303-58-2
Formula: C27H30N2O5
GëÑ95%
1255303-58-2
(3-{4-[(4-Ethylbenzyl)oxy]-3-methoxyphenyl}-1-azetidinyl)[4-(2-hydroxyethoxy)-2-pyridinyl]methanone; Methanone, [3-[4-[(4-ethylphenyl)methoxy]-3-methoxyphenyl]-1-azetidinyl][4-(2-hydroxyethoxy)-2-pyridinyl]-

C-FMS-IN-9
CAS:1628574-50-4
Formula: C21H23N7O2
GëÑ95%
1628574-50-4
3-(tert-butyl)-1-(6-methyl-5-((2-(1-methyl-1H-pyrazol-4-yl)pyridin-4-yl)oxy)pyridin-2-yl)-1H-1,2,4-triazol-5(4H)-one; 2-(6-Methyl-5-{[2-(1-methyl-1H-pyrazol-4-yl)-4-pyridinyl]oxy}-2-pyridinyl)-5-(2-methyl-2-propanyl)-1,2-dihydro-3H-1,2,4-tr

C-HEXAAMP
CAS:232933-63-0
Formula: C60H72N30O36P6 (free acid)
GëÑ 95% by HPLC
232933-63-0

C-HOMOERYTHRINAN, 1,2-DIDEHYDRO-6,7-EPOXY-3,15,16-TRIMETHOXY-, (3ALPHA ,6XI)-
CAS:39024-12-9
Formula: C20H25NO4
>98%
NP0357
C-Homoerythrinan, 1,2-didehydro-6,7-epoxy-3,15,16-trimethoxy-, (3alpha ,6xi)-

C-JUN PEPTIDE
CAS:610273-01-3
Formula: C121H210N36O34S
>98%
BAT-009135
(2S)-4-amino-2-[[(2S)-6-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-1-[(2S)-6-amino-2-[[(2S)-2-[[(2S)-2-[[2-[[(2S)-2-[[(2S)-1-[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-4-amino-2-[[(2S)-2-[[(2S,3R)-2-[[(2S)-2-[[(2S)-2-[[(2S)-5-amino-2-[[(2S)-6

C-JUN-AMINO-TERMINAL KINASE-INTERACTING PROTEIN 2 (683-692)
BAT-009842

C-KIT-IN-2
CAS:2121515-37-3
Formula: C25H29N9O2S
GëÑ95%
2121515-37-3
1-(5-Ethyl-1,2-oxazol-3-yl)-3-[4-(2-{[6-(4-ethyl-1-piperazinyl)-4-pyrimidinyl]amino}-1,3-thiazol-5-yl)phenyl]urea; Urea, N-(5-ethyl-3-isoxazolyl)-N'-[4-[2-[[6-(4-ethyl-1-piperazinyl)-4-pyrimidinyl]amino]-5-thiazolyl]phenyl]-

C-KIT-IN-3
CAS:2363169-01-9
Formula: C26H20ClF3N2O4
2363169-01-9
c-Kit IN 3; c-Kit IN-3; c-Kit-IN 3

C-Laurdan
CAS:959839-06-6
Formula: C25H35NO3
GëÑ95% (HPLC)
A16-0206

C-lock-G5-Dxd
Formula: C48H48Br2FN11O12
BADC-01418

C-lock-GGFG-Dxd
Formula: C53H51Br2FN10O11
BADC-01419

C-lock-GGFG-Exatecan
Formula: C50H46Br2FN9O9
BADC-01420

C-lock-PEG4-MMAE
Formula: C61H94Br2N8O13
BADC-01416

C-MET INHIBITOR 1
CAS:1357072-61-7
Formula: C17H14N8S
>98%
1357072-61-7
c-Met inhibitor 1; c Met inhibitor 1

C-MET-IN-1
CAS:2084836-84-8
Formula: C35H37FN6O5
GëÑ95%
2084836-84-8
N-[3-Fluoro-4-[6-methoxy-7-[3-(4-methylpiperazino)propoxy]quinoline-4-yloxy]phenyl]-1-(2-methoxyphenyl)-1H-imidazole-4-carboxamide; 1H-Imidazole-4-carboxamide, N-[3-fluoro-4-[[6-methoxy-7-[3-(4-methyl-1-piperazinyl)propoxy]-4-quinolinyl]oxy

C-MET-IN-2
CAS:1635406-73-3
Formula: C24H21FN10O
GëÑ95%
1635406-73-3
2-[4-(1-{1-[7-Fluoro-3-(1-methyl-1H-pyrazol-4-yl)-6-quinolinyl]ethyl}-1H-[1,2,3]triazolo[4,5-b]pyrazin-6-yl)-1H-pyrazol-1-yl]ethanol; 1H-Pyrazole-1-ethanol, 4-[1-[1-[7-fluoro-3-(1-methyl-1H-pyrazol-4-yl)-6-quinolinyl]ethyl]-1H-1,2,3-triazol

c-Myc inhibitor 4
Formula: C26H33FN6O3
2-[6-[(2S,5S)-2,5-dimethylpyrrolidin-1-yl]pyridin-3-yl]-4-fluoro-7-methoxy-N-methyl-1-[[(2S)-morpholin-2-yl]methyl]benzimidazole-5-carboxamide

C-MYC PEPTIDE
CAS:145646-22-6
Formula: C51H86N12O21
GëÑ95%
BAT-016308
H-Glu-Gln-Lys-Leu-Ile-Ser-Glu-Glu-Asp-Leu-OH; L-alpha-glutamyl-L-glutaminyl-L-lysyl-L-leucyl-L-isoleucyl-L-seryl-L-alpha-glutamyl-L-alpha-glutamyl-L-alpha-aspartyl-L-leucine; L-Leucine, L-+¦-glutamyl-L-glutaminyl-L-lysyl-L-leucyl-L-isoleucyl

C-MYC PEPTIDE TRIFLUOROACETATE
CAS:2918768-02-0
Formula: C51H86N12O21.C2HF3O2
GëÑ95%
BAT-009358
C-MYC PEPTIDE EPITOPE TFA; Glu-Gln-Lys-Leu-Ile-Ser-Glu-Glu-Asp-Leu TFA; c-Myc peptide epitope TFA; L-alpha-Glutamyl-L-glutaminyl-L-lysyl-L-leucyl-L-isoleucyl-L-seryl-L-alpha-glutamyl-L-alpha-glutamyl-L-alpha-aspartyl-L-leucine trifluoroacet

C-NH-BOC-C-BIS-(C-PEG1-BOC)
CAS:1807503-91-8
Formula: CGééGééHGéäGéüNOGéê
BP-501432

C-NH-BOC-C-BIS-(C1-PEG1-PFP)
CAS:1807521-01-2
Formula: CGééGéåHGééGéâFGéüGéÇNOGéê
BP-501339

c-PB2(OH)2
Formula: C46H30N4O6

C-Peptide (human)-[Val7.10-d16]
CAS:1802078-41-6
Formula: C129H195D16N35O48
BLP-014094
L-+¦-Glutamyl-L-alanyl-L-+¦-glutamyl-L-+¦-aspartyl-L-leucyl-L-glutaminyl-L-(2,3,4,4,4,4',4',4'-2H8)valylglycyl-L-glutaminyl-L-(2,3,4,4,4,4',4',4'-2H8)valyl-L-+¦-glutamyl-L-leucylglycylglycylglycyl-L-prolylglycyl-L-alanylglycyl-L-seryl-L-leucyl-

C-PEPTIDE 1 (RAT)
CAS:41475-27-8
Formula: C140H228N38O51
GëÑ95%
BAT-015331
Insulin 1 Precursor (57-87) (rat); H-Glu-Val-Glu-Asp-Pro-Gln-Val-Pro-Gln-Leu-Glu-Leu-Gly-Gly-Gly-Pro-Glu-Ala-Gly-Asp-Leu-Gln-Thr-Leu-Ala-Leu-Glu-Val-Ala-Arg-Gln-OH; L-alpha-glutamyl-L-valyl-L-alpha-glutamyl-L-alpha-aspartyl-L-prolyl-L-gluta

C-PEPTIDE 2 (RAT)
CAS:41594-08-5
Formula: C135H222N38O49
GëÑ95% by HPLC
BAT-015253
Preproinsulin 2 (57-87) (rat); H-Glu-Val-Glu-Asp-Pro-Gln-Val-Ala-Gln-Leu-Glu-Leu-Gly-Gly-Gly-Pro-Gly-Ala-Gly-Asp-Leu-Gln-Thr-Leu-Ala-Leu-Glu-Val-Ala-Arg-Gln-OH; L-alpha-glutamyl-L-valyl-L-alpha-glutamyl-L-alpha-aspartyl-L-prolyl-L-glutaminy

C-PEPTIDE, DOG
CAS:39016-05-2
Formula: C137H225N37O49
>95% by HPLC
BAT-010667
C-Peptide (dog)

C-REACTIVE PROTEIN (CRP) (174-185)
CAS:160369-86-8
Formula: C62H93N13O16
GëÑ98%
BAT-006208
H-Ile-Tyr-Leu-Gly-Gly-Pro-Phe-Ser-Pro-Asn-Val-Leu-OH; C-Reactive Protein (174-185); C-Reactive Protein 174-185

C-REACTIVE PROTEIN (CRP) (77-82)
CAS:130349-01-8
Formula: C23H40N6O10
98%
BAT-006207
H-Val-Gly-Gly-Ser-Glu-Ile-OH

C-REACTIVE PROTEIN (CRP) 201-206
CAS:130348-99-1
Formula: C38H57N9O8
GëÑ95%
BAT-010457
H-Lys-Pro-Gln-Leu-Trp-Pro-OH; L-lysyl-L-prolyl-L-glutaminyl-L-leucyl-L-tryptophyl-L-proline; C-reactive protein fragment 201-206

C-Reactive Protein (CRP) 201-206 acetate
CAS:2918771-38-5
Formula: C40H61N9O10
GëÑ95%
BAT-016229
H-Lys-Pro-Gln-Leu-Trp-Pro-OH.CH3CO2H; L-lysyl-L-prolyl-L-glutaminyl-L-leucyl-L-tryptophyl-L-proline acetic acid

C-Reactive Protein (CRP) 77-82 acetate
CAS:2918768-27-9
Formula: C25H44N6O12
GëÑ95%
BAT-016228
H-Val-Gly-Gly-Ser-Glu-Ile-OH.CH3CO2H; L-valyl-glycyl-glycyl-L-seryl-L-alpha-glutamyl-L-isoleucine acetic acid

C-TELOPEPTIDE
CAS:162929-64-8
Formula: C34H56N14O13
GëÑ95%
BAT-010461
H-Glu-Lys-Ala-His-Asp-Gly-Gly-Arg-OH; L-alpha-glutamyl-L-lysyl-L-alanyl-L-histidyl-L-alpha-aspartyl-glycyl-glycyl-L-arginine; (2S,11S,14S,17S,20S,23S)-14-((1H-imidazol-4-yl)methyl)-23-amino-20-(4-aminobutyl)-11-(carboxymethyl)-2-(3-guanidin

C-telopeptide acetate
Formula: C36H60N14O15
BAT-016264
CTX acetate

C-TOM-CE PHOSPHORAMIDITE
CAS:253586-12-8
Formula: C51H72N5O10PSi
GëÑ95%
BRP-02199
5'-Dimethoxytrityl-N-acetyl-Cytidine, 2'-O-triisopropylsilyloxymethyl-3'-[(2-cyanoethyl)-(N,N-diisopropyl)]-phosphoramidite; N-Acetyl-2'-O-[(triisopropylsilyloxy)methyl]-3'-O-[diisopropylamino(2-cyanoethoxy)phosphino]-5'-O-(4,4'-dimethoxytr

C-TYPE NATRIURETIC PEPTIDE (1-53), HUMAN
CAS:141294-77-1
Formula: C251H417N81O71S3
GëÑ95%
BAT-010463
CNP-53 (human); Asp-Leu-Arg-Val-Asp-Thr-Lys-Ser-Arg-Ala-Ala-Trp-Ala-Arg-Leu-Leu-Gln-Glu-His-Pro-Asn-Ala-Arg-Lys-Tyr-Lys-Gly-Ala-Asn-Lys-Lys-Gly-Leu-Ser-Lys-Gly-Cys-Phe-Gly-Leu-Lys-Leu-Asp-Arg-Ile-Gly-Ser-Met-Ser-Gly-Leu-Gly-Cys (Disulfide b

C-TYPE NATRIURETIC PEPTIDE (CNP) (1-22), HUMAN
CAS:127869-51-6
Formula: C93H157N27O28S3
GëÑ95%
BAT-010464
H-Gly-Leu-Ser-Lys-Gly-Cys(1)-Phe-Gly-Leu-Lys-Leu-Asp-Arg-Ile-Gly-Ser-Met-Ser-Gly-Leu-Gly-Cys(1)-OH; glycyl-L-leucyl-L-seryl-L-lysyl-glycyl-L-cysteinyl-L-phenylalanyl-glycyl-L-leucyl-L-lysyl-L-leucyl-L-alpha-aspartyl-L-arginyl-L-isoleucyl-gl

C-TYPE NATRIURETIC PEPTIDE-22 (HUMAN, PORCINE, RAT) TRIFLUOROACETATE SALT
Formula: C93H157N27O28S3-+xCF3COOH
GëÑ95%
CNP-22; glycyl-L-leucyl-L-seryl-L-lysylglycyl-L-cysteinyl-L-phenylalanylglycyl-L-leucyl-L-lysyl-L-leucyl-L-+¦-aspartyl-L-arginyl-L-isoleucylglycyl-L-seryl-L-methionyl-L-serylglycyl-L-leucylglycyl-L-cysteine cyclic (6GåÆ22)-disulfide trifluoroa

C-VERATROYLGLYCOL
CAS:168293-10-5
Formula: C10H12O5
98.0%
NP5422
2,3-dihydroxy-1-(4-hydroxy-3-methoxyphenyl)-1-propanone

C.I. BASIC YELLOW 40
CAS:12221-86-2
Formula: C20H20ClN3O2
95%
B2699-162398
C.I. Basic Yellow 40; Brilliant Flavine 10GFH; Basonyl Brilliant Yellow FF 4048; Atacryl Brilliant Flavine 9GFF

C.I. DIRECT BLUE 218
CAS:10401-50-0
Formula: C32H20Cu2N6Na4O16S4
95%
10401-50-0
DIRECT BLUE 218; DIRECTBLUE218; C.I. 24401

C.I. DISPERSE RED 362
CAS:158129-94-3
158129-94-3
Dianix Luminous Red 3B; Disperse Red 362; Kayalon Polyester Brilliant Red FB-S

C.I. PIGMENT BROWN 24
CAS:68186-90-3
Formula: (Ti,Sb,Cr)O2
68186-90-3
Chrome antimony titanium buff rutile; Chrome rutile yellow; Titanium, Antimony, Chromium III oxide rutile

C.I. PIGMENT WHITE 19
CAS:8047-76-5
95%
8047-76-5
Pyrophyllite; C.I.77004; Diapone P; Dutch Pink; Levitex P; Necophyl P; Neuberg Chalk; SSClay; Snowcel; Varon A; Wilkinite

C.I.BASIC BLUE 41
CAS:12270-13-2
Formula: C20H26N4O6S2
12270-13-2
2-[[4-[ethyl(2-hydroxyethyl)amino]phenyl]azo]-; 2-[[4-[ethyl(2-hydroxyethyl)amino]phenyl]azo]-6-methoxy-3-; 2-[[4-[ethyl(2-hydroxyethyl)amino]phenyl]azo]-6-methoxy-3-methylbenzothiazolium; 2-[[4-[ethyl(2-hydroxyethyl)amino]phenyl]azo]-6-met

C[3'-AHC-G(2',5')PA(3',5')P]
Formula: C27H38N12O14P2 (free acid)
GëÑ 95% by HPLC
Cyclic (3'- O- (6- aminohexylcarbamoyl)guanosine- (2' GêÆGëÑ 5')- monophosphate- adenosine- (3' GêÆGëÑ 5')- monophosphate), sodium salt

C[3'-BIOTIN-16-G(2',5')PA(3',5')P]
Formula: C43H63N15O17P2S (free acid)
GëÑ 95% by HPLC

C[3'-FLUO-AHC-G(2',5')PA(3',5')P]
Formula: C48H48N12O20P2
GëÑ 95% by HPLC
Cyclic(3'-O-(6-[fluoresceinyl]aminohexylcarbamoyl)guanosine-(2'GåÆ5')-monophosphate-adenosine-(3'GåÆ5')-monophosphate), sodium salt

C[8-AET-G(2',5')PA(3',5')P]
Formula: C22H29N11O13P2S (free acid)
GëÑ 95% by HPLC
Cyclic (8- (2- aminoethylthio)guanosine- (2' GêÆGëÑ 5')- monophosphate- adenosine- (3' GêÆGëÑ 5')- monophosphate), sodium salt

C[8-AET-G(2',5')PA(3',5')P]-AGAROSE
Cyclic (8- (2- aminoethylthio)guanosine- (2' GêÆGëÑ 5')- monophosphate- adenosine- (3' GêÆGëÑ 5')- monophosphate), immobilized on agarose gel

C[8-BIOTIN-11-G(2',5')PA(3',5')P]
Formula: C38H54N14O16P2S2 (free acid)
GëÑ 95% by HPLC

C[8-BR-G(2',5')PA(3',5')P]
Formula: C20H23BrN10O13P2 (free acid)
GëÑ 95% by HPLC
Cyclic (8- bromoguanosine- (2' GêÆGëÑ 5')- monophosphate- adenosine- (3' GêÆGëÑ 5')- monophosphate), sodium salt

C[8-FLUO-AET-G(2',5')PA(3',5')P]
Formula: C43H39N11O19P2S (free acid)
GëÑ 95% by HPLC
Cyclic(8-(2-[fluoresceinyl]aminoethylthio)-guanosine-(2'GåÆ5')-monophosphate-adenosine-(3'GåÆ5')-monophosphate), sodium salt

C[A(2',5')PA(2',5')P]
Formula: C20H24N10O12P2
GëÑ 95% by HPLC
Cyclic (adenosine- (2' GêÆGëÑ 5')- monophosphate- adenosine- (2' GêÆGëÑ 5')- monophosphate), sodium salt

C[A(2',5')PS[SP]-A(3',5')PS[RP]]
CAS:1638242-31-5
Formula: C20H24N10O10P2S2 (free acid)
GëÑ 95% by HPLC
1638242-31-5

c[G(2',5')p-+¦-A(3',5')p]
Formula: C22H24N10O13P2 (free acid)
GëÑ 95% by HPLC

C[G(2',5')P-2'-AHC-A(3',5')P]
Formula: C27H38N12O14P2 (free acid)
GëÑ 95% by HPLC
Cyclic (guanosine- (2' GêÆGëÑ 5')- monophosphate- 2'- O- (6- aminohexylcarbamoyl)adenosine- (3' GêÆGëÑ 5')- monophosphate), sodium salt

C[G(2',5')P-2'-BIOTIN-16-A(3',5')P]
Formula: C43H63N15O17P2S (free acid)
GëÑ 95% by HPLC

C[G(2',5')P-2'-DA(3',5')P]
Formula: C20H24N10O12P2 (free acid)
GëÑ 95% by HPLC
Cyclic (guanosine- (2' GêÆGëÑ 5')- monophosphate- 2'- deoxyadenosine- (3' GêÆGëÑ 5')- monophosphate), sodium salt

C[G(2',5')P-2'-FLUO-AHC-A(3',5')P]
Formula: C48H48N12O20P2
GëÑ 95% by HPLC
Cyclic(guanosine-(2'GåÆ5')-monophosphate-2'-O-(6-[fluoresceinyl]aminohexylcarbamoyl)adenosine-(3'GåÆ5')-monophosphate), sodium salt

C[G(2',5')PG(2',5')P]
CAS:389873-75-0
Formula: C20H24N10O14P2 (free acid)
GëÑ 95% by HPLC
389873-75-0
Cyclic diguanosine- (2' GêÆGëÑ 5')- monophosphate / cyclic bis (2' GêÆGëÑ 5') diguanylic acid, sodium salt

C[G(2',5')PS-A(3',5')PS], ISOMER 1 AND ISOMER 2
CAS:1638242-56-4 / 1638243-00-1
Formula: C20H24N10O11P2S2 (free acid)
GëÑ 95% by HPLC
1638242-56-4 / 1638243-00-1

C086
CAS:1160107-44-7
Formula: C29H28O8
>98%
1160107-44-7
C086; C 086; C-086

C10 AV CERAMIDE
CAS:1263052-40-9
Formula: C44H65NO3
GëÑ98%
1263052-40-9
Anthrylvinyl Ceramide; (11E)-12-(9-anthracenyl)-N-[(1S,2R,3E)-2-hydroxy-1-(hydroxymethyl)-3-heptadecen-1-yl]-11-dodecenamide

C10 BISPHOSPHONATE
CAS:15049-93-1
Formula: C10H25NO6P2
>99%
15049-93-1
1-aminodecane-1,1-bisphosphonic acid

C11 BODIPY 581/591
CAS:217075-36-0
Formula: C30H35BF2N2O2
F01-0257

C11 TopFluor-« Ceramide-1-Phosphate Ammonium salt
CAS:2260795-50-2
Formula: C42H74BF2N4O6P
>99%
2260795-50-2
N-[11-(dipyrrometheneboron difluoride)undecanoyl]-D-erythro-sphingosine-1-phosphate (ammonium salt); N-[11-(TopFluor)undecanoyl]-D-ceramide-1-phosphate (ammonium salt)

C11 TopFluor-« Galactosyl Ceramide
CAS:1246355-61-2
Formula: C48H80N3O8F2
>99%
1246355-61-2
N-[11-(dipyrrometheneboron difluoride)undecanoyl]-D-galactosyl-beta1-1'-D-erythro-sphingosine

C11 TopFluor-« Glucosyl Ceramide
CAS:1246355-70-3
Formula: C48H80N3O8F2
>99%
1246355-70-3
N-[11-(dipyrrometheneboron difluoride)undecanoyl]-D-glucosyl-beta1-1'-D-erythro-sphingosine

C11 TopFluor-« GM3 Ammonium salt
CAS:2260795-48-8
Formula: C65H110BF2N5O21
2260795-48-8
C11 TopFluor GM3 Ganglioside (ammonium salt); Borate(1-), [N-[(1S,2R,3E)-1-[[[O-(N-acetyl-+¦-neuraminosyl)-(2GåÆ3)-O-+¦-D-galactopyranosyl-(1GåÆ4)-+¦-D-glucopyranosyl]oxy]methyl]-2-hydroxy-3-heptadecen-1-yl]-++-(3,5-dimethyl-2H-pyrrol-2-ylidene-+¦N)

C11 TopFluor-« MG
CAS:2260795-64-8
Formula: C27H41BF2N2O4
>99%
2260795-64-8
1-[11-(dipyrrometheneboron difluoride)undecanoyl]-rac-glycerol

C11 TopFluor-«Sphingomyelin
CAS:886209-09-2
Formula: C47H82N4O6PF2
>99%
886209-09-2
N-[11-(dipyrrometheneboron difluoride)undecanoyl]-D-erythro-sphingosylphosphorylcholine; N-[11-(TopFluor)undecanoyl]-D-erythro-sphingosine-1-phosphocholine

C11-PEG13-ALCOHOL
Formula: C35H72O13
0.95
BPG-4327
C11-PEG13-alcohol; DTXSID001025209; BP-23155; NS00076734; 3,6,9,12,15,18,21,24,27,30,33,36-dodecaoxaheptatetracontan-1-ol

C11-PEG4-ALCOHOL
CAS:88299-47-2
Formula: C17H36O4
0.95
BPG-4324
Undeceth-3; Tomadol 1-3; Neodol 1-3; Genapol UD 030; Undeceth-3 [INCI]; 88299-47-2; 3O5BS8YJVJ; C11-PEG4-alcohol

C11-PEG6-ALCOHOL
CAS:92691-26-4
Formula: C21H44O6
0.95
BPG-4325
3,6,9,12,15-Pentaoxahexacosan-1-ol; 92691-26-4; C11-PEG6-alcohol; CHEMBL1213506; DTXSID60435152; BP-23169; CS-0254643; NS00076625

C11-PEG9-ALCOHOL
CAS:35056-97-4
Formula: C27H56O9
0.95
BPG-4326
C11-PEG9-alcohol; 3,6,9,12,15,18,21,24-Octaoxapentatriacontan-1-ol; 35056-97-4; Octaethylene glycol undecyl ether; DTXSID101025040; BP-23279; CS-0254641; NS00076641

C12 +¦-D-galactosyl ceramide
CAS:41613-14-3
Formula: C36H69NO8
>99%
41613-14-3
C12 beta-GalCer; C12 Galactosyl(+¦) Ceramide (d18:1/12:0); beta-D-galactosyl-N-(dodecanoyl)sphingosine; D-galactosyl-+¦-1,1' N-lauroyl-D-erythro-sphingosine

C12 CERAMIDE
CAS:74713-60-3
Formula: C30H59NO3
>99%
74713-60-3
Laurylsphingosine; C12 Ceramide (d18:1/12:0); N-lauroyl-D-erythro-Sphingosine; N-dodecanoylsphingosine; Dodecyl sphingosine; N-(dodecanoyl)-sphing-4-enine

C12 ceramide-1,3-cyclic-phosphate (d18:1/12:0)
CAS:2410279-77-3
Formula: C30H61N2O5P
>99%
2410279-77-3
N-lauroyl-ceramide-1,3-cyclic-phosphate (ammonium salt)

C12 Ceramide-1-Phosphate (d18:1/12:0) (ammonium salt)
CAS:799812-62-7
Formula: C30H63N2O6P
>99%
799812-62-7
N-lauroyl-ceramide-1-phosphate (ammonium salt); N-(dodecanoyl)-sphing-4-enine-1-phosphate (ammonium salt); CerP(d18:1/12:0) (ammonium salt)

C12 Di-Sulfo Galactosyl(+¦) Ceramide (d18:1/12:0) (ammonium salt)
CAS:852043-40-4
Formula: C36H75N2O14S2
>99%
852043-40-4
3,6-di-O-sulfo-D-galactosyl-+¦1-1'-N-lauroyl-D-erythro-sphingosine (ammonium salt); 3,6-Sulfo-C12 GalCer (ammonium salt); 3,6-di-O-sulfo-+¦-D-C12-galactosylceramide (ammonium salt)

C12 DIHYDROCERAMIDE (D18:0/12:0)
CAS:197302-96-8
Formula: C30H61NO3
>99%
197302-96-8
N-lauroyl-D-erythro-sphinganine; N-dodecanoylsphinganine; Cer(d18:0/12:0); N-12:0 Sphinganine; C12 Sphinganine; C12 dihydrosphingosine; N-(dodecanoyl)-sphinganine; N-lauroylsphinganine; N-lauroyldihydrosphingosine; N-dodecanoyldihydrosphing

C12 GLUCOSYL(BETA) CERAMIDE (D18:1/12:0)
CAS:111956-48-0
Formula: C36H69NO8
>99%
111956-48-0
D-glucosyl-beta-1,1'-N-lauroyl-D-erythro-sphingosine; C12 beta-D-glucosyl ceramide; N-(dodecanoyl)-1-beta-glucosyl-sphing-4-enine; Dodecanamide, N-[1-[(beta-D-glucopyranosyloxy)methyl]-2-hydroxy-3-heptadecen-1-yl]-

C12 Lactosyl(+¦) Ceramide (d18:1/12:0)
CAS:474943-80-1
Formula: C42H79NO13
>99%
474943-80-1
D-lactosyl-beta-1,1' N-lauroyl-D-erythro-sphingosine; Dodecanamide, N-[(1S,2R,3E)-1-[[(4-O-+¦-D-galactopyranosyl-+¦-D-glucopyranosyl)oxy]methyl]-2-hydroxy-3-heptadecen-1-yl]-; D-lactosyl-+¦-1,1' N-lauroyl-D-erythro-sphingosine

C12 LISSAMINE-RHODAMINE GALACTOSYLCERAMIDE
Formula: C63H98N4O14S2
GëÑ98%
Lissamine-rhodamine B-dodecanoyl Galactosylceramide; 2-(6-(diethylamino)-3-(diethyliminio)-3H-xanthen-9-yl)-5-(N-(12-(((2S,E)-3R-hydroxy-1-((3R,4S,5R-trihydroxy-6R-(hydroxymethyl)tetrahydro-2H-pyran-2R-yl)oxy)octadec-4-en-2-yl)amino)-12-oxo

C12 Mono-Sulfo Galactosyl(+¦) Ceramide (d18:1/12:0) (ammonium salt)
CAS:852043-39-1
Formula: C36H72N2O11S
>99%
852043-39-1
3-O-sulfo-D-galactosyl-+¦1-1'-N-lauroyl-D-erythro-sphingosine (ammonium salt); 3-Sulfo-C12:0 GalCer (ammonium salt); 3-O-sulfo-+¦-D-C12-galactosylceramide (ammonium salt)

C12 NBD 3'-SULFO GALACTOSYLCERAMIDE
Formula: C42H71N5O14S
GëÑ98%
C12 NBD Sulfatide; N-dodecanoyl-NBD-Sulfatide; (2R,3R,4S,5S,6R)-3,5-dihydroxy-2-(((2S,3R,E)-3-hydroxy-2-(12-((7-nitrobenzo[c][1,2,5]oxadiazol-4-yl)amino)dodecanamido)octadec-4-en-1-yl)oxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-4-yl hydrogen

C12 NBD CERAMIDE
CAS:202850-01-9
Formula: C36H61N5O6
>99%
202850-01-9
N-[12-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]dodecanoyl]-D-erythro-sphingosine; C12-NBD Ceramide; N-Dodecanoyl-NBD-D-erythro-sphingosine; N-(NBD-Aminolauroyl)ceramide; N-C12-NBD-D-erythro-Sphingosine; N-[(1S,2R,3E)-2-hydroxy-1-(hydroxymet

C12 NBD DIHYDRO CERAMIDE
CAS:474943-05-0
Formula: C36H63N5O6
GëÑ98%
474943-05-0
C-12 NBD-dihydro-Ceramide; C12-NBD Sphinganine; N-[(1S,2R)-2-hydroxy-1-(hydroxymethyl)heptadecyl]-12-[(7-nitro-2,1,3-benzoxadiazol-4-yl)amino]-dodecanamide; 6-[Fluorescein-5(6)-carboxamido]hexanoic acid N-hydroxysuccinimide ester

C12 NBD GALACTOSYLCERAMIDE
CAS:474942-98-8
Formula: C42H71N5O11
GëÑ98%
474942-98-8
N-Dodecanoyl-NBD-galactosylceramide; N-[(1S,2R,3E)-1-[(+¦-D-galactopyranosyloxy)methyl]-2-hydroxy-3-heptadecen-1-yl]-12-[(7-nitro-2,1,3-benzoxadiazol-4-yl)amino]-dodecanamide

C12 NBD GLOBOTRIAOSYLCERAMIDE
Formula: C54H91N5O21
GëÑ98%
N-dodecanoyl-NBD-Ceramide Trihexoside

C12 NBD L-THREO-CERAMIDE
Formula: C36H61N5O6
GëÑ98%
N-dodecanoyl-NBD L-threo-Sphingosine; N-((2R,3R,E)-1,3-dihydroxyoctadec-4-en-2-yl)-12-((7-nitrobenzo[c][1,2,5]oxadiazol-4-yl)amino)dodecanamide

C12 NBD LACTOSYLCERAMIDE
CAS:474943-06-1
Formula: C48H81N5O16
GëÑ98%
474943-06-1
N-dodecanoyl-NBD-lactosylceramide; N-[(1S,2R,3E)-1-[[(4-O-+¦-D-galactopyranosyl-+¦-D-glucopyranosyl)oxy]methyl]-2-hydroxy-3-heptadecen-1-yl]-12-[(7-nitro-2,1,3-benzoxadiazol-4-yl)amino]-dodecanamide; C12 NBD Lactosylceramide (d18:1/12:0)

C12 NBD PHYTOCERAMIDE
Formula: C36H63N5O7
GëÑ98%
C12 NBD Phytosphingosine; N-dodecanoyl-NBD Phytosphingosine; 12-((7-nitrobenzo[c][1,2,5]oxadiazol-4-yl)amino)-N-((2R,3R,4R)-1,3,4-trihydroxyoctadecan-2-yl)dodecanamide

C12 NBD SPHINGOMYELIN
Formula: C41H73N6O9P
GëÑ98%
N-dodecanoyl-NBD Sphingosylphosphorylcholine; (E)-3-hydroxy-2-(12-((7-nitrobenzo[c][1,2,5]oxadiazol-4-yl)amino)dodecanamido)octadec-4-en-1-yl (2-(trimethylammonio)ethyl) phosphate

C12 SPHINGOSYL PE (D17:1/12:0)
CAS:1246303-21-8
Formula: C31H63N2O6P
>99%
1246303-21-8
N-lauroyl-D-erythro-sphingosyl phosphoethanolamine (C17 base); N-C12 Sphingosylphosphoethanolamine (C17 base)2-ammonioethyl; (2R,3S,E)-2-dodecanamido-3-hydroxyheptadec-4-enyl phosphate; PE-Cer(d17:1(4E)/12:0)

C12-200
CAS:1220890-25-4
Formula: C70H145N5O5
>98%
B1370-358162
1,1'-((2-(4-(2-((2-(Bis(2-hydroxydodecyl)amino)ethyl)(2-hydroxydodecyl)amino)ethyl)piperazin-1-yl)ethyl)azanediyl)bis(dodecan-2-ol)

C12-iE-DAP
CAS:1269619-57-9
Formula: C24H43N3O8
GëÑ95%
1269619-57-9
Lauroyl-+¦-D-glutamyl-meso-diaminopimelic acid; Heptanedioic acid, 2-amino-6-[[(4R)-4-carboxy-1-oxo-4-[(1-oxododecyl)amino]butyl]amino]-; 2-Amino-6-[[(4R)-4-carboxy-1-oxo-4-[(1-oxododecyl)amino]butyl]amino]heptanedioic acid; C12IE-DAP; 2-ami

C12-NBD GLUCOSYL CERAMIDE
CAS:474943-01-6
Formula: C42H71N5O11
>99%
474943-01-6
N-[12-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]dodecanoyl]-D-glucosyl-+¦1-1'-sphingosine

C12-NBD PHYTOSPHINGOSINE
CAS:388566-94-7
Formula: C36H63N5O7
>99%
388566-94-7
N-[12-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]dodecanoyl]-phytosphingosine

C12-NBD SPHINGOMYELIN
CAS:254117-01-6
Formula: C41H73N6O9P
>99%
254117-01-6
N-[12-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]dodecanoyl]-sphingosine-1-phosphocholine

C12-SPM
CAS:2055647-81-7
Formula: C82H170N4O6
BL-M001398
13,17,22,26-tetrakis(2-hydroxydodecyl)-13,17,22,26-tetraazaoctatriacontane-11,28-diol

C12:0 L-carnitine-d9 (HCl salt)
Formula: C19H29D9ClNO4
>99%
BL-M001231
Lauroyl L-carnitine-d9 (HCl salt)

C12E5
CAS:3055-95-6
Formula: C22H46O6
GëÑ95%
3055-95-6
Pentaethylene glycol monododecyl ether; Dodecyl pentaethylene glycolether; n-Dodecylpentaoxyethylene; Laureth-5; Pentaethylene glycol lauryl ether; Pentaoxyethylene monododecyl ether; Polyoxyethylene (5) lauryl ether; PEG-5 Lauryl ether; 3,

C12FDGLCU
Formula: C44H51NO18

C13 3-O-sulfogalactostyl(+¦) Ceramide-[d7] Ammonium salt
CAS:2315262-25-8
Formula: C37H67D7N2O11S
>99%
BLP-011318
3-O-sulfo-D-galactosyl-+¦-1,1'-N-tridecanoyl-D-erythro-sphingosine (d7) (ammonium salt); C13 3-O-sulfogalactostyl(+¦) Ceramide-d7 (d18:1(d7)/13:0)

C13 Galactosyl(+¦) Ceramide-[d7]
CAS:2315262-19-0
Formula: C37H64D7NO8
>99%
BLP-011313
D-galactosyl-+¦-1,1'-N-tridecanoyl-D-erythro-sphingosine-d7; C13 Galactosyl(+¦) Ceramide-d7 (d18:1-d7/13:0); GalCer (d18:1-d7/13:0)

C13-112-TETRA-TAIL
CAS:1381861-92-2
Formula: C58H120N2O6
0.95
BPG-3616
C13-112-tetra-tail; 1381861-92-2; C13-112-tetra-tail?; DTXSID701134764; HY-W440683; BP-20308; CS-0435697; 17,20-Dioxa-14,23-diazahexatriacontane-12,25-diol, 14,23-bis(2-hydroxytridecyl)-

C13-112-TRI-TAIL
CAS:1381861-96-6
Formula: C45H94N2O5
0.95
BPG-3614

C13-113-TETRA-TAIL
CAS:1381861-97-7
Formula: C57H119N3O4
0.95
BPG-3617
C13-113-tetra-tail; 1381861-97-7; C13-113-tetra-tail?; HY-W440684; BP-20310; CS-0435700

C13-113-TRI-TAIL
CAS:1381861-86-4
Formula: C44H93N3O3
0.95
BPG-3615
C13-113-tri-tail; 1381861-86-4; C13-113-tri-tail?; HY-W440682; BP-20311; CS-0435694

C13-dihydroceramide-[d7]
CAS:2315262-21-4
Formula: C31H56D7NO3
>99%
BLP-011315
N-tridecanoyl-D-erythro-sphinganine-d7; C13-dihydroceramide-d7 (d18:0-d7/13:0)

C14 Carnitine (HCl salt)
Formula: C21H42ClNO4
>99%
BL-M000584
Myristoyl L-carnitine (HCl salt)

C14 CERAMIDE (D18:1/14:0)
CAS:123408-74-2
Formula: C32H63NO3
>99%
123408-74-2
N-myristoyl-D-erythro-sphingosine; N-(tetradecanoyl)-sphing-4-enine

C14-Tri-LAN-Gly
CAS:1863978-69-1
Formula: C30H53N5O10S
GëÑ95%
1863978-69-1
Myristic-Alanine-D-iso-Glutamine-+¦-meso-Lanthionine-Glycine; N5-((S)-3-(((R)-2-amino-2-carboxyethyl)thio)-1-((carboxymethyl)amino)-1-oxopropan-2-yl)-N2-(tetradecanoyl-L-alanyl)-D-glutamine

C14ORF49 PROTEIN (221-232)
BAT-009511
SYNE3 (221-232)

C14TKL-1
CAS:1423381-12-7
Formula: C63H98N20O13S2
GëÑ95%
BAT-016413
H-Arg-His-Arg-Thr-Pro-Met-Phe-Tyr-Gly-Leu-Met-NH2; L-arginyl-L-histidyl-L-arginyl-L-threonyl-L-prolyl-L-methionyl-L-phenylalanyl-L-tyrosyl-glycyl-L-leucyl-L-methioninamide; Chromosome 14 tachykinin-like peptide 1; C14TKL1; C14TKL 1

C14TKL-1 acetate
Formula: C65H102N20O15S2
GëÑ95%
BAT-016414
H-Arg-His-Arg-Thr-Pro-Met-Phe-Tyr-Gly-Leu-Met-NH2.CH3CO2H; L-arginyl-L-histidyl-L-arginyl-L-threonyl-L-prolyl-L-methionyl-L-phenylalanyl-L-tyrosyl-glycyl-L-leucyl-L-methioninamide acetate; Chromosome 14 tachykinin-like peptide 1 acetate; C1

C15 CERAMIDE (D18:1/15:0)
CAS:67492-15-3
Formula: C33H65NO3
>99%
67492-15-3
N-(pentadecanoyl)-4E-sphingenine; N-pentadecanoyl-D-erythro-sphingosine; Cer(d18:1(4E)/15:0); C15 D-erythro Ceramide (d18:1/15:0)

C15 Ceramide-[d7]
Formula: C33H58D7NO3
>99%
BLP-011439
N-pentadecanoyl-D-erythro-sphingosine(d7); C15 Ceramide-[d7] (d18:1-[d7]/15:0)

C15 Ceramide-1-Phosphate-[d7] Ammonium salt
CAS:2315262-27-0
Formula: C33H62D7N2O6P
>99%
BLP-011319
N-pentadecanoyl-ceramide-1-phosphate-d7 (ammonium salt); C15 Ceramide-1-Phosphate-d7 (d18:1-d7/15:0)

C15 CERAMIDE-D7 (D18:1-D7/15:0)
Formula: C33H58 D7NO3
>99%
BPG-3115
N-pentadecanoyl-D-erythro-sphingosine(d7)

C15 Glucosyl(+¦) Ceramide-[d7]
CAS:2315262-18-9
Formula: C39H68D7NO8
>99%
BLP-011312
D-glucosyl-+¦-1,1'-N-pentadecanoyl-D-erythro-sphingosine-d7; C15 Glucosyl(+¦) Ceramide-d7 (d18:1-d7/15:0); GlcCer (d18:1-d7/15:0)

C15 Lactosyl(+¦) Ceramide-[d7]
CAS:2315262-20-3
Formula: C45H78D7NO13
>99%
BLP-011314
D-lactosyl-+¦-1,1'-N-pentadecanoyl-D-erythro-sphingosine-d7; C15 Lactosyl(+¦) Ceramide-d7 (d18:1-d7/15:0)

C16
CAS:608512-97-6
Formula: C13H8N4OS
GëÑ98% by HPLC
608512-97-6
GW-506033X; GW 506033X; GW506033X; C16, PKR Inhibitor; 6,8-Dihydro-8-(1H-imidazol-5-ylmethylene)-7H-pyrrolo[2,3-g]benzothiazol-7-one

C16 3-ketodihydroceramide
Formula: C34H67NO3
>99%
BL-M001175
N16:0 3-ketosphinganine

C16 CARNITINE
CAS:1935-18-8
Formula: C23H45NO4
GëÑ98%
1935-18-8
palmitoyl L-carnitine; Palmitoylcarnitine; [3-Carboxylato-2-(palmitoyloxy)propyl]trimethylaminium; CPD-419; (+/-)-palmitoyl carnitine; O-palmitoylcarnitine; O-hexadecanoylcarnitine; 3-(palmitoyloxy)-4-(trimethylammonio)butanoate; 1-Propanam

C16 CERAMIDE
CAS:24696-26-2
Formula: C34H67NO3
98%
B1370-059982
C16 Ceramide (d18:1/16:0); N-(hexadecanoyl)-sphing-4-enine; N-Palmitoylsphingosine

C16 CERAMIDE (D14:1/16:0)
CAS:1228440-96-7
Formula: C30H59NO3
>99%
1228440-96-7
N-palmitoyl-D-erythro-sphingosine (C14 base); Cer(d14:1/16:0); N-(hexadecanoyl)-tetradecasphing-4-enine

C16 Ceramide (d18:1/16:0)-[d7]
CAS:1840942-13-3
Formula: C34H60D7NO3
99% by CP; 99% atom D
BLP-011236
N-palmitoyl-D-erythro-sphingosine (d7); N-[2R-hydroxy-1S-(hydroxymethyl)-3E-heptadecen-1-yl-d7]-hexadecanamide

C16 Ceramide-[d7]
Formula: C34H60D7NO3
BLP-014071
Ceramide C16:0 (d18:1 D7 /16:0)-[D7]; N-(1,3-dihydroxyoctadec-4-en-2-yl-16,16,17,17,18,18,18-d7)palmitamide; C16 Ceramide (d18:1/16:0-[D7]); N-(hexadecanoyl)-sphing-4-enine-[D7]

C16 ceramide-1,3-cyclic-phosphate (d18:1/16:0)
CAS:2410279-79-5
Formula: C34H69N2O5P
>98%
2410279-79-5
N-palmitoyl-ceramide-1,3-cyclic-phosphate (ammonium salt)

C16 CERAMIDE-1-PHOSPHATE (D18:1/16:0) AMMONIUM SALT
CAS:1246303-22-9
Formula: C34H71N2O6P
GëÑ98%
1246303-22-9
C16 C1P; C16 Ceramide-1-phosphate; N-(hexadecanoyl)-sphing-4-enine-1-phosphate; CerP(d18:1/16:0)

C16 CPG; 1000 +à
BRP-02309
C16 CPG (1-DMT-2-Hexadecyl-Glyc-CPG); 1000 +à

C16 CY5 SM
CAS:2342574-13-2
Formula: C72H119ClN5O7P
>99%
2342574-13-2
N-palmitoyl sphingomyelin-N-(Cyanine 5); 2-[{2-[(6-{3,3-Dimethyl-2-[(1E,3E,5E)-5-(1,3,3-trimethyl-1,3-dihydro-2H-indol-2-ylidene)-1,3-pentadien-1-yl]-3H-indolium-1-yl}hexanoyl)amino]ethyl}(dimethyl)ammonio]ethyl (2S,3R,4E)-3-hydroxy-2-(palm

C16 Cyclic LPA (ammonium salt)
CAS:799268-68-1
Formula: C19H42NO5P
>99%
799268-68-1
1-O-hexadecyl-sn-glycero-2,3-cyclic-phosphate (ammonium salt); 1-hexadecyl-sn-glycero-2,3-cyclic-phosphate (ammonium salt)

C16 DIHYDROCERAMIDE (D18:0/16:0)
CAS:5966-29-0
Formula: C34H69NO3
>99%
5966-29-0
N-(hexadecanoyl)-sphinganine; N-palmitoyl-D-erythro-sphinganine; N-16:0 Sphinganine; C16 Sphinganine; C16 dihydrosphingosine; Cer(d18:0/16:0)

C16 Dihydroceramide-1-Phosphate (d18:0/16:0) ammonium salt
CAS:1246303-17-2
Formula: C34H73N2O6P
>99%
1246303-17-2
N-palmitoyl-D-erythro-dihydroceramide-1-phosphate (ammonium salt); 16:0 Sphinganine-1-phosphate (ammonium salt); CerP(d18:0/16:0)

C16 Galactosyl (+¦) Dihydroceramide (d18:0/16:0)
CAS:942223-45-2
Formula: C40H79NO8
>99%
942223-45-2
D-galactosyl-a-1,1' N-palmitoyl-D-erythro-sphinganine

C16 GALACTOSYL (B) DIHYDROCERAMIDE (D18:0/16:0)
CAS:54947-67-0
Formula: C40H79NO8
>99%
54947-67-0
D-galactosyl-+¦-1,1'N-palmitoyl-D-erythro-sphinganine; N-[(1S,2R)-2-hydroxy-1-[[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxymethyl]heptadecyl]hexadecanamide

C16 Galactosyl(+¦) Ceramide (d18:1/16:0)
CAS:2260795-77-3
Formula: C40H77NO8
>99%
2260795-77-3
D-galactosyl-+¦-1,1'-N-palmitoyl-D-erythro-sphingosine; Hexadecanamide, N-[(1S,2R,3E)-1-[(+¦-D-galactopyranosyloxy)methyl]-2-hydroxy-3-heptadecen-1-yl]-; +¦ C16 Galactosylceramide (d18:1/16:0); C16 +¦-D-galactosyl ceramide; N-(hexadecanoyl)-1-+¦

C16 Glucosyl(+¦) Ceramide (d18:1/16:0)
CAS:74365-77-8
Formula: C40H77NO8
>99%
74365-77-8
D-glucosyl-+¦-1,1'-N-palmitoyl-D-erythro-sphingosine; C16 +¦-D-glucosyl ceramide; N-(hexadecanoyl)-1-+¦-glucosyl-sphing-4-enine; Glucosylceramide (d18:1/16:0); beta-D-glucosyl-N-hexadecanoylsphingosine

C16 LPA (ammonium salt)
CAS:799279-66-6
Formula: C19H44NO6P
>99%
799279-66-6
1-O-hexadecyl-2-hydroxy-sn-glycero-3-phosphate (ammonium salt); 1-hexadecyl-sn-glycero-3-phosphate (ammonium salt); PA(16:0e/0:0) (ammonium salt)

C16 PEG2000 CERAMIDE
CAS:212116-78-4
Formula: (C2H4O)nC39H73NO6
>99%
212116-78-4
N-palmitoyl-sphingosine-1-{succinyl[methoxy(polyethylene glycol)2000]}; C16 PEG 2000 Ceramide; C16 PEG Ceramide; CerC16-PEG; Poly(oxy-1,2-ethanediyl), a-[4-[[(2S,3R,4E)-3-hydroxy-2-[(1-oxohexadecyl)amino]-4-octadecen-1-yl]oxy]-1,4-dioxobuty

C16 PEG5000 CERAMIDE
Formula: C265H525NO119 (average MW due to polydispersity of PEG)
>99%
N-palmitoyl-sphingosine-1-{succinyl[methoxy(polyethylene glycol)5000]}

C16 PEG750 CERAMIDE
Formula: C71H137NO22 (average MW due to polydispersity of PEG)
>99%
N-palmitoyl-sphingosine-1-{succinyl[methoxy(polyethylene glycol)750]}

C16(PLASM) LPC
CAS:97802-53-4
Formula: C24H50NO6P
>99%
97802-53-4
1-(1Z-hexadecenyl)-sn-glycero-3-phosphocholine; 1-O-1'-(Z)-hexadecenyl-2-hydroxy-sn-glycero-3-phosphocholine; PC(O-16:1(1Z)/0:0); PC(16:0p/0:0); LPlasCho; LysoPC(P-16:0)

C16(plasm)-18:1(d9) PC
CAS:2770684-41-6
Formula: C42H73D9NO7P
>99%
BL-M001206
1-(1Z-hexadecenyl)-2-oleoyl(d9)-sn-glycero-3-phosphocholine

C16-18:1 PC
CAS:95403-34-2
Formula: C42H84NO7P
>99%
95403-34-2
1-O-hexadecyl-2-oleoyl-sn-glycero-3-phosphocholine; 1-O-hexadecyl-2-(9Z-octadecenoyl)-sn-glycero-3-phosphocholine; PC(16:0e/18:1(9Z)); C16:0-18:1 PAF

C16-18:1 PE
CAS:119904-40-4
Formula: C39H78NO7P
119904-40-4
1-hexadecyl-2-(9Z-octadecenoyl)-sn-glycero-3-phosphoethanolamine; 1-O-hexadecyl-2-oleoyl-sn-glycero-3-phosphoethanolamine; PE(O-16:0/18:1(9Z))

C16-20:3 PC
CAS:155575-01-2
Formula: C44H84NO7P
95%
155575-01-2
1-O-hexadecyl-2-eicosatrienoyl-sn-glycero-3-phosphocholine; PC(16:0e/20:3(8Z,11Z,14Z)); C16:0-20:3 PAF

C16-20:4 PC
CAS:86288-11-1
Formula: C44H82NO7P
>99%
86288-11-1
1-O-hexadecyl-2-arachidonoyl-sn-glycero-3-phosphocholine; 1-O-hexadecyl-2-eicosatetraenoyl-sn-glycero-3-phosphocholine; PC(16:0e/20:4(5Z,8Z,11Z,14Z)); C16:0-20:4 PAF; 1-hexadecyl-2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycero-3-phosphocholin

C16-20:5 PC
CAS:132196-28-2
Formula: C44H80NO7P
95%
132196-28-2
1-O-hexadecyl-2-eicosapentaenoyl-sn-glycero-3-phosphocholine; PC(O-16:0/20:5(5Z,8Z,11Z,14Z,17Z)); PC(o36:5); 1-hexadecyl-2-(5Z,8Z,11Z,14Z,17Z-eicosapentaenoyl)-sn-glycero-3-phosphocholine

C16-Sphingomyelin (d18:1/16:0)-[d9]
Formula: C39H70N2O6D9P
GëÑ98% atom D
BLP-014077
C16-Sphingomyelin (d18:1/16:0)-d9; N-Palmitoyl-D-sphingomyelin-D9; (2S,3R,4E)-2-(Palmitoylamino)-4-octadecene-3-hydroxy-1-phosphocholine-D9; N-(Hexadecanoyl)-sphing-4-enine-1-phosphocholine-D9; N-Palmitoyl-D-erythro-sphingosylphosphorylchol

C16-UREA-CERAMIDE
CAS:361450-27-3
Formula: C35H70N2O3
>99%
361450-27-3
D-erythro-N-[2-(1,3-dihydroxy-4E-octadecene)]-N'-hexadecane-urea; D-erythro-C16-urea-ceramide

C16/C11-TF/C12-DNP TG
CAS:2260795-46-6
Formula: C61H98BF2N5O9
>99%
2260795-46-6
1-O-hexadecyl-2-(dipyrrometheneboron difluoride)undecanoyl-3-(dinitrophenylamino)dodecanoyl-sn-glycerol

C16:0 anandamide phosphate Sodium salt
CAS:2260670-49-1
Formula: C18H37NNaO5P
>99%
2260670-49-1
palmitoyl ethanolamide phosphate (sodium salt); Sodium 2-(palmitoylamino)ethyl hydrogen phosphate; Hexadecanamide, N-[2-(phosphonooxy)ethyl]-, sodium salt (1:1)

C16:0 CERAMIDE (D18:2(4E,8Z)/16:0)
CAS:1919028-96-8
Formula: C34H65NO3
1919028-96-8
N-palmitoyl-D-erythro-sphingosine (d18:2(4E,8Z) base); (4E,8Z)-N-hexadecanoylsphinga-4,8-dienine

C16:0 L-carnitine-d9
Formula: C23H36D9NO4
>99%
BL-M001281
Palmitoyl L-carnitine-d9

C16:1 Ceramide-[d7]
CAS:1942907-49-4
Formula: C34H58D7NO3
>99%
BLP-011245
N-palmitoleoyl-D-erythro-sphingosine-d7; C16:1 Ceramide-d7 (d18:1-d7/16:1)

C17 Glucosyl(beta) Ceramide (d18:1/17:0)
CAS:1252807-00-3
Formula: C41H79NO8
>99%
1252807-00-3
D-glucosyl-beta-1,1'-N-heptadecanoyl-D-erythro-sphingosine; C17 beta-D-Glucosyl Ceramide

C17 LACTOSYL(BETA) CERAMIDE (D18:1/17:0)
CAS:1354699-26-5
Formula: C47H89NO13
>99%
1354699-26-5
D-Lactosyl-beta-1,1'-N-Heptadecanoyl-D-erythro-Sphingosine; C17 beta-D-Lactosyl Ceramide

C17 LYSO PAF
CAS:111858-52-7
Formula: C25H54NO6P
>99%
111858-52-7
1-O-heptadecyl-2-hydroxy-sn-glycero-3-phosphocholine; 1-heptadecyl-sn-glycero-3-phosphocholine; 3,5,9-Trioxa-4-phosphahexacosan-1-aminium, 4,7-dihydroxy-N,N,N-trimethyl-, inner salt, 4-oxide, (R)-

C17 Mono-Sulfo Galactosyl(beta) Ceramide (d18:1/17:0) ammonium salt
CAS:1246303-23-0
Formula: C41H82N2O11S
>99%
1246303-23-0
3-O-sulfo-D-galactosyl-beta1-1'-N-heptadecanoyl-D-erythro-sphingosine (ammonium salt); 3-Sulfo-C17:0 GalCer

C17 SPHINGOSINE
CAS:6918-48-5
Formula: C17H35NO2
>99%
6918-48-5
D-erythro-sphingosine (C17 base); heptadecasphing-4-enine; C17-Sphingosine; 2S-Amino-4E-heptadecene-1,3R-diol

C17-02:0 PC
CAS:93037-84-4
Formula: C27H56NO7P
>99%
93037-84-4
1-O-Heptadecyl-2-Acetyl-sn-Glycero-3-Phosphocholine (C17 PAF); PC(O-17:0/2:0); PC(17:0e/2:0); C17-02:0 PAF

C17:0 anandamide phosphate Sodium salt
CAS:2260670-51-5
Formula: C19H39NNaO5P
>99%
2260670-51-5
heptadecanoyl ethanolamide phosphate (sodium salt); sodium 2-(heptadecanoylamino)ethyl hydrogen phosphate

C17:0 GA2
CAS:2315262-51-0
Formula: C47H89NO13
>99%
2315262-51-0
C17:0 Galabiosylceramide; N-[(1S,2R,3E)-1-[[(4-O-+¦-D-Galactopyranosyl-+¦-D-galactopyranosyl)oxy]methyl]-2-hydroxy-3-heptadecen-1-yl]heptadecanamide

C17:0 GB3
CAS:536745-81-0
Formula: C53H99NO18
>99%
536745-81-0
C17:0 Globotriaosylceramide; N-Heptadecanoyl ceramide trihexoside; C17 Ceramide Trihexoside (d18:1/17:0)

C17:0 GD1a (d18:1/17:0)
CAS:2707415-34-5
Formula: C83H149N5O39
>99%
BL-M001148
C17:0 GD1a Ganglioside (d18:1/17:0, ammonium salt)

C17:0 GD1a (d18:1/17:0) (ammonium salt)
Formula: C83H149N5O39
>99%
C17:0 GD1a Ganglioside (d18:1/17:0, ammonium salt)

C17:0 GM1
CAS:2456349-02-1
Formula: C72H132N4O31
>99%
2456349-02-1
C17:0 GM1 Ganglioside (ammonium salt)

C17:0 iGB3
CAS:2315262-50-9
Formula: C53H99NO18
>99%
2315262-50-9
C17:0 Isoglobotriaosylceramide; N-[(1S,2R,3E)-1-[[(O-+¦-D-Galactopyranosyl-(1GåÆ3)-O-+¦-D-galactopyranosyl-(1GåÆ4)-+¦-D-glucopyranosyl)oxy]methyl]-2-hydroxy-3-heptadecen-1-yl]heptadecanamide

C17:1 ANANDAMIDE
CAS:1094209-17-2
Formula: C19H37NO2
>99%
1094209-17-2
10Z-heptadecenoylethanolamide; 17:1 ethanolamide

C18 BULK SORBENT
BB070698

C18 CERAMIDE
CAS:2304-81-6
Formula: C36H71NO3
98%
B1370-058857
N-Stearoyl-D-erythro-sphingosine; N-(octadecanoyl)-sphing-4-enine; C18 Ceramide (d18:1/18:0); N-[(1S,2R,3E)-2-Hydroxy-1-(hydroxymethyl)-3-heptadecen-1-yl]octadecanamide; D-erythro-1,3-Dihydroxy-2-octadecanoylamido-trans-4-octadecene; N-Stea

C18 CERAMIDE (D17:1/18:0)
CAS:123065-42-9
Formula: C35H69NO3
>99%
123065-42-9
N-stearoyl-D-erythro-sphingosine (C17 base); N-(octadecanoyl)-sphing-4-enine (C17 base)

C18 Ceramide (d18:1/18:0)-[d7]
CAS:1840942-14-4
Formula: C36H64D7NO3
99% by CP; 99% atom D
BLP-011237
N-stearoyl-D-erythro-sphingosine (d7)

C18 DIHYDROCERAMIDE
CAS:2304-80-5
Formula: C36H73NO3
>99%
2304-80-5
N-stearoyl-D-erythro-sphinganine; C18 Dihydroceramide (d18:0/18:0); N-18:0 Sphinganine; C18 Sphinganine; C18 dihydrosphingosine; N-(octadecanoyl)-sphinganine; Dihydroceramide; N-Stearoylsphinganine; Octadecanoylsphinganine; Cer(d18:0/18:0);

C18 Glucosyl(+¦) Ceramide (d18:1/18:0)
CAS:95119-86-1
Formula: C42H81NO8
>99%
95119-86-1
D-glucosyl-+¦-1,1'-N-stearoyl-D-erythro-sphingosine; C18 +¦-D-glucosyl ceramide; N-(octadecanoyl)-1-+¦-glucosyl-sphing-4-enine; GlcCer(d18:1/18:0)

C18 Glucosyl(+¦) Ceramide-[d5]
CAS:2260670-13-9
Formula: C42H76D5NO8
>99%
BLP-011291
D-glucosyl-+¦-1,1'-N-stearoyl-D-erythro-sphingosine-d5; C18 Glucosyl(+¦) Ceramide-d5; beta-D-glucosyl-N-octadecanoylsphingosine-d5; GlcCer(d18:1/18:0)-d5; Glucosylceramide (d18:1/18:0)-d5; beta-D-glucosyl-N-stearoylsphingosine-d5; 1-O-(beta-D

C18 L-ERYTHRO CERAMIDE (D18:1/18:0)
CAS:252039-52-4
Formula: C36H71NO3
GëÑ98%
252039-52-4
L-erythro Cer(d18:1/18:0); L-erythro Ceramide (d18:1/18:0); N-octadecanoyl-L-erythro-sphingosine

C18 L-THREO CERAMIDE (D18:1/18:0)
CAS:95037-06-2
Formula: C36H71NO3
GëÑ98%
95037-06-2
N-octadecanoyl-L-threo-sphingosine; L-threo Cer(d18:1/18:0); L-threo Ceramide (d18:1/18:0)

C18 LACTOSYL(BETA) CERAMIDE (D18:1/18:0)
CAS:125712-73-4
Formula: C48H91NO13
>99%
125712-73-4
D-lactosyl-beta-1,1' N-stearoyl-D-erythro-sphingosine; C18 beta-D-Lactosyl Ceramide; Lactosylceramide; beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1)-N-octadecanoylsphingosine; LacCer(d18:1/18:0)

C18 LPA (ammonium salt)
CAS:799279-67-7
Formula: C21H48NO6P
>99%
799279-67-7
1-O-octadecyl-2-hydroxy-sn-glycero-3-phosphate (ammonium salt); 1-octadecyl-sn-glycero-3-phosphate (ammonium salt); PA(18:0e/0:0) (ammonium salt); (R)GÇï-GÇï2-GÇïHydroxy-GÇï3-GÇï(octadecyloxy)GÇïpropyl dihydrogen phosphate, Ammonia Salt

C18 spherical silica resin (120+à, 20-¦m)
BB057739

c18(2R-OH) galactosyl(+¦) ceramide
CAS:35823-62-2
Formula: C42H81NO9
>99%
35823-62-2
D-galactosyl-beta1-1'-N-[2''(R)-hydroxystearoyl]-D-erythro-sphingosine

C18(2S-OH) Galactosyl(beta) Ceramide
CAS:168395-96-8
Formula: C42H81NO9
>99%
168395-96-8
D-galactosyl-beta1-1'-N-[2''(S)-hydroxystearoyl]-D-erythro-sphingosine

C18(PLASM) LPC
CAS:97802-55-6
Formula: C26H54NO6P
>99%
97802-55-6
1-O-1'-(Z)-octadecenyl-2-hydroxy-sn-glycero-3-phosphocholine; PC(18:1p/0:0); 1-(1Z-octadecenyl)-sn-glycero-3-phosphocholine; 1-(1-enyl-stearoyl)-glycero-3-phosphocholine; 1-(1-enyl-stearoyl)-GPC

C18(PLASM) LPE
CAS:174062-73-8
Formula: C23H48NO6P
>99%
174062-73-8
1-O-1'-(Z)-octadecenyl-2-hydroxy-sn-glycero-3-phosphoethanolamine; phosphoethanolamine (P-18:0); PE(18:1p/0:0)

C18(PLASM) MG
CAS:18330-10-4
Formula: C21H42O3
>99%
18330-10-4
1-O-1'-(Z)-octadecenyl-sn-glycerol; 1-(1Z-Octadecenyl)-sn-glycerol; MG(P-18:0e/0:0/0:0)

C18(PLASM)-18:1 PC
CAS:799268-63-6
Formula: C44H86NO7P
>99%
799268-63-6
1-(1Z-octadecenyl)-2-oleoyl-sn-glycero-3-phosphocholine; 1-O-1'-(Z)-octadecenyl-2-(9Z-octadecenoyl)-sn-glycero-3-phosphocholine; GPCho(18:0p/18:1(9Z)); PC(P-18:0/18:1(9Z))

C18(plasm)-18:1 PC-[d9]
CAS:2315262-03-2
Formula: C44H77D9NO7P
>99%
BLP-011310
1-(1Z-octadecenyl)-2-oleoyl(d9)-sn-glycero-3-phosphocholine; C18(plasm)-18:1(d9) PC; PC(P-18:0/18:1(9Z))-d9; 1-(1-enyl-stearoyl)-2-oleoyl-GPC-d9

C18(PLASM)-18:1 PE
CAS:144371-68-6
Formula: C41H80NO7P
>99%
144371-68-6
1-(1Z-octadecenyl)-2-oleoyl-sn-glycero-3-phosphoethanolamine; 1-O-1'-(Z)-octadecenyl-2-(9Z-octadecenoyl)-sn-glycero-3-phosphoethanolamine; PE(P-18:0/18:1(9Z))

C18(plasm)-18:1 PE-[d9]
CAS:2315262-04-3
Formula: C41H71D9NO7P
>99%
BLP-011311
1-(1Z-octadecenyl)-2-oleoyl(d9)-sn-glycero-3-phosphoethanolamine; C18(plasm)-18:1(d9) PE; 1-(1Z-octadecenyl)-2-(9Z-octadecenoyl)-sn-glycero-3-phosphoethanolamine-d9; 1-(1-enyl-stearoyl)-2-oleoyl-GPE-d9; GPE(P-18:0/18:1)-d9

C18(PLASM)-20:4 PC
CAS:97802-56-7
Formula: C46H84NO7P
>99%
97802-56-7
1-(1Z-octadecenyl)-2-arachidonoyl-sn-glycero-3-phosphocholine; PC(P-18:0/20:4(5Z,8Z,11Z,14Z)); PC(P-18:0/20:4); 1-(1-enyl-stearoyl)-2-arachidonoyl-GPC

C18(PLASM)-20:4 PE
CAS:144371-69-7
Formula: C43H78NO7P
>99%
144371-69-7
1-(1Z-octadecenyl)-2-arachidonoyl-sn-glycero-3-phosphoethanolamine; 1-O-1'-(Z)-octadecenyl-2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycero-3-phosphoethanolamine; 1-(1-enyl-stearoyl)-2-arachidonoyl-GPE; GPEtn(18:0p/20:4(5Z,8Z,11Z,14Z))

C18(PLASM)-22:6 PC
CAS:799268-64-7
Formula: C48H84NO7P
>99%
799268-64-7
1-(1Z-octadecenyl)-2-docosahexaenoyl-sn-glycero-3-phosphocholine; 1-O-1'-(Z)-octadecenyl-2-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-sn-glycero-3-phosphocholine; GPCho(18:0p/22:6(4Z,7Z,10Z,13Z,16Z,19Z)); PC(P-18:0/22:6)

C18(PLASM)-22:6 PE
CAS:206059-98-5
Formula: C45H78NO7P
>99%
206059-98-5
1-(1Z-octadecenyl)-2-docosahexaenoyl-sn-glycero-3-phosphoethanolamine; 1-O-1'-(Z)-octadecenyl-2-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-sn-glycero-3-phosphoethanolamine; GPEtn(18:0p/22:6(4Z,7Z,10Z,13Z,16Z,19Z)); 1-(1Z-octadecenyl)-2-(4Z,7Z,

C18-PEG12-COOH, PEG MW 528 Da
BPG-0382
Dodecaethylene glycol octadecyl carboxylic acid

C18-PEG12-Hydrazide, PEG MW 528 Da
BPG-0376
Dodecaethylene glycol octadecyl ether hydrazide

C18-PEG12-MAL, PEG MW 528 Da
BPG-0385
Dodecaethylene glycol octadecyl ether maleimide

C18-PEG12-N3, PEG MW 528 Da
BPG-0394
Dodecaethylene glycol octadecyl ether azide

C18-PEG12-NH2, PEG MW 528 Da
BPG-0391
Dodecaethylene glycol octadecyl ether amine

C18-PEG12-NHS, PEG MW 528 Da
BPG-0379
Dodecaethylene glycol octadecyl succinimidyl ester

C18-PEG12-OH, PEG MW 528 Da
BPG-0388
Dodecaethylene glycol octadecyl ether

C18-PEG12-OPSS, PEG MW 528 Da
BPG-0397
Dodecaethylene glycol octadecyl pyridyldisulfide

C18-PEG12-SH, PEG MW 528 Da
BPG-0399
Dodecaethylene glycol octadecyl thiol

C18-PEG4-AZIDE
CAS:1807539-11-2
Formula: C26H53N3O4
0.98
BPG-4521
C18-PEG4-Azide; 1807539-11-2; DTXSID401296692; BP-22408; 3,6,9,12-Tetraoxatriacontane, 1-azido-; 1-[2-[2-[2-(2-azidoethoxy)ethoxy]ethoxy]ethoxy]octadecane

C18-PEG4-COOH, PEG MW 176 Da
BPG-0380
Tetraethylene glycol octadecyl ether carboxyl acid

C18-PEG4-Hydrazide, PEG MW 176 Da
BPG-0374
Tetraethylene glycol octadecyl ether hydrazide

C18-PEG4-MAL, PEG MW 176 Da
BPG-0383
Tetraethylene glycol octadecyl ether maleimide

C18-PEG4-N3, PEG MW 176 Da
BPG-0392
Tetraethylene glycol octadecyl ether azide

C18-PEG4-NH2, PEG MW 176 Da
BPG-0389
Tetraethylene glycol octadecyl ether amine

C18-PEG4-NHS, PEG MW 176 Da
BPG-0377
Tetraethylene glycol octadecyl succinimidyl ester

C18-PEG4-OH, PEG MW 176 Da
BPG-0386
Tetraethylene glycol octadecyl ether

C18-PEG4-OPSS, PEG MW 176 Da
BPG-0395
Tetraethylene glycol octadecyl O-pyridyl disulfide

C18-PEG4-Thiol, PEG MW 176 Da
BPG-0400
Tetraethylene glycol octadecyl ether sulfhydryl

C18-PEG5-ACID
CAS:1807534-83-3
Formula: C29H58O7
0.98
BPG-4520
C18-PEG5-Acid; 1807534-83-3; DTXSID601256806; BP-22406; 4,7,10,13,16-Pentaoxatetratriacontanoic acid; 3-[2-[2-[2-(2-octadecoxyethoxy)ethoxy]ethoxy]ethoxy]propanoic acid

C18-PEG6-COOH, PEG MW 264 Da
BPG-0381
Hexaethylene glycol octadecyl ether carboxyl acid

C18-PEG6-Hydrazide, PEG MW 264 Da
BPG-0375
Hexaethylene glycol octadecyl ether hydrazide

C18-PEG6-MAL, PEG MW 264 Da
BPG-0384
Hexaethylene glycol octadecyl ether maleimide

C18-PEG6-N3, PEG MW 264 Da
BPG-0393
Hexaethylene glycol octadecyl ether azide

C18-PEG6-NH2, PEG MW 264 Da
BPG-0390
Hexaethylene glycol octadecyl ether amine

C18-PEG6-NHS, PEG MW 264 Da
BPG-0378
Hexaethylene glycol octadecyl succinimidyl ester

C18-PEG6-OH, PEG MW 264 Da
BPG-0387
Hexaethylene glycol octadecyl ether

C18-PEG6-OPSS, PEG MW 264 Da
BPG-0396
Hexaethylene glycol octadecyl pyridyldisulfide

C18-PEG6-SH, PEG MW 264 Da
BPG-0398
Hexaethylene glycol octadecyl ether thiol

C18:0 GD1a (d18:1/18:0)
CAS:2707415-32-3
Formula: C84H154N6O39
>99%
BL-M001152
C18:0 disialoganglioside-GD1a (d18:1/18:0, diammonium salt)

C18:0 GD1a (d18:1/18:0) (triammonium salt)
Formula: C84H154N6O39
>99%
C18:0 trisialoganglioside-GD1a (d18:1/18:0, triammonium salt)

C18:0 GM1-[d5] Ammonium salt
CAS:2260669-93-8
Formula: C73H129D5N4O31
>99%
BLP-011286
C18:0 GM1 Ganglioside-d5 (ammonium salt); C18:0 GM1-d5 ammonium salt

C18:0 GM1-Biotin (synthetic)
CAS:2770684-25-6
Formula: C89H160N8O36S
>99%
BL-M001154
C18:0 GM1 Ganglioside-Biotin (synthetic, ammonium salt)

C18:0 GM3 ammonium salt
CAS:1246353-19-4
Formula: C59H111N3O21
>99%
1246353-19-4
C18:0 GM3 Ganglioside (ammonium salt)

C18:0 GM3-[d5] Ammonium salt
CAS:2260669-91-6
Formula: C59H106D5N3O21
>99%
BLP-011285
C18:0 GM3 Ganglioside-d5 (ammonium salt); C18:0 GM3-d5 ammonium salt

C18:0 GT1b (d18:1/18:0)
CAS:2707481-39-6
Formula: C95H174N8O47
>99%
BL-M001151
C18:0 trisialoganglioside-GT1b (d18:1/18:0, triammonium salt)

C18:0 GT1b (d18:1/18:0) (triammonium salt)
Formula: C95H174N8O47
>99%
C18:0 trisialoganglioside-GT1b (d18:1/18:0, triammonium salt)

C18:0(2-NBD) GM1 (synthetic)
CAS:2770684-35-8
Formula: C79H136N8O34
>99%
BL-M001143
C18:0(2-NBD) GM1 Ganglioside (synthetic, ammonium salt)

C18:1 ANANDAMIDE
CAS:7545-20-2
Formula: C20H39NO2
>99%
7545-20-2
9Z-octadecenoylethanolamide; oleoylethanolamide(9Z-octadecenoyl)ethanolamide; 9-cis-octadecenoylethanolamide; N-(2-hydroxyethyl)-9Z-octadecenamide OEA; OLEAMIDE MEA

C18:1 CERAMIDE (D18:1/18:1(9Z))
CAS:5966-28-9
Formula: C36H69NO3
>99%
5966-28-9
N-(oleoyl)-ceramide; N-oleoyl-D-erythro-sphingosine; N-(9Z-octadecenoyl)-sphing-4-enine; C18:1 Cer; Cer(d18:1/18:1(9Z))

C18:1 Ceramide-[d7]
CAS:1942907-50-7
Formula: C36H62D7NO3
>99%
BLP-011246
N-oleoyl-D-erythro-sphingosine-d7; C18:1 Ceramide-d7 (d18:1-d7/18:1); N-[(1S,2R,3E)-2-hydroxy-1-(hydroxymethyl)-3-heptadecen-1-yl]-9Z-octadecenamide-d7; Cer 18:1-d7 (d18:1-d7/18:1); Cer(d18:1/18:1(9Z))-d7; Ceramide (d18:1/18:1(9Z))-d7; N-Oc

C18:1 Ceramide-1-Phosphate (d18:1/18:1(9Z)) ammonium salt
CAS:1246304-33-5
Formula: C36H73N2O6P
>99%
1246304-33-5
N-oleoyl-ceramide-1-phosphate (ammonium salt)

C18:1 Cyclic LPA (ammonium salt)
CAS:799268-69-2
Formula: C21H44NO5P
>99%
799268-69-2
1-O-(9Z-octadecenyl)-sn-glycero-2,3-cyclic-phosphate (ammonium salt); 1-O-octadecenyl-sn-glycero-2,3-cyclic-phosphate (ammonium salt)

C18:1 Galactosyl(+¦) Ceramide (d18:1/18:1(9Z))
CAS:73039-25-5
Formula: C42H79NO8
>99%
73039-25-5
D-galactosyl-+¦-1,1'-N-oleoyl-D-erythro-sphingosine; C18:1 +¦-D-galactosyl ceramide; N-(9Z-octadecenoyl)-1-+¦-galactosyl-sphing-4-enine; GalCer(d18:1/18:1(9Z))

C18:1 Glucosyl Ceramide-[d5]
CAS:2260670-16-2
Formula: C42H74D5NO8
>99%
BLP-011294
D-glucosyl-+¦-1,1'-N-oleoyl-D-erythro-sphingosine-d5; C18:1 Glucosyl Ceramide-d5; Glucosylceramide (d18:1/9Z-18:1)-d5; beta-D-glucosyl-N-(oleoyl)sphingosine-d5; beta-D-glucosyl-N-(oleoyl)sphing-4-enine-d5; N-(9Z-octadecenoyl)-1--glucosyl-sph

C18:1 Glucosyl(+¦) Ceramide (d18:1/18:1(9Z))
CAS:852060-65-2
Formula: C42H79NO8
>99%
852060-65-2
D-glucosyl-+¦-1,1'-N-oleoyl-D-erythro-sphingosine; C18:1 +¦-D-glucosyl ceramide; N-(9Z-octadecenoyl)-1-+¦-glucosyl-sphing-4-enine; GlcCer(d18:1/18:1(9Z))

C18:1 L-carnitine-d9
Formula: C25H38D9NO4
>99%
BL-M001279
Oleoy L-carnitine-d9

C18:1 Lactosyl(beta) Ceramide (d18:1/18:1)
CAS:109719-59-7
Formula: C48H89NO13
<99%
109719-59-7
D-lactosyl-beta-1,1' N-oleyol-D-erythro-sphingosine

C18:1 LPA (ammonium salt)
CAS:799279-68-8
Formula: C21H46NO6P
>99%
799279-68-8
1-(9Z-octadecenyl)-2-hydroxy-sn-glycero-3-phosphate (ammonium salt); 1-O-9-(Z)-octadecenyl-sn-glycero-3-phosphate (ammonium salt); PA(18:1(9Z)e/0:0) (ammonium salt)

C18:1 LYSO PAF
CAS:87907-66-2
Formula: C26H54NO6P
>99%
87907-66-2
1-O-(9Z)octadecenyl-2-hydroxy-sn-glycero-3-phosphocholine; 1-O-oleyl-sn-glycero-3-phosphocholine; PC(18:1(9Z)e/0:0); lysoPC(O-18:1)

C18:1(+ö9-cis) Carnitine
CAS:13962-05-5
Formula: C25H47NO4
>99%
13962-05-5
oleoyl L-carnitine; acylcarnitine C18:1; (9Z)-octadec-9-enoylcarnitine

C18:2 anandamide phosphate Sodium salt
CAS:2260670-52-6
Formula: C20H37NO5PNa
>99%
2260670-52-6
linoleoyl ethanolamide phosphate (sodium salt); Sodium 2-[(9Z,12Z)-9,12-octadecadienoylamino]ethyl hydrogen phosphate; 9,12-Octadecadienamide, N-[2-(phosphonooxy)ethyl]-, sodium salt, (9Z,12Z)- (1:1)

C18:2 L-carnitine-d9
Formula: C25H36D9NO4
>99%
BL-M001280
Linoleoy L-carnitine-d9

C188-9
CAS:432001-19-9
Formula: C27H21NO5S
>98%
432001-19-9
N-[4-hydroxy-3-(2-hydroxynaphthalen-1-yl)naphthalen-1-yl]-4-methoxybenzenesulfonamide

C2 ADAMANTANYL GALACTOSYLCERAMIDE (D18:1/2:0)
CAS:574738-16-2
Formula: C36H63NO8
GëÑ98%
574738-16-2
[(2S,3R,4E)-2-[(1-Adamantyl)acetylamino]-3-hydroxy-4-octadecenyl]beta-D-galactopyranoside; N-(1-Adamantaneacetyl)-galactosylceramide; Adamantanyl Galactosyl(+¦) Ceramide; AdaGalCer(d18:1/2:0)

C2 ADAMANTANYL GLUCOSYLCERAMIDE (D18:1/2:0)
Formula: C36H61NO8
GëÑ98%
N-(1-Adamantaneacetyl) Glucosylceramide; Adamantanyl GluCer(d18:1/2:0); Adamantanyl Glucosylceramide (d18:1/2:0); AdaGluCer(d18:1/2:0)

C2 CERAMIDE (D14:1/2:0)
CAS:2097561-20-9
Formula: C16H31NO3
GëÑ95%
2097561-20-9
N-[(1S,2R,3E)-2-hydroxy-1-(hydroxymethyl)-3-tridecen-1-yl]-acetamide; N-[(2S,3R,4E)-1,3-Dihydroxy-4-tetradecen-2-yl]acetamide; Cer(d14:1/2:0); N-acetyl-D-erythro-Sphingosine C14

C2 Ceramide-1-Phosphate (d18:1/2:0) (ammonium salt)
CAS:474943-68-5
Formula: C20H43N2O6P
>99%
474943-68-5
N-acetoyl-ceramide-1-phosphate (ammonium salt); N-(acetoyl)-sphing-4-enine-1-phosphate (ammonium salt)

C2 CPG; 500 +à
BRP-02310
C2 CPG (DMT-1,2-Etheyleneglycol-Suc-CPG); 500 +à

C2 DIHYDROCERAMIDE
CAS:13031-64-6
Formula: C20H41NO3
>99%
13031-64-6
N-acetoyl-D-erythro-sphinganine; C2 Dihydroceramide (d18:0/2:0); N-Acetyl dihydrosphingosine

C2,C8-DIMETHYLADENOSINE
Formula: C12H17N5O4

C2-Amide-C4-NH2
CAS:99789-97-6
Formula: C7H16N2O
BADC-01744

C2-BIS-PHOSPHORAMIDIC ACID DIETHYL ESTER
CAS:34008-16-7
Formula: CGéüGéÇHGééGéåNGééOGéåPGéé
BP-500762

C2-CERAMIDE
CAS:3102-57-6
Formula: C20H39NO3
GëÑ98% by HPLC
3102-57-6
N-acetoyl-D-erythro-sphingosine; N-(acetoyl)-sphing-4-enine; Cer(d18:1/2:0); N-(acetyl)-ceramide; Acetamide, N-(2-hydroxy-1-(hydroxymethyl)-3-heptadecenyl)-, (R-(R*,S*-(E)))-; D-erythro-N-acetyl-sphingosine; C2 Ceramide (d18:1/2:0); N-Acety

C2:0 L-carnitine (HCl salt)
Formula: C9H18ClNO4
>99%
BL-M000556
Acetyl L-carnitine (HCl salt)

C20 CERAMIDE (D17:1/20:0)
CAS:474944-00-8
Formula: C37H73NO3
>99%
474944-00-8
N-arachidoyl-D-erythro-sphingosine (C17 base); N-(eicosanoyl)-sphing-4-enine (C17 base)

C20 CERAMIDE (D18:1/20:0)
CAS:123482-93-9
Formula: C38H75NO3
>99%
123482-93-9
N-arachidoyl-D-erythro-sphingosine; N-(eicosanoyl)-sphing-4-enine

C20 Sphingosine
CAS:6918-49-6
Formula: C20H41NO2
>99%
6918-49-6
Sphingosine (d20:1); D-erythro-sphingosine (C20 base); icosasphing-4-enine; eicosasphing-4-enine; 2S-Amino-4E-eicosene-1,3R-diol

C20-OtBu-Glu-OtBu
CAS:1119061-70-9
Formula: C33H61NO7
BAT-016660
(S)-2-(19-tert-Butoxycarbonylnonadecanoylamino)pentanedioic acid 1-tert-butyl ester; (S)-5-(tert-Butoxy)-4-(20-(tert-butoxy)-20-oxoicosanamido)-5-oxopentanoic acid

C20:0 GM1
CAS:2456349-05-4
Formula: C75H138N4O31
>99%
2456349-05-4
C20:0 GM1 Ganglioside (ammonium salt)

C20:1 Ceramide-[d7] (d18:1-d7/20:1)
CAS:2342574-60-9
Formula: C38H66D7NO3
>99%
BLP-011340
N-eicos-11-enoyl-D-erythro-sphingosine-d7; C20:1 Ceramide-d7 (d18:1-d7/20:1)

C20:4 ANANDAMIDE (AEA)
CAS:913692-69-0
Formula: C22H37NO2
>99%
913692-69-0
5Z,8Z,11Z,14Z-eicosatetraenoylethanolamide; 20:4 ethanolamide; Arachidonoyl ethanolamide; Anandamide (20.4, n-6)

C20:4 anandamide phosphate Sodium salt
CAS:2260670-53-7
Formula: C22H37NO5PNa
>99%
2260670-53-7
arachidonoyl ethanolamide phosphate (sodium salt); Sodium 2-[(5Z,8Z,11Z,14Z)-5,8,11,14-icosatetraenoylamino]ethyl hydrogen phosphate; 5,8,11,14-Eicosatetraenamide, N-[2-(phosphonooxy)ethyl]-, sodium salt, (5Z,8Z,11Z,14Z)- (1:1)

C22 CERAMIDE (D14:1/22:0)
CAS:1338915-24-4
Formula: C36H71NO3
>99%
1338915-24-4
N-behenoyl-D-erythro-sphingosine (C14 base)

C22:1 Ceramide-[d7] (d18:1-d7/22:1)
CAS:2342574-57-4
Formula: C40H70D7NO3
>99%
BLP-011339
N-erucoyl-D-erythro-sphingosine (d7); C22:1 Ceramide-d7 (d18:1-d7/22:1)

C24 CERAMIDE (D17:1/24:0)
CAS:123065-50-9
Formula: C41H81NO3
>99%
123065-50-9
N-lignoceroyl-D-erythro-sphingosine (C17 base); N-(tetracosanoyl)-sphing-4-enine (C17 base)

C24 CERAMIDE (D18:1/24:0)
CAS:102917-80-6
Formula: C42H83NO3
>99%
102917-80-6
N-lignoceroyl-D-erythro-sphingosine; N-(tetracosanoyl)-sphing-4-enine; N-tetracosanoylsphingosine; C24 Cer; N-Lignoceroylsphingosine; Lignoceric Ceramide

C24 Ceramide (d18:1/24:0)-[d7]
Formula: C42H76D7NO3
BLP-014070
Ceramide C24:0 (d18:1 D7 /24:0)-[D7]; N-((2R,3R,E)-1,3-dihydroxyoctadec-4-en-2-yl-16,16,17,17,18,18,18-d7)tetracosanamide

C24 Ceramide-1-Phosphate (d18:1/24:0) ammonium salt
CAS:1246303-20-7
Formula: C42H87N2O6P
>99%
1246303-20-7
N-lignoceroyl-ceramide-1-phosphate (ammonium salt); N-(tetracosanoyl)-sphing-4-enine-1-phosphate; CerP(d18:1/24:0)

C24 DIHYDROCERAMIDE (D18:0/24:0)
CAS:6063-36-1
Formula: C42H85NO3
>99%
6063-36-1
N-(tetracosanoyl)-sphinganine; Cer(d18:0/24:0); N-tetracosanoylsphinganine; N-lignoceroyl-D-erythro-sphinganine; C24 Sphinganine

C24 Dihydroceramide-1-Phosphate (d18:0/24:0) ammonium salt
CAS:1246303-18-3
Formula: C42H89N2O6P
>99%
1246303-18-3
N-lignoceroyl-D-erythro-dihydroceramide-1-phosphate (ammonium salt); 24:0 Sphinganine-1-phosphate (ammonium salt); CerP(d18:0/24:0)

C24 LACTOSYL(BETA) CERAMIDE (D18:1/24:0)
CAS:105087-85-2
Formula: C54H103NO13
>99%
105087-85-2
D-lactosyl-beta-1,1' N-lignoceroyl-D-erythro-sphingosine; C24 beta-D-lactosyl ceramide; N-(tetracosanoyl)-1-beta-lactosyl-sphing-4-enine

C24 Mono-Sulfo Galactosyl(beta) Ceramide (d18:1/24:0) ammonium salt
CAS:1246304-32-4
Formula: C48H96N2O11S
>99%
1246304-32-4
3-O-sulfo-D-galactosyl-beta1-1'-N-lignoceroyl-D-erythro-sphingosine (ammonium salt); 3-Sulfo-C24:0 GalCer

C24:0 CERAMIDE (D18:2(4E,8Z)/24:0)
CAS:135941-18-3
Formula: C42H81NO3
135941-18-3
N-lignoceroyl-D-erythro-sphingosine (d18:2(4E,8Z) base)

C24:1 B-D-GALACTOSYL CERAMIDE
CAS:17283-91-9
Formula: C48H91NO8
>99%
17283-91-9
Galactosyl-b-1,1 N-nervonoyl-D-erythro-sphingosine

C24:1 CERAMIDE (D17:1/24:1(15Z))
CAS:352518-77-5
Formula: C41H79NO3
>99%
352518-77-5
N-nervonoyl-D-erythro-sphingosine (C17 base); N-(15Z-tetracosenoyl)-sphing-4-enine (C17 base)

C24:1 Ceramide (d18:1/24:1(15Z))-[d7]
CAS:1840942-16-6
Formula: C42H74D7NO3
99% by CP; 99% atom D
BLP-011239
N-nervonoyl-D-erythro-sphingosine (d7); Cer 24:1-d7 (d18:1-d7/24:1)

C24:1 CERAMIDE (D18:2(4E,8Z)/24:1(15Z))
CAS:2260670-17-3
Formula: C42H79NO3
>99%
2260670-17-3
N-nervonoyl-D-erythro-sphingosine (d18:2(4E,8Z) base); (15Z)-N-[(2S,3R,4E,8Z)-1,3-Dihydroxy-4,8-octadecadien-2-yl]-15-tetracosenamide; 15-Tetracosenamide, N-[(1S,2R,3E,7Z)-2-hydroxy-1-(hydroxymethyl)-3,7-heptadecadien-1-yl]-, (15Z)-

C24:1 Galactosyl(+ƒ) Ceramide-d7 (d18:1/24:1(15Z))
CAS:2770684-23-4
Formula: C48H84D7O8
>99%
BL-M000926
D-galactosyl-+ƒ-1,1' N-nervonoyl-D-erythro-sphingosine-d7

C24:1 Galactosyl(alpha) Ceramide (d18:1/24:1(15Z))
CAS:1639008-30-2
Formula: C48H91NO8
>99%
1639008-30-2
D-galactosyl-alpha-1,1' N-nervonoyl-D-erythro-sphingosine; N-(15Z-tetracosenoyl)-1-alpha-galactosyl-sphing-4-enine

C24:1 Glucosyl(+¦) Ceramide (d18:1/24:1(15Z))
CAS:887907-50-8
Formula: C48H91NO8
>99%
887907-50-8
D-glucosyl-+¦-1,1'-N-nervonoyl-D-erythro-sphingosine; GlcCer(d18:1/24:1(15Z)); Glucosyl(+¦) Ceramide (d18:1/24:1(15Z)); D-glucosyl-+¦-1,1'-N-(15Z-tetracosenoyl)-D-erythro-sphingosine N-(15Z-tetracosenoyl)-1-+¦-glucosyl-sphing-4-ene; C24:1 +¦-D-g

C24:1 Lactosyl(+ƒ) Ceramide-d7 (d18:1/24:1(15Z))
CAS:2770684-31-4
Formula: C54H94D7NO13
>99%
BL-M000929
D-Lactosyl-+ƒ-1,1' N-nervonoyl-D-erythro-sphingosine-d7

C24:1 Lactosyl(+¦) Ceramide (d18:1/24:1)
CAS:483370-78-1
Formula: C54H101NO13
>99%
483370-78-1
beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1)-N-[(15Z)-tetracosenoyl]sphingosine; Galabiosylceramide (d18:1/24:1(15Z)); D-lactosyl-1-1'-N-nervonoyl-D-erythro-sphingosine; D-lactosyl-+¦1-1'-N-nervonoyl-D-erythro-sphingosine

C24:1 Mono-sulfo galactosyl (alpha) ceramide (d18:1/24:1) Ammonium salt
CAS:2260670-38-8
Formula: C48H94N2O11S
>99%
2260670-38-8
3-O-Sulfo-D-galactosyl-alpha-1,1'-N-Nervonoyl-D-erythro-sphingsoine (ammonium salt); 3-O-sulfo-alpha-D-C24:1-galactosylceramide (ammonium salt); ammonium (2S,3R,4S,5S,6R)-3,5-dihydroxy-2-(((2S,3R,E)-3-hydroxy-2-((Z)-tetracos-15-enamido)octa

C24:1 mono-sulfo galactosyl(+ƒ) ceramide-d7 (d18:1/24:1)
CAS:2770684-30-3
Formula: C48H87D7N2O11S
>99%
BL-M000933
3-O-sulfo-D-galactosyl-+ƒ1-1'-N-nervonoyl-D-erythro-sphingosine-d7 (ammonium salt)

C24:1 Mono-Sulfo Galactosyl(beta) Ceramide (d18:1/24:1) ammonium salt
CAS:1246355-69-0
Formula: C48H94N2O11S
>99%
1246355-69-0
3-O-sulfo-D-galactosyl-beta1-1'-N-nervonoyl-D-erythro-sphingosine (ammonium salt)

C25-140
CAS:1358099-18-9
Formula: C26H31N7O
1358099-18-9

C26 L-Carnitine-[d9]
CAS:2260670-67-3
Formula: C33H56D9NO4
>99%
BLP-011308
hexacosanoyl L-carnitine-d9; C26 D,L-Carnitine-d9; (R)-3-(hexacosanoyloxy)-4-(tris(methyl-d3)ammonio)butanoate; (3R)-3-(Hexacosanoyloxy)-4-{tris[(2H3)methyl]ammonio}butanoate; 1-Propanaminium, 3-carboxy-N,N,N-tri(methyl-d3)-2-[(1-oxohexacos

C26:0 Ceramide (d18:1/26:0)
Formula: C44H87NO3
>99%
BL-M001171
N-Hexacosanoyl-D-erythro-sphingosine

C28:0 Ceramide
CAS:871540-95-3
Formula: C46H91NO3
>99%
BL-M001170
N-octacosanoyl-D-erythro-sphingosine

C29
CAS:363600-92-4
Formula: C16H15NO4
B1370-007320
TLR2-IN-C29; TLR2 IN C29; TLR2INC29; TLR2-inhibitor-C29; TLR2 inhibitor-C29; TLR2 inhibitor C29

C3 CERAMIDE
CAS:362678-52-2
Formula: C21H41NO3
BPG-3759
C3 Ceramide; 362678-52-2; N-[(E,2S,3R)-1,3-dihydroxyoctadec-4-en-2-yl]propanamide; BP-28804

C3 CPG; 1000 +à
BRP-02311
C3 CPG (DMT-1,3-Propanediol-Suc-CPG); 1000 +à

C3-Amide-C4-NH2
CAS:65389-82-4
Formula: C8H18N2O
BADC-01685
N-butyrylputrescine

C3-K2-E14
CAS:2933215-86-0
Formula: C69H141N5O6
BPG-3687

C3-OXACYANINE
Formula: C21H21N2O2.I
F02-0034

C3-SPACER-CEP
CAS:110894-23-0
Formula: C33H43N2O5P
GëÑ98.0%
B2706-331216
3-(4,4'-Dimethoxytrityloxy)propyl-1-[(2-cyanoethyl)-(N,N-diisopropyl)] phosphoramidite; Spacer Phosphoramidite C3; 3-(Bis(4-methoxyphenyl)phenylmethoxy)propyl 2-cyanoethyl N,N-bis(1-methylethyl)phosphoramidite; Phosphoramidous acid, N,N-bis

C3-THIACYANINE DYE (ETOH)
Formula: C21H21N2S2.I
F02-0035

C3-THIACYANINE DYE (PROH)
F02-0036

C34
CAS:40592-88-9
Formula: C17H27NO9
GëÑ98%
B2693-473904
C 34; C-34; TLR4-IN-C34; 1-Methylethyl 2-(acetylamino)-2-deoxy-+¦-D-glucopyranoside 3,4,6-triacetate; Isopropyl 2-acetamido-3,4,6-tri-O-acetyl-2-deoxy-+¦-D-glucopyranoside; +¦-D-Glucopyranoside, 1-methylethyl 2-(acetylamino)-2-deoxy-, 3,4,6-tr

C34 peptide
Formula: C186H298F3N69O45S

C3A 70-77
CAS:63555-63-5
Formula: C35H61N13O10
GëÑ95%
BAT-010550
Complement 3a (70-77); H-Ala-Ser-His-Leu-Gly-Leu-Ala-Arg-OH; L-alanyl-L-seryl-L-histidyl-L-leucyl-glycyl-L-leucyl-L-alanyl-L-arginine; (2S,5S,8S,14S,17S,20S,23S)-17-((1H-imidazol-4-yl)methyl)-23-amino-2-(3-guanidinopropyl)-20-(hydroxymethyl

C3a 70-77 2TFA
Formula: C39H63F6N13O14
BAT-016259
Complement 3a (70-77) 2TFA

C3a 70-77 acetate
Formula: C37H65N13O12

C3A RECEPTOR AGONIST
CAS:944997-60-8
Formula: C27H35N3O2
GëÑ98%
944997-60-8
C3A Receptor Agonist; 944997-60-8; C3a receptor agonist 1; 2-cyclohexyl-2-phenyl-N-[1-(3-pyridin-3-ylpropanoyl)piperidin-4-yl]acetamide; CHEMBL390036; CHEMBL535625; 2-cyclohexyl-2-phenyl-N-(1-(3-(pyridin-3-yl)propanoyl)piperidin-4-yl)acetam

C3BOT (154-182)
CAS:1246280-79-4
Formula: C137H221N37O40S
1246280-79-4
C3bot (154-182); 1246280-79-4

C4 CERAMIDE
CAS:74713-58-9
Formula: C22H43NO3
>99%
74713-58-9
Ceramide 4; C4 Ceramide (d18:1/4:0); N-butyroyl-D-erythro-sphingosine; N-(butyroyl)-sphing-4-enine

C4 TopFluor-« MG
CAS:2260795-61-5
Formula: C20H27BF2N2O4
>99%
2260795-61-5
1-[4-(dipyrrometheneboron difluoride)butanoyl]-rac-glycerol

C5 LENALIDOMIDE
CAS:191732-70-4
Formula: C13H13N3O3
GëÑ95%
BP-502133
3-(5-Amino-1-oxoisoindolin-2-yl)piperidine-2,6-dione; 2,6-Piperidinedione, 3-(5-amino-1,3-dihydro-1-oxo-2H-isoindol-2-yl)-; 3-(5-Amino-1,3-dihydro-1-oxo-2H-isoindol-2-yl)-2,6-piperidinedione; 2-(2,6-Dioxo-3-piperidinyl)-5-aminoisoindoline-1

C5-INDOCYANINE
Formula: C29H35N2.I
F02-0037
Indodicarbocyanine (C5)dye; C5_DI (C5-di-indolenine); (2Z)-1-ethyl-2-[(2E,4Z)-5-(1-ethyl-3,3-dimethylindol-1-ium-2-yl)penta-2,4-dienylidene]-3,3-dimethylindole;iodide; 1-ethyl-2-[5-(1-ethyl-3,3-dimethyl-1,3-dihydro-2H-indol-2-ylidene)penta-

C5-OXACYANINE
Formula: C23H23N2O2.I
F02-0038

C5-THIACYANINE
Formula: C23H23N2S2.I
F02-0039

C5:0 L-carnitine-d9
Formula: C12H14D9NO4
>99%
BL-M000920
Pentanoyl L-carnitine-d9

C527
CAS:192718-06-2
Formula: C17H8FNO3
GëÑ98%
192718-06-2
C-527; C 527

C545T
CAS:155306-71-1
Formula: C26H26N2O2S
98% 99% 99.5%
155306-71-1
Coumarine 545T;10-(2-Benzothiazolyl)-2,3,6,7-tetrahydro-1,1,7,7-tetramethyl-1H,5H,11H-[1]benzopyrano[6,7,8-ij]quinolizin-11-one

C5A ANAPHYLATOXIN (HUMAN)
CAS:1816940-05-2
Formula: C350H578N108O107S8
GëÑ95%
BAT-014552
H-Thr-Leu-Gln-Lys-Lys-Ile-Glu-Glu-Ile-Ala-Ala-Lys-Tyr-Lys-His-Ser-Val-Val-Lys-Lys-Cys-Cys-Tyr-Asp-Gly-Ala-Cys-Val-Asn-Asn-Asp-Glu-Thr-Cys-Glu-Gln-Arg-Ala-Ala-Arg-Ile-Ser-Leu-Gly-Pro-Arg-Cys-Ile-Lys-Ala-Phe-Thr-Glu-Cys-Cys-Val-Val-Ala-Ser-Gl

C6 ceramide-1,3-cyclic-phosphate (d18:1/6:0)
CAS:2410310-25-5
Formula: C24H49N2O5P
>99%
2410310-25-5
N-hexanoyl-ceramide-1,3-cyclic-phosphate (ammonium salt)

C6 CPG; 1000 +à
BRP-02312
C6 CPG (DMT-1,6-Hexanediol-Glyc-CPG); 1000 +à

C6 DIHYDROCERAMIDE (D18:0/6:0)
CAS:171039-13-7
Formula: C24H49NO3
>99%
171039-13-7
N-hexanoyl-D-erythro-sphinganine; N-06:0 Sphinganine; C6 Sphinganine; N-hexanoyldihydroceramide

C6 NBD CERAMIDE
CAS:94885-02-6
Formula: C30H49N5O6
GëÑ98%
94885-02-6
N-C6-NBD-D-erythro-Sphingosine; N-[7-(4-nitrobenzo-2-oxa-1,3-diazole)]-6-aminocaproyl-D-erythro-sphingosine

C6 NBD DIHYDRO CERAMIDE
CAS:114301-97-2
Formula: C30H51N5O6
GëÑ98%
114301-97-2
N-[6-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]hexanoyl]-sphinganine; C6-NBD Sphinganine; N-C6-NBD-D-erythro-dihydro-Sphingosine

C6 NBD GALACTOSYLCERAMIDE
CAS:170212-26-7
Formula: C36H59N5O11
GëÑ98%
170212-26-7
N-hexanoyl-NBD-Galactosylceramide; N-[(1S,2R,3E)-1-[(+¦-D-galactopyranosyloxy)methyl]-2-hydroxy-3-heptadecen-1-yl]-6-[(7-nitro-2,1,3-benzoxadiazol-4-yl)amino]-hexanamide

C6 NBD GLUCOSYLCERAMIDE
CAS:94885-03-7
Formula: C36H59N5O11
GëÑ98%
94885-03-7
GÇïN-hexanoyl-NBD-Glucosylceramide; N-[(1S,2R,3E)-1-[(+¦-D-glucopyranosyloxy)methyl]-2-hydroxy-3-heptadecen-1-yl]-6-[(7-nitro-2,1,3-benzoxadiazol-4-yl)amino]-hexanamide

C6 NBD L-THREO-CERAMIDE
Formula: C30H49N5O6
GëÑ98%
N-hexanoyl-NBD L-threo-Sphingosine; [R-[R*,R*-(E)]]-N-[2-hydroxy-1-(hydroxymethyl)-3-heptadecenyl]-6-[(7-nitro-2,1,3-benzoxadiazol-4-yl)amino]-hexanamide

C6 NBD L-THREO-DIHYDROCERAMIDE
CAS:114301-95-0
Formula: C30H51N5O6
GëÑ98%
114301-95-0
N-hexanoyl-NBD L-threo-Dihydrosphingosine; N-(1,3R-dihydroxyoctadecan-2R-yl)-6-((7-nitrobenzo[c][1,2,5]oxadiazol-4-yl)amino)hexanamide

C6 NBD LACTOSYLCERAMIDE
CAS:474943-04-9
Formula: C42H69N5O16
GëÑ98%
474943-04-9
N-[6-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]hexanoyl]-D-lactosyl-+¦1-1'-sphingosine; C6 NBD Lactosylceramide (d18:1/6:0); N-[(1S,2R,3E)-1-[[(4-O-+¦-D-galactopyranosyl-+¦-D-glucopyranosyl)oxy]methyl]-2-hydroxy-3-heptadecen-1-yl]-6-[(7-nitro-2

C6 NBD PHYTOCERAMIDE
Formula: C30H51N5O7
GëÑ98%
C6 NBD Phytosphingosine; N-hexanoyl-NBD Phytosphingosine; 6-((7-nitrobenzo[c][1,2,5]oxadiazol-4-yl)amino)-N-((2R,3R,4R)-1,3,4-trihydroxyoctadecan-2-yl)hexanamide

C6 NBD SPHINGOMYELIN
CAS:94885-04-8
Formula: C35H61N6O9P
GëÑ98%
94885-04-8
N-hexanoyl-NBD Sphingosylphosphorylcholine; (7S)-4-hydroxy-7-[(1R,2E)-1-hydroxy-2-hexadecen-1-yl]-N,N,N-trimethyl-14-[(7-nitro-2,1,3-benzoxadiazol-4-yl)amino]-9-oxo-3,5-dioxa-8-aza-4-phosphatetradecan-1-aminium, 4-oxide inner salt; N-[6-[(7

C6(6-AZIDO) CERAMIDE
CAS:2108102-18-5
Formula: C24H46N4O3
>99%
2108102-18-5
N-(6-azidohexanoyl)-D-erythro-sphingosine; 6-Azido-N-[(2S,3R,4E)-1,3-dihydroxy-4-octadecen-2-yl]hexanamide; Hexanamide, 6-azido-N-[(1S,2R,3E)-2-hydroxy-1-(hydroxymethyl)-3-heptadecen-1-yl]-

C6(6-AZIDO) GALCER
CAS:2260670-20-8
Formula: C30H56N4O8
>99%
2260670-20-8
D-Galactosyl-+¦-1,1'-N-(6''-azidohexanoyl)-D-erythro-sphingosine; C6(6-azido) Galactosyl(+¦) Ceramide; 6-Azido-N-[(1S,2R,3E)-1-[(+¦-D-galactopyranosyloxy)methyl]-2-hydroxy-3-heptadecen-1-yl]hexanamide

C6(6-AZIDO) GLUCER
CAS:2260670-21-9
Formula: C30H56N4O8
>99%
2260670-21-9
D-Gluctosyl-+¦-1,1'-N-(6''-azidohexanoyl)-D-erythro-sphingosine; C6(6-azido) Gluctosyl(+¦) Ceramide; 6-Azido-N-[(1S,2R,3E)-1-[(+¦-D-glucopyranosyloxy)methyl]-2-hydroxy-3-heptadecen-1-yl]hexanamide

C6(6-AZIDO) LACCER
CAS:2260670-19-5
Formula: C36H66N4O13
>99%
2260670-19-5
D-Lactosyl-+¦-1,1'-N-(6''-azidohexanoyl)-D-erythro-sphingosine; C6(6-azido) Lactosyl(+¦) Ceramide; 6-Azido-N-[(1S,2R,3E)-1-[[(4-O-+¦-D-galactopyranosyl-+¦-D-glucopyranosyl)oxy]methyl]-2-hydroxy-3-heptadecen-1-yl]hexanamide

C6-BIS-PHOSPHORAMIDIC ACID DIETHYL ESTER
CAS:1446282-35-4
Formula: CGéüGéäHGéâGéäNGééOGéåPGéé
BP-500336

C6-Ceramide
CAS:124753-97-5
Formula: C24H47NO3
>98%
124753-97-5
N-hexanoyl-D-erythro-sphingosine; C6 Ceramide (d18:1/6:0); N-hexanoylsphingosine

C6-CERAMIDE-[D11]
Formula: C24H36D11NO3
BLP-002122
C6-Ceramide-D11; N-[(2S,3R,4E)-1,3-dihydroxyoctadec-4-en-2-yl](D11)hexanamide

C6-NBD PHYTOSPHINGOSINE
CAS:477239-93-3
Formula: C30H51N5O7
>99%
477239-93-3
N-[6-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]hexanoyl]-phytosphingosine

C6-SPHINGOSINE
Formula: C6H13NO2
BB057770

C6-UREA-CERAMIDE
CAS:486991-52-0
Formula: C25H50N2O3
>99%
486991-52-0
D-erythro-N-[2-(1,3-dihydroxy-4E-octadecene)]-N'-hexane-urea-sphingosine; D-erythro-C6-urea-ceramide

C6:0 L-carnitine-d9
Formula: C13H16D9NO4
>99%
BL-M001283
Hexanoyl L-carnitine-d9

C646
CAS:328968-36-1
Formula: C24H19N3O6
>98%
B0084-370250
C646; C-646; C 646.

C7-INDOCYANINE
Formula: C31H37N2.I
F02-0040
1-Ethyl-2-(7-(1-ethyl-3,3-dimethylindolin-2-ylidene)hepta-1,3,5-trien-1-yl)-3,3-dimethyl-3H-indol-1-ium iodide; Indotricarbocyanine (C7) dye; (2Z)-1-ethyl-2-[(2E,4E,6E)-7-(1-ethyl-3,3-dimethylindol-1-ium-2-yl)hepta-2,4,6-trienylidene]-3,3-d

C7-OXACYANINE
Formula: C25H25N2O2.I
F02-0041

C7280948
CAS:587850-67-7
Formula: C14H16N2O2S
GëÑ95%
587850-67-7
C7280948; C-7280948; C 7280948; 4-amino-N-(2-phenylethyl)benzenesulfonamide; 4-amino-N-phenethylbenzenesulfonamide;

C75
CAS:218137-86-1
Formula: C14H22O4
>98%
218137-86-1
C 75 trC-75 trans-racemic; trans-C75; C 75; C75; C-75

C75 TRANS
CAS:191282-48-1
Formula: C14H22O4
>98%
191282-48-1
C 75 trC-75 trans-racemic; trans-C75

C8 +¦-D-galactosyl ceramide
CAS:41613-16-5
Formula: C32H61NO8
>99%
41613-16-5
C8 beta-D-galactosyl N-acylsphingosine; C8 Galactosyl(+¦) Ceramide (d18:1/8:0); beta-D-galactosyl-N-octanoylsphingosine; N-[(2S,3S,4E)-1-(beta-D-galactopyranosyloxy)-3-hydroxyoctadec-4-en-2-yl]octanamide

C8 CERAMIDE
CAS:74713-59-0
Formula: C26H51NO3
>99%
74713-59-0
C8 Ceramide (d18:1/8:0); N-octanoyl-D-erythro-sphingosine; N-(octanoyl)-sphing-4-enine; N-octanoylsphingosine

C8 Ceramide-1-Phosphate (d17:1/8:0) (ammonium salt)
CAS:474944-04-2
Formula: C25H53N2O6P
>99%
474944-04-2
N-octanoyl-ceramide-1-phosphate (C17 base) (ammonium salt); CerP(d17:1/8:0) (ammonium salt)

C8 Ceramide-1-Phosphate (d18:1/8:0) (ammonium salt)
CAS:474943-70-9
Formula: C26H55N2O6P
>99%
474943-70-9
N-octanoyl-ceramide-1-phosphate (ammonium salt); N-(octanoyl)-sphing-4-enine-1-phosphate (ammonium salt); CerP(d18:1/8:0) (ammonium salt)

C8 DIHYDROCERAMIDE (D18:0/8:0)
CAS:145774-33-0
Formula: C26H53NO3
95%
145774-33-0
N-octanoyl-D-erythro-sphinganine; N-(octanoyl)-sphinganine; n-octanoyldihydrosphingosine; N-08:0 Sphinganine

c8 Galactosyl(+¦) ceramide (d18:1/8:0)
CAS:2260669-95-0
Formula: C32H61NO8
>99%
2260669-95-0
D-galactosyl-+¦-1,1' N-octanoyl-D-erythro-sphingosine; N-((2S,3R,E)-3-hydroxy-1-(((2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)octadec-4-en-2-yl)octanamide; N-[(2S,3R,4E)-1-(+¦-D-threo-Hexopyranosyloxy)-3-hy

C8 GLUCOSYL(BETA) CERAMIDE (D18:1/8:0)
CAS:111956-47-9
Formula: C32H61NO8
>99%
111956-47-9
D-glucosyl-beta-1,1'-N-octanoyl-D-erythro-sphingosine; N-{(2S,3R,4E)-1-[(beta-D-glycero-Hexopyranosyl)oxy]-3-hydroxyoctadec-4-en-2-yl}octanamide; C8 beta-D-glucosyl ceramide; N-(octanoyl)-1-beta-glucosyl-sphing-4-enine GlcCer(d18:1/8:0)

C8 Lactosyl(+¦) Ceramide (d18:1/8:0)
CAS:384842-72-2
Formula: C38H71NO13
>99%
384842-72-2
D-lactosyl-+¦-1,1' N-octanoyl-D-erythro-sphingosine; C8 +¦-D-lactosyl ceramide; N-(octanoyl)-1-+¦-lactosyl-sphing-4-enine

C8 PEG2000 CERAMIDE
CAS:212116-76-2
Formula: (C2H4O)nC31H57NO6
>99%
212116-76-2
N-octanoyl-sphingosine-1-{succinyl[methoxy(polyethylene glycol)2000]}; C8 PEG 2000 Ceramide; C8 PEG Ceramide; Poly(oxy-1,2-ethanediyl), a-[4-[[(2S,3R,4E)-3-hydroxy-2-[(1-oxooctyl)amino]-4-octadecen-1-yl]oxy]-1,4-dioxobutyl]--ë-methoxy-

C8 PEG5000 CERAMIDE
Formula: C257H509NO119 (average MW due to polydispersity of PEG)
>99%
N-octanoyl-sphingosine-1-{succinyl[methoxy(polyethylene glycol)5000]}

C8 PEG750 CERAMIDE
Formula: C63H121NO22 (average FW due to polydispersity of PEG)
>99%
N-octanoyl-sphingosine-1-{succinyl[methoxy(polyethylene glycol)750]}; (2S,3R,E)-3-hydroxy-2-octanamidooctadec-4-en-1-yl (2,5,8,11,14,17,20,23,26,29,32,35,38,41,44,47-hexadecaoxanonatetracontan-49-yl) succinate

C8-Alkyne-dA CEP
CAS:1002322-75-9
Formula: C53H63N6O7P
GëÑ95%
BRP-02198
C8-Alkyne-dA Phosphoramidite; Propanamide, N-[7-[5-O-[bis(4-methoxyphenyl)phenylmethyl]-3-O-[[bis(1-methylethyl)amino](2-cyanoethoxy)phosphino]-2-deoxy-+¦-D-erythro-pentofuranosyl]-5-(1,7-octadiyn-1-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]-2-met

C8-ALKYNE-DCTP
Formula: C17H24N3O13P3 (free acid)
GëÑ 99%
5-(Octa-1,7-diynyl)-2'-deoxycytidine 5'-triphosphate, Sodium salt

C8-ALKYNE-DUTP
Formula: C17H23N2O14P3 (free acid)
GëÑ 99%
5-(Octa-1,7-diynyl)-2'-deoxyuridine 5'-triphosphate, Sodium salt

C8:0 L-carnitine-d9
Formula: C15H20D9NO4
>99%
BL-M001282
Octanoyl L-carnitine-d9

C9-12 ALKANE

CA 074
CAS:134448-10-5
Formula: C18H29N3O6
GëÑ98% by HPLC
BAT-015973
CA-074; CA074; CA 074; N-[[(2S,3S)-3-[(Propylamino)carbonyl]-2-oxiranyl]carbonyl]-L-isoleucyl-L-proline

CA-074 METHYL ESTER
CAS:147859-80-1
Formula: C19H31N3O6
99.04 %
147859-80-1
Ca-074Me; Ca 074Me; Ca074Me; Cathepsin B Inhibitor IV; MFCD03452890; (S)-methyl 1-((2S,3S)-3-methyl-2-((2S,3S)-3-(propylcarbamoyl)oxirane-2-carboxamido)pentanoyl)pyrrolidine-2-carboxylate; CA-074 Me

CA-4948
CAS:1801343-74-7
Formula: C21H19N7O3
>98%
B0084-054015
CA-4948; CA 4948; CA4948; 6'-Amino-N-[2-(4-morpholinyl)oxazolo[4,5-b]pyridin-6-yl][2,3'-bipyridine]-6-carboxamide

CA-5F
CAS:1370032-19-1
Formula: C24H24N2O3
GëÑ98%
1370032-19-1
CA5f

CA2+ CHANNEL AGONIST 1
CAS:1402821-24-2
Formula: C19H26N6O
98%
1402821-24-2
Ca2+ channel agonist 1; SCHEMBL17628623; CS-5169; CS 5169; CS5169

CA77.1
CAS:2412270-22-3
Formula: C16H12ClN3O
2412270-22-3
CA

CABAZITAXEL
CAS:183133-96-2
Formula: C45H57NO14
>98%
B0084-461977
XRP6258; XRP-6258; XRP 6258; TXD 258; TXD-258; TXD258; RPR116258A; axoid XRP6258; dimethoxydocetaxel US brand name: Jevtana.

CABAZITAXEL IMPURITY
CAS:183133-94-0
Formula: C31H40O10
> 95%
183133-94-0
(2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-12b-(Acetyloxy)-12-(benzoyloxy)-1,2a,3,4,4a,6,9,10,11,12,12a,12b-dodecahydro-9,11-dihydroxy-4,6-dimethoxy-4a,8,13,13-tetramethyl-7,11-methano-5H-cyclodeca[3,4]benz[1,2-b]oxet-5-one; [2aR-(2a+¦,4+¦,4a+¦,6+¦,9

CABAZITAXEL IMPURITY (DITROC)
CAS:95603-44-4
Formula: C35H38Cl6O14
> 95%
95603-44-4
Carbonic Acid (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-12b-(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-9,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxete-4,6-diyl bis(2,2,2-tr

CABAZITAXEL IMPURITY (OXAZOLIDINE PROTECTED)
CAS:1373171-12-0
Formula: C48H61NO14
> 95%
1373171-12-0
(4S,5R)-2,2-Dimethyl-4-phenyl-3,5-oxazolidinedicarboxylic Acid 5-[(2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-12b-(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-11-hydroxy-4,6-dimethoxy-4a,8,13,13-tetramethyl-5-oxo-7,11-m

CABAZITAXEL IMPURITY 12
CAS:146924-92-7
Formula: C9H9NO2
> 95%
146924-92-7
2-GÇïAzetidinone, 3-GÇïhydroxy-GÇï4-GÇïphenyl-GÇï, (3S,GÇï4R)GÇï-

CABAZITAXEL IMPURITY 15
CAS:859498-34-3
Formula: C22H25NO6
> 95%
859498-34-3
3,GÇï5-GÇïOxazolidinedicarboxyGÇïlic acid, 2-GÇï(4-GÇïmethoxyphenyl)GÇï-GÇï4-GÇïphenyl-GÇï, 3-GÇï(1,GÇï1-GÇïdimethylethyl) ester, (4R,GÇï5S)GÇï-

CABAZITAXEL INTERMEDIATE
CAS:1354900-65-4
Formula: C51H59NO15
97.0%
NP1479
5-[(2+¦,5+¦,7+¦,10+¦,13+¦)-4-Acetoxy-2-(benzoyloxy)-1,7,10-trihydroxy-9-oxo-5,20-epoxytax-11-en-13-yl] 3-(2-methyl-2-propanyl) (4S,5R)-2-(4-methoxyphenyl)-4-phenyl-1,3-oxazolidine-3,5-dicarboxylate; 3,5-Oxazolidinedicarboxylic acid, 2-(4-methoxy

CABAZITAXEL N-1
CAS:1354900-66-5
Formula: C53H63NO15
1354900-66-5
5-((2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-12b-acetoxy-12-(benzoyloxy)-11-hydroxy-4,6-dimethoxy-4a,8,13,13-tetramethyl-5-oxo-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-1H-7,11-methanocyclodeca[3,4]benzo[1,2-b]oxet-9-yl) 3-(tert-butyl) (4S,5R

CABAZITAXEL N-3
CAS:859498-31-0
Formula: C57H61Cl6NO19
859498-31-0

CABAZITAXEL-[D6]
CAS:1383561-29-2
Formula: C45H51D6NO14
90% (CP); 99% atom D
BLP-002123
Cabazitaxel D6

Cabazitaxel-[d9]
CAS:1383572-19-7
Formula: C45H48D9NO14
>95%
BLP-011823
Cabazitaxel D9; (alphaR,betaS)-beta-[[[1,1-di(methyl-d3)ethoxy-2,2,2-d3]carbonyl]amino]-alpha-hydroxy-benzenepropanoic acid, (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-12b-(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-1

CABBAGE, EXT.
CAS:89958-13-4
95%
89958-13-4
Cabbage extract; brassica oleracea capitata leaf extract

Cabenoside D
CAS:88901-40-0
Formula: C24H15ClF5NO5
88901-40-0
Cabenoside D;88901-40-0;11-Oxomogroside I-E1;CHEMBL510167;AT41796;NS00094090;

CABERGOLINE
CAS:81409-90-7
Formula: C26H37N5O2
>98%
81409-90-7
CG-101; FCE-21336; CG 101; FCE 21336; CG101; FCE21336; Cabaser; Cabaseril; 6-Allyl-n-[3-(dimethylamino)propyl]-n-(ethylcarbamoyl)ergoline-8-carboxamide; (8-Beta)-(2-propenyl);n-(3-(dimethylamino)propyl)-n-((ethylamino)carbonyl)-6-ergoline-8

CABERGOLINE IMPURITY A
CAS:81409-74-7
Formula: C18H20N2O2
> 95%
B0497-467954
(8+¦)-6-(2-Propen-1-yl)-ergoline-8-carboxylic Acid; 6-(2-Propenyl)dihydrolysergic Acid; FCE 21589

CABERGOLINE IMPURITY B
CAS:166533-36-4
Formula: C26H37N5O2
> 95%
B0497-467955
(8+¦)-N8-[3-(Dimethylamino)propyl]-N1-ethyl-6-(2-propen-1-yl)-ergoline-1,8-dicarboxamide; (8+¦)-N8-[3-(Dimethylamino)propyl]-N1-ethyl-6-(2-propenyl)-ergoline-1,8-dicarboxamide; Cabergoline EP Impurity B

CABERGOLINE IMPURITY C
CAS:126554-50-5
Formula: C29H42N6O3
> 95%
B0497-467956
(8+¦)-N8-[3-(Dimethylamino)propyl]-N1-ethyl-N8-[(ethylamino)carbonyl]-6-(2-propen-1-yl)-ergoline-1,8-dicarboxamide; (8+¦)-N8-[3-(dimethylamino)propyl]-N1-ethyl-N8-[(ethylamino)carbonyl]-6-(2-propenyl)--ergoline-1,8-dicarboxamide;

CABERGOLINE IMPURITY D
CAS:85329-86-8
Formula: C23H32N4O
> 95%
B0497-467953
N-[3-(Dimethylamino)propyl]-6-(2-propen-1-yl)-(8+¦)-ergoline-8-carboxamide; (5R,8R,10R)-6-Allyl-N-[3-(dimethylamino)propyl]ergoline-8-carboxamide; FCE 21590

CABERGOLINE-[D5]
CAS:1426173-20-7
Formula: C26H32D5N5O2
96% (CP); 98% atom D
BLP-002124
Cabergoline D5

Cabergoline-[d6]
CAS:2738376-76-4
Formula: C26H31D6N5O2
>95%
BLP-014933
(6aR,9R,10aR)-7-Allyl-N-(3-(bis(methyl-d3)amino)propyl)-N-(ethylcarbamoyl)-4,6,6a,7,8,9,10,10a-octahydroindolo[4,3-fg]quinoline-9-carboxamide; Cabergoline D6; Cabergoline-d6; N-[3-((dimethyl-d3)amino)propyl]-N-[(ethylamino)carbonyl]-6-(2-pr

CABIRALIZUMAB
CAS:1613144-80-1
1613144-80-1

CABOTEGRAVIR (GSK744, GSK1265744)
CAS:1051375-10-0
Formula: C19H17F2N3O5
>98%
B0084-463362
S/GSK1265744; S/GSK 1265744; S/GSK-1265744; GSK744; GSK-744; GSK 744; Cabotegravir.

CABOTEGRAVIR-[13C,D5]
Formula: C18[13C]H12D5F2N3O5
BLP-002125
Cabotegravir 13CD5

Cabotegravir-[d3]
Formula: C19H14D3F2N3O5
>95%
BLP-014935
(3S,11aR)-N-((2,4-difluorophenyl-3-d)methyl-d2)-6-hydroxy-3-methyl-5,7-dioxo-2,3,5,7,11,11a-hexahydrooxazolo[3,2-a]pyrido[1,2-d]pyrazine-8-carboxamide; Cabotegravir D3; Cabotegravir-d3; GSK744-d3; GSK1265744-d3

Cabotegravir-[d5]
CAS:2750534-77-9
Formula: C19H12D5F2N3O5
>95%
BLP-014934
(3S,11aR)-N-(2,4-Difluorobenzyl)-6-hydroxy-3-(methyl-d3)-5,7-dioxo-2,3,5,7,11,11a-hexahydrooxazolo[3,2-a]pyrido[1,2-d]pyrazine-2,2-d2-8-carboxamide; Cabotegravir-D5; Cabotegravir-d5; GSK744-d5; GSK1265744-d5

Cabotegravir-[methyl-d3]
CAS:2734920-43-3
Formula: C19H14D3F2N3O5
>95%
BLP-014936
(3S,11aR)-N-(2,4-Difluorobenzyl)-6-hydroxy-3-(methyl-d3)-5,7-dioxo-2,3,5,7,11,11a-hexahydrooxazolo[3,2-a]pyrido[1,2-d]pyrazine-8-carboxamide; Cabotegravir D3; Cabotegravir-methyl-d3; GSK744-d3; GSK1265744-d3; Cabotegravir-d3; (3S,11aR)-N-[(

CABOXINE A
CAS:53851-13-1
Formula: C22H26N2O5
96%
NP0365
3-epi-Isocaboxine A; 3-epi-Vineridine; 7-epi-Caboxine B; Methyl (7+¦,19+¦,20+¦)-11-methoxy-19-methyl-2-oxoformosanan-16-carboxylate

CABOZANTINIB
CAS:849217-68-1
Formula: C28H24FN3O5
>98%
NP3655

CABOZANTINIB DES-O-FLUOROANILINE
CAS:849217-77-2
Formula: C22H20N2O6
849217-77-2
1-((4-((6,7-dimethoxyquinolin-4-yl)oxy)phenyl)carbamoyl)cyclopropane-1-carboxylic acid; Cabozantinib Impurity 03

CABOZANTINIB N-OXIDE
CAS:1621681-63-7
Formula: C28H24FN3O6
1621681-63-7
4-(4-(1-((4-fluorophenyl)carbamoyl)cyclopropane-1-carboxamido)phenoxy)-6,7-dimethoxyquinoline 1-oxide; 1,1-Cyclopropanedicarboxamide, N-(4-((6,7-dimethoxy-1-oxido-4-quinolinyl)oxy)phenyl)-N'-(4-fluorophenyl)-; Cabozantinib Impurity 04

CABOZANTINIB S-MALATE
CAS:1140909-48-3
Formula: C28H24FN3O5.C4H6O5
>98%
B2693-457054
Cabozantinib malate; cabozantinib (S)-malate; Cabometyx; 1-N-[4-(6,7-dimethoxyquinolin-4-yl)oxyphenyl]-1-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide (2S)-2-hydroxybutanedioic acid

CABOZANTINIB-[D4]
Formula: C28H20D4FN3O5
>95%
BLP-002126
N-(4-((6,7-Dimethoxyquinolin-4-yl)oxy)phenyl)-N-(4-fluorophenyl-2,3,5,6-d4)cyclopropane-1,1-dicarboxamide; Cabozantinib D4; N-[4-[(6,7-Dimethoxy-4-quinolinyl)oxy]phenyl]-N'-(4-fluorophenyl-2,3,5,6-d4)-1,1-cyclopropanedicarboxamide; Cabozant

Cabozantinib-[d6]
CAS:1802168-46-2
Formula: C28H18D6FN3O5
BLP-013515
Cabozantinib bis(Trideuteromethoxy)

Cabozantinib-[fluorophenyl-d4]
CAS:1802168-53-1
Formula: C28H20D4FN3O5
>95%
BLP-014937
N-(4-((6,7-Dimethoxyquinolin-4-yl)oxy)phenyl)-N-(4-fluorophenyl-2,3,5,6-d4)cyclopropane-1,1-dicarboxamide; Cabozantinib D4; N-[4-[(6,7-Dimethoxy-4-quinolinyl)oxy]phenyl]-N'-(4-fluorophenyl-2,3,5,6-d4)-1,1-cyclopropanedicarboxamide; Cabozant

CABRALEADIOL
CAS:67253-01-4
Formula: C30H52O3
0.985
NP6815
(3+¦,24S)-20,24-Epoxydammarane-3,25-diol

CABRALEADIOL 3-ACETATE
CAS:35833-62-6
Formula: C32H54O4
NP6777
Cabraleadiol monoacetate

CABRALEAHYDROXYLACTONE
CAS:35833-69-3
Formula: C27H44O3
0.98
NP6620
(5S)-5-[(3+¦,5+¦,17+¦)-3-Hydroxy-4,4,8,10,14-pentamethylgonan-17-yl] -5-methyldihydro-2(3H)-furanone; 3-hydroxy-25,26,27-trinordammaran-24,20-olide;

CABRALEAHYDROXYLACTONE ACETATE
CAS:35833-70-6
Formula: C29H46O4
98%
NP6965
(3+¦,5+¦,17+¦)-4,4,8,10,14-Pentamethyl-17-[(2S)-2-methyl-5-oxotetrah ydro-2-furanyl]gonan-3-yl acetate

CABRALEALACTONE
CAS:19865-87-3
Formula: C27H42O3
98.5%
NP6871
(5+¦,17+¦)-4,4,8,10,14-Pentamethyl-17-[(2S)-2-methyl-5-oxotetrahydr o-2-furanyl]gonan-3-one

CABRALEONE
CAS:35761-54-7
Formula: C30H50O3
>98%
NP6891
20,24-Epoxy-25-hydroxydammaran-3-one

cAC 253 acetate
Formula: C128H206N42O42S2
>98.0%
BAT-016455

CACALOL
CAS:24393-79-1
Formula: C15H18O2
24393-79-1
(5S)-3,4,5-trimethyl-5,6,7,8-tetrahydrobenzo[f][1]benzofuran-9-ol

CACALONE
CAS:26294-92-8
Formula: C15H18O3
26294-92-8
(4R,5S)-4-hydroxy-3,4,5-trimethyl-5,6,7,8-tetrahydronaphtho[2,3-b]furan-9(4H)-one

CACCINH-A01
CAS:407587-33-1
Formula: C18H21NO4S
GëÑ99% by HPLC
407587-33-1
CaCCinh-A01; CaCC(inh)-A01, TMEM16 Blocker I. 6-(1,1-Dimethylethyl)-2-[(2-furanylcarbonyl)amino]-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylic acid

CACODYLIC ACID-[D7]
CAS:93954-09-7
Formula: C2D7AsO2
GëÑ98%; GëÑ98% atom D
BLP-010728
Cacodylic Acid D7; Dimethylarsinic acid-d7; Hydroxydimethylarsine oxide-d7; Chexmate-d7; Silvisar-d7; Phytar-d7; Arsan-d7; Erase-d7; Moncide-d7; Dilic-d7; Dimethylarsinic Acid-d7; NSC 103115-d7; Sylvicor-d7

Cactus flower ext.
CAS:8007-78-1
8007-78-1
Selenicereus grandiflorus, ext.; Cactus Extract

CAD-2
>98%
BAT-013319

CADALIN
CAS:483-78-3
Formula: C15H18
> 95%
483-78-3
Naphthalene, 1,GÇï6-GÇïdimethyl-GÇï4-GÇï(1-GÇïmethylethyl)GÇï-

CADAMBINE
CAS:54422-49-0
Formula: C27H32N2O10
98%
NP0625
Methyl (1S,17S)-17-[(2R,3S,4R,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-18,23-dioxa-3,13-diazahexacyclo[13.7.1.01,13.02,10.04,9.016,21]tricosa-2(10),4,6,8,19-pentaene-20-carboxylate

CADAVERINE-[15N2] DIHYDROCHLORIDE
CAS:2747-91-3
Formula: C5H16Cl2[15N]2
BLP-002127
1,5-Pentanediamine-15N2 Dihydrochloride; 1,5-Amylene Diamine-15N2 Dihydrochloride; Cadaverine-15N2 Dihydrochloride

CADAZOLID
CAS:1025097-10-2
Formula: C29H29F2N3O8
B2692-007705
ACT-179811; ACT 179811; ACT179811

CADD522
CAS:199735-88-1
Formula: C15H13Cl2NO3
199735-88-1
3-([(3,4-Dichlorophenyl)amino]carbonyl)bicyclo[2.2.1]hept-5-ene-2-carboxylic acid

CADEIN1
Formula: C33H48F2INO2
Cadein1; HY-131143; CS-0129442

CADENSIN D
CAS:102349-35-9
Formula: C25H22O9
93.0%
NP7314
Hypericorin;(2R,3R)-3-(4-hydroxy-3,5-dimethoxyphenyl)-2-(hydroxymethyl)-5-methoxy-2,3-dihydro-7h-[1,4]dioxino[2,3-c]xanthen-7-one

CADEROFLOXACIN
CAS:153808-85-6
Formula: C19H20F3N3O4
98%
153808-85-6
(S)-1-Cyclopropyl-8-(difluoromethoxy)-6-fluoro-7-(3-methylpiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid; Caderofloxacin; CS-940

Cadherin Peptide, avian Acetate
Formula: C46H79N17O15
BAT-016239

CADINENE
CAS:29350-73-0
Formula: C15H24
95%
29350-73-0
3,4,4abeta,5,8,8a-Hexahydro-4beta-isopropyl-1,6-dimethylnaphthalin; (1S-(1alpha,4alpha,4aalpha,6alpha,8abeta))-Decahydro-4-isopropyl-1,6-dimethylnaphthalene, didehydro derivative

CADION
CAS:5392-67-6
Formula: C18H14N6O2
GëÑ95%
B1370-026187
1-(4-Nitrophenyl)-3-(4-(phenyldiazenyl)phenyl)triaz-1-ene; Triazene, 3-(p-nitrophenyl)-1-(p-(phenylazo)phenyl)-; 1-(4-Nitrophenyl)-3-(4-phenylazophenyl)triazene

CADION 2B
CAS:6708-61-8
Formula: C22H16N6O2
GëÑ95%
B1370-221105
1-Triazene, 1-(4-nitro-1-naphthalenyl)-3-[4-(phenylazo)phenyl]-; 4-(4-Nitro-1-naphthyl-2-triazeno)azobenzene

CADMIUM MONOCARBONATE
CAS:513-78-0
Formula: CCdO3
BB069316
Cadmium Carbonate; Chemcarb; Kalcit; Mikrokalcit; Supermikrokalcit

CADMIUM NITRATE TETRAHYDRATE
CAS:10022-68-1
Formula: CdH8N2O10
BB062227
Cadmium nitrate tetrahydrate; Cadmium dinitrate tetrahydrate; Nitric acid, cadmium salt, hydrate (2:1:4); Cadmium(II) nitrate tetrahydrate; cadmium nitrate--water (1/4)

CADMIUM SUCCINATE
CAS:141-00-4
Formula: C4H4CdO4
BB069317
Cadmium succinate; Cadminate; Butanedioic acid, cadmium salt (1:1); butanedioate; cadmium(2+); PI6PK28624; Cadmium butanedioate

CADMIUM SULFATE OCTAHYDRATE
CAS:7790-84-3
Formula: CdSO4-+8/3H2O
BB069315

Cadonilimab
CAS:2394841-59-7
2394841-59-7

CADP-RIBOSE (CADPR) AMMONIUM SALT
Formula: C15H21N5O13P2.x(NH3)
90%
cADP-Ribose Ammonium Salt; cADPR Ammonium Salt; cyclic ADP-ribose ammonium salt; Cyclic Adenosine Diphosphate Ribose ammonium salt; Cyclic adenosine 5'-diphosphate ribose ammonium salt

CADUSAFOS-[D5]
CAS:1215380-71-4
Formula: C10H18D5O2PS2
> 98%
BLP-002128
Phosphorodithioic Acid O-Ethyl-d5 S,S-Bis(1-methylpropyl) Ester; Sebufos-d5; Sebuphos-d5; Cadusafos D5

CADY
Formula: C132H205N41O26S
>98%
BAT-013320
Ac-Gly-Leu-Trp-Arg-Ala-Leu-Trp-Arg-Leu-Leu-Arg-Ser-Leu-Trp-Arg-Leu-Leu-Trp-Arg-Ala-cysteamide

Caelsalpinia Sappan Extract
Sappanwood extract; Brazilian redwood extract; Sappan wood extract

Caenacin-1
BAT-013562

Caenacin-5
BAT-013563

Caerin 1.11
BAT-013564

Caerin 1.12
BAT-013565

Caerin 1.13
BAT-013566

Caerin 1.14
BAT-013567

Caerin 1.15
BAT-013568

Caerin 1.20
Formula: C124H201N33O28
>98% by HPLC
BAT-013569

Caerin 1.3
BAT-013570

Caerin 1.5
BAT-013571

CAERIN 1.9
Formula: C124H206N32O28
BAT-013572
Caerin 1.9; NH2-Gly-Leu-Phe-Gly-Val-Leu-Gly-Ser-Ile-Ala-Lys-His-Val-Leu-Pro-His-Val-Val-Pro-Val-Ile-Ala-Glu-Lys-Leu-NH2

Caerin 11
BAT-013573

Caerin 2.6
BAT-013574

Caerin 2.7
BAT-013575

Caerin 21
BAT-013576

Caerin-1.1
BAT-013577

Caerin-1.1.2
Formula: C107H178N30O26
>97% by HPLC
BAT-013578

Caerin-1.10
BAT-013579

Caerin-1.17
Formula: C124H206N32O29
>95% by HPLC
BAT-013580

Caerin-1.18
>96% by HPLC
BAT-013581

Caerin-1.19
BAT-013582

Caerin-1.2
BAT-013583

Caerin-1.4
BAT-013584

Caerin-1.6
BAT-013585

Caerin-1.7
BAT-013586

Caerin-1.8
BAT-013587

Caerin-2.1
BAT-013588

Caerin-2.2
BAT-013589

Caerin-2.4
BAT-013590

Caerin-2.5
BAT-013591

Caerin-3.2
BAT-013592

Caerin-3.3
BAT-013593

Caerin-3.4
BAT-013594

Caerin-3.5
BAT-013595

Caerin-4.1
Formula: C104H175N29O31
>97% by HPLC
BAT-013596

Caerin-4.2
BAT-013597

Caerin-4.3
BAT-013598

Caerulein precursor-related fragment Ea
BAT-013599
CPRF-Ea

Caerulein precursor-related fragment Eb
BAT-013600
CPRF-Eb

Caerulein precursor-related fragment Ec
BAT-013601
CPRF-Ec

CAERULEIN, DESULFATED
CAS:20994-83-6
Formula: C58H73N13O18S
>97% by HPLC
BAT-010551
4-Desulfocaerulein; H-Pyr-Gln-Asp-Tyr-Thr-Gly-Trp-Met-Asp-Phe-NH2; L-pyroglutamyl-L-glutaminyl-L-alpha-aspartyl-L-tyrosyl-L-threonyl-glycyl-L-tryptophyl-L-methionyl-L-alpha-aspartyl-L-phenylalaninamide; Pyr-QDYTGWMDF-NH2

CAERULOMYCIN
CAS:21802-37-9
Formula: C12H11N3O2
GëÑ98% by HPLC
BBF-00595
Caerulomycin A

CAESALMIN B
CAS:352658-23-2
Formula: C22H28O6
>95%
NP1675
(3bS,3b1R,5aS,6aR,10S,10aS,10bS)-6a-hydroxy-7,7,10a-trimethyl-4-oxo-3b,3b1,5a,6,6a,7,8,9,10,10a,10b,11-dodecahydro-4H-phenanthro[3,2-b:10,1-b'c']difuran-10-yl acetate

CAESALMIN E
CAS:204185-91-1
Formula: C12H13NO3
>95%
NP1665
CAESALMIN E;204185-91-1;[(1S,4aR,5S,6R,6aS,7S,11aS,11bS)-5,6-diacetyloxy-4a,7-dihydroxy-4,4,7,11b-tetramethyl-1,2,3,5,6,6a,11,11a-octahydronaphtho[2,1-f][1]benzofuran-1-yl] acetate;CHEMBL517323;HY-N2982;AKOS032949103;DA-51529;CS-0023633;

CAESALPIN J
CAS:99217-67-1
Formula: C17H16O6
>98%
99217-67-1

CAESALPINE A
CAS:1616757-59-5
Formula: C23H32O7
NP1602

CAESALPINE B
CAS:1616757-60-8
Formula: C23H30O7
NP1395
Caesalpinin F1

CAESAPPANIN C
CAS:1913319-59-1
Formula: C32H32O10
0.98
1913319-59-1
CID 137796430; 9,24-Bis(hydroxymethyl)pentacyclo[24.4.0.02,7.011,16.017,22]triaconta-1(26),2,4,6,11(16),12,14,17,19,21,27,29-dodecaene-4,5,9,13,19,20,24,28-octol; C32H32O10; 9,24-bis(hydroxymethyl)pentacyclo[24.4.0.0(2),?.0(1)(1),(1)?.0(1)?

CAFEDRINE
CAS:58166-83-9
Formula: C18H23N5O3
GëÑ95%
58166-83-9
(-)-Cafedrine; 7-(2-(beta-Hydroxy-alpha-methylphenethylamino)ethyl)theophylline; Brn 0583473; L-Cafedrine; 3,7-Dihydro-7-[2-[[(1S,2R)-2-hydroxy-1-methyl-2-phenylethyl]amino]ethyl]-1,3-dimethyl-1H-purine-2,6-dione; 7-[2-(+¦-Hydroxy-+¦-methylph

CAFEDRINE HYDROCHLORIDE
CAS:3039-97-2
Formula: C18H23N5O3.ClH
GëÑ95%
3039-97-2
(-)-Cafedrine hydrochloride; 7-(2-(beta-Hydroxy-alpha-methylphenethylamino)ethyl)theophylline hydrochloride; Brn 0583473 hydrochloride; L-Cafedrine hydrochloride; 3,7-Dihydro-7-[2-[[(1S,2R)-2-hydroxy-1-methyl-2-phenylethyl]amino]ethyl]-1,3-

CAFESTOL
CAS:469-83-0
Formula: C20H28O3
98%
B1370-118807
Cafesterol; (3bS,5aS,7R,8R,10aR,10bS)-3b,4,5,6,7,8,9,10,10a,10b,11,12-Dodecahydro-7-hydroxy-10b-methyl-5a,8-methano-5aH-cyclohepta[5,6]naphtho[2,1-b]furan-7-methanol

CAFFEIC ACID
CAS:331-39-5
Formula: C9H8O4
GëÑ98%
NP5450
3-(3,4-Dihydroxyphenyl)-2-propenoic Acid; 3,4-Dihydroxycinnamic Acid; 3,4-Dihydroxybenzeneacrylic Acid; 4-(2-Carboxyethenyl)-1,2-dihydroxybenzene; NSC 57197; NSC 623438; 3-(3,4-Dihydroxy-phenyl)-acrylic acid

CAFFEIC ACID 3-METHYL PHENETHYL ESTER
CAS:71835-85-3
Formula: C18H18O4
98%
71835-85-3
Phenethyl 3-Methylcaffeate; 2-Phenylethyl Ferulate; Ferulic Acid Phenethyl Ester

CAFFEIC ACID 3-O-B-D-GLUCOPYRANOSIDE
CAS:24959-81-7
Formula: C15H18O9
24959-81-7
3-[3-(b-D-Glucopyranosyloxy)-4-hydroxyphenyl]-2-propenoic acid; 3-(b-D-Glucopyranosyloxy)-4-hydroxy-cinnamic acid; 3-(b-D-Glucopyranosyloxy)-4-hydroxycinnamic acid

CAFFEIC ACID BENZYL ESTER-[D5]
CAS:1331655-92-5
Formula: C16H9D5O4
> 98%
BLP-002129
3-(3,4-Dihydroxyphenyl)-2-propenoic Acid Phenylmethyl Ester-d5; 3-(3,4-Dihydroxyphenyl)-2-propenoic Acid Benzyl Ester-d5; Benzyl Caffeate-d5; NSC 666590-d5; Caffeic Acid Benzyl Ester D5

Caffeic acid diacetate-[13C6]
Formula: C7[13C]6H12O6
GëÑ99% atom 13C
BLP-014073
[U-Ring-13C6]-(E)-3-(3,4-diacetoxyphenyl)acrylic acid; (E)-3-(3,4-diacetoxyphenyl 1,2,3,4,5,6-13C6)acrylic acid

CAFFEIC ACID PHENETHYL ESTER
CAS:104594-70-9
Formula: C17H16O4
>95%
BBF-03792
CAPE; BAF-IN-C09; 2-Phenylethyl Caffeate; +¦-Phenylethyl Caffeate

Caffeic Acid-[13C3]
CAS:1185245-82-2
Formula: C6[13C]3H8O4
GëÑ97% by HPLC; GëÑ99% atom 13C
BLP-011824
Caffeic Acid-13C3; 3-(3,4-Dihydroxyphenyl)-2-propenoic Acid-13C3; 3,4-Dihydroxycinnamic Acid-13C3; 3,4-Dihydroxybenzeneacrylic Acid-13C3; 4-(2-Carboxyethenyl)-1,2-dihydroxybenzene-13C3; NSC 57197-13C3

CAFFEIC ACID-[13C6] SODIUM SALT
Formula: C3[13C]6H7O4.Na
98%
BLP-000995
[13C6]-Caffeic acid sodium salt

CAFFEIC ACID-[13C9]
CAS:1173097-51-2
Formula: C3[13C]6H8O4
97% (CP); 99% atom 13C
BLP-000126
3,4-Dihydroxycinnamic acid-13C9

CAFFEIC ACID-PYEEIE
CAS:507471-72-9
Formula: C39H50N5O19P
GëÑ95% by HPLC
507471-72-9
N-[3-(3,4-Dihydroxyphenyl)-1-oxo-2-propenyl]-O-phosphono-L-tyrosyl-L-+¦-glutamyl-L-+¦-glutamyl-L-isoleucyl-L-glutamic acid

Caffeic-PH
CAS:1240406-70-5
Formula: C20H23N5O5
GëÑ95%
BAT-016695
Caffeic acid-Pro-His-NH2; CA-proline-histidine amide; CA-Pro-His-NH2; Caffeoyl-prolyl-histidine amide; 1-[3-(3,4-Dihydroxyphenyl)-1-oxo-2-propen-1-yl]-L-prolyl-L-histidinamide; Coumaroyl(3-OH)-Pro-His-NH2; N-(3-Hydroxycoumaroyl)-L-prolyl-L-

CAFFEIDINE ACID
CAS:54536-15-1
Formula: C8H12N4O3
96%
54536-15-1
Caffeidinecarboxylic Acid; 1-Methyl-4-[methyl[(methylamino)carbonyl]amino]-1H-imidazole-5-carboxylic Acid; 4-(1,3-Dimethylureido)-1-methyl-1H-imidazole-5-carboxylic Acid

CAFFEIDINE ACID SODIUM SALT
Formula: C8H11N4O3.Na
1-Methyl-4-[methyl[(methylamino)carbonyl]amino]-1H-Imidazole-5-carboxylic Acid Sodium Salt; Caffeidinecarboxylic Acid Sodium Salt; 4-(1,3-dimethylureido)-1-methyl-1H-imidazole-5-carboxylate, sodium salt (1:1); Caffeine Impurity 1 Sodium Sal

CAFFEINE IMPURITY 1 (SODIUM 4-[N-METHYL-N-(N-METHYLAMINOCARBONYL)AMINO]-1-METHYLIMIDAZOLE-5-CARBOXYLATE)
Formula: C8H11N4O3. Na
> 95%
1-Methyl-4-[methyl[(methylamino)carbonyl]amino]-1H-Imidazole-5-carboxylic Acid Sodium Salt; Caffeidinecarboxylic Acid Sodium Salt

CAFFEINE IMPURITY 1 AMMONIUM SALT
Formula: C8H11N4O3.NH4
4-(1,3-dimethylureido)-1-methyl-1H-imidazole-5-carboxylate, ammonium salt (1:1)

CAFFEINE IMPURITY 5
CAS:10184-35-7
Formula: C9H10N4O5
98%
10184-35-7
(1,3-dimethyl-2,6,8-trioxo-1,2,3,6,8,9-hexahydro-purin-7-yl)-acetic acid; (8-Hydroxy-1,3-dimethyl-2,6-dioxo-1,2,3,6-tetrahydro-purin-7-yl)-acetic acid; 1,2,3,6,8,9-hexahydro-1,3-dimethyl-2,6,8-trioxo-7H-purine-7-acetic Acid

CAFFEINE IMPURITY B
CAS:7597-60-6
Formula: C7H10N4O3
> 95%
7597-60-6
6-Amino-5-formamido-1,3-dimethyl-uracil; 1,3-Dimethyl-4-amino-5-(formylamino)uracil; 6-Amino-1,3-dimethyl-5-(formylamino)pyrimidine-2,4-dione; N-(6-Amino-1,2,3,4-tetrahydro-1,3-dimethyl-2,4-dioxo-5-pyrimidinyl)-formamide; N-(6-Amino-1,3-dim

CAFFEINE IMPURITY C (ISOCAFFEINE)
CAS:519-32-4
Formula: C8H10N4O2
> 95%
519-32-4
3,9-Dihydro-1,3,9-trimethyl-1H-purine-2,6-dione; 1,3,9-Trimethylxanthine; 9-Methyltheophylline; NSC 28332; EP Impurity C for Caffeine

CAFFEINE IMPURITY E
CAS:20041-90-1
Formula: C7H12N4O
> 95%
20041-90-1
Caffeidine; 1H-GÇïImidazole-GÇï5-GÇïcarboxamide, N,GÇï1-GÇïdimethyl-GÇï4-GÇï(methylamino)GÇï-GÇï, hydrochloride

CAFFEINE IMPURITY F
CAS:611-59-6
Formula: C7H8N4O2
> 95%
B0084-129330
1,7-Dimethylxanthine; P-Xanthine; Xanthine, 1,7-dimethyl-; 3,7-Dihydro-1,7-dimethyl-1H-purine-2,6-dione

Caffeine-[d10]
CAS:1220356-33-1
Formula: C8D10N4O2
BLP-014378
3,7-Dihydro-1,3,7-tri(methyl-d3)-1H-purine-2,6-dione-8-d

CAFTARIC ACID
CAS:67879-58-7
Formula: C13H12O9
>98%
B2703-075022
2-Caffeoyl-L-tartaric acid; (2R,3R)-2-{[(2E)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy}-3-hydroxybutanedioic acid

CAGE
CAS:2396582-22-0
Formula: C10H16O2.C10H15O2.C5H14NO
2396582-22-0
Choline geranate deep eutectic solvent/ionic liquid; Ethanaminium, 2-hydroxy-N,N,N-trimethyl-, (2E)-3,7-dimethyl-2,6-octadienoate, compd. with (E)-Geranic acid (1:1:1); Choline, geraniol, and geranic acid (1:1:1)

Cagrilintide
CAS:1415456-99-3
1415456-99-3

CAIROMYCIN A
CAS:78859-46-8
Formula: C9H14N2O4
BBF-00196
3,6-Dioxo-5-isopropyl-2-piperazineacetic acid; 2-Piperazineacetic acid, 5-(1-methylethyl)-3,6-dioxo-, (2S-cis)-; 2-Piperazineacetic acid, 3,6-dioxo-5-isopropyl-, (2S-cis)-

CAIROMYCIN B
CAS:62901-99-9
Formula: C10H15N3O3
BBF-00197
6,11,13-triazabicyclo[7.2.2]tridecane-7,10,12-trione

CAIROMYCIN C
CAS:78922-12-0
Formula: C23H38N6O6
BBF-00198

CAJANIN
CAS:32884-36-9
Formula: C16H12O6
>98%
NP2416
3-(2,4-Dihydroxyphenyl)-5-hydroxy-7-methoxy-4H-1-benzopyran-4-one

CAL Fluor Orange 560 CPG; 500 +à
BRP-02313
CAL Fluor Orange 560 CPG (5'-DMT-T(C6-CAL Fluor Orange 560)-Glyc-CPG); 500 +à

CAL FLUOR RED 610 CE PHOSPHORAMIDITE
CAS:861143-34-2
Formula: C46H57N5O4P2F6P
95%
B1370-362811
1H,5H,11H,15H-Xantheno[2,3,4-ij:5,6,7-i'j']diquinolizin-18-ium, 9-[2-[[4-[[[bis(1-methylethyl)amino](2-cyanoethoxy)phosphino]oxy]-1-piperidinyl]carbonyl]phenyl]-2,3,6,7,12,13,16,17-octahydro-, hexafluorophosphate(1-) (1:1); CAL Fluor Red 61

CAL FLUOR RED 610 CPG 1000

CAL Fluor Red 610 CPG 500 +à
BRP-02314
CAL Fluor Red 610 CPG (5'-DMT-T(C6-CAL Fluor Red 610)-Glyc-CPG); 500 +à

CAL-130
CAS:1431697-74-3
Formula: C23H22N8O
>98%
1431697-74-3
CAL130; CAL 130

CAL-130 HYDROCHLORIDE
CAS:1431697-78-7
Formula: C23H23ClN8O
>98%
1431697-78-7
CAL-130 Hydrochloride; CAL 130 Hydrochloride; CAL130 Hydrochloride;(S)-2-(1-((2-amino-9H-purin-6-yl)amino)ethyl)-5-methyl-3-(o-tolyl)quinazolin-4(3H)-one hydrochloride

CAL-130 RACEMATE
CAS:474012-90-3
Formula: C23H22N8O
>98%
474012-90-3
CAL-130 Racemate; CAL 130 Racemate; CAL130 Racemate

CALANOLIDE E
CAS:142566-61-8
Formula: C22H28O6
>98%
NP1191
5-Hydroxy-6-(3-hydroxy-2-methylbutanoyl)-2,2-dimethyl-10-propyl-9 ,10-dihydro-2H,8H-pyrano[2,3-f]chromen-8-one

Calarene
CAS:17334-55-3
Formula: C15H24
17334-55-3
1(10)-Aristolene; (+)-Calarene

CALBISTRIN A
CAS:147384-55-2
Formula: C31H40O8
BBF-00199

CALBISTRIN B
CAS:147384-56-3
Formula: C31H40O8
BBF-00200

CALBISTRIN C
CAS:147385-34-0
Formula: C31H42O8
BBF-00201

CALBISTRIN D
Formula: C31H42O8
BBF-00202

CALCEIN
CAS:1461-15-0
Formula: C30H26N2O13
GëÑ95%
1461-15-0
Fluorescein Complexone; Fluorexon; Oftasceine; Fluorescein, 2',7'-bis[[bis(carboxymethyl)amino]methyl]-; N,N'-[(3',6'-Dihydroxy-3-oxospiro[isobenzofuran-1(3H),9'-[9H]xanthene]-2',7'-diyl)bis(methylene)]bis[N-(carboxymethyl)glycine]; 2,2',2'

CALCEIN AM
CAS:148504-34-1
Formula: C46H46N2O23
GëÑ90%
148504-34-1
Calcein Acetoxymethyl ester; N,N'-[[3',6'-bis(acetyloxy)-3-oxospiro[isobenzofuran-1(3H),9'-[9H]xanthene]-2',7'-diyl]bis(methylene)]bis[N-[2-[(acetyloxy)methoxy]-2-oxoethyl]]-glycine, 1,1'-bis[(acetyloxy)methyl] ester

CALCEIN BLUE
CAS:54375-47-2
Formula: C15H15NO7
GëÑ90%
54375-47-2
N-(carboxymethyl)-N-[(7-hydroxy-4-methyl-2-oxo-2H-1-benzopyran-8-yl)methyl]-glycine; [(Carboxymethyl)[(7-hydroxy-4-methyl-2-oxochromen-8-yl)methyl]amino]acetic acid

CALCEIN BLUE AM
CAS:168482-84-6
Formula: C21H23NO11
GëÑ90%
168482-84-6
Calcein Blue Acetoxymethyl ester; N-[2-[(acetyloxy)methoxy]-2-oxoethyl]-N-[(7-hydroxy-4-methyl-2-oxo-2H-1-benzopyran-8-yl)methyl]-glycine, (acetyloxy)methyl ester

CALCEOLARIOSIDE A
CAS:84744-28-5
Formula: C32H30N2O4
98%
84744-28-5
Calceolarioside A;84744-28-5;Calceolarioside;[(2R,3S,4R,5R,6R)-6-[2-(3,4-dihydroxyphenyl)ethoxy]-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl] (E)-3-(3,4-dihydroxyphenyl)prop-2-enoate;CHEMBL481635;beta-D-Glucopyranoside, 2-(3,4-dihydroxyphenyl)

CALCEOLARIOSIDE B
CAS:105471-98-5
Formula: C23H26O11
>98%
105471-98-5
2-(3,4-Dihydroxyphenyl)ethyl 6-O-[(E)-3-(3,4-dihydroxyphenyl)propenoyl]-+¦-D-glucopyranoside; 3,4-Dihydroxyphenethyl 6-O-(3,4-dihydroxycinnamoyl)-+¦-D-glucopyranoside; Calceolarioside B; Calceorioside B; Desrhamnosyl isoacteoside; (E)-beta-D-

CALCICHROME
CAS:3810-39-7
Formula: C30H14N4Na6O22S6
B1370-020412
Calcion; 2,7-Naphthalenedisulfonic acid, 5-[2-(1,8-dihydroxy-3,6-disulfo-2-naphthalenyl)diazenyl]-4-hydroxy-3-[2-(8-hydroxy-3,6-disulfo-1-naphthalenyl)diazenyl]-, sodium salt (1:6)

CALCIFEDIOL
CAS:19356-17-3
Formula: C27H44O2
>98%
BBF-05871
(3+¦,5Z,7E)-9,10-Secocholesta-5,7,10(19)-triene-3,25-diol; 25-Hydroxycholecalciferol; 25-Hydroxyvitamin D; 25-Hydroxyvitamin D3; Calcidiol; Didrogyl; Hidroferol; Ro 8-8892; U 32070E; 25-OH Vitamin D3; Rayaldee; 5,6-cis-25-Hydroxyvitamin D3;

CALCIFEDIOL IMPURITY 1
CAS:23357-18-8
Formula: C27H44O2
B2694-054152
9,10-Secocholesta-5(10),6,8-triene-3,25-diol, (3b,6Z)-

CALCIFEDIOL INTERMEDIATE
Formula: C33H56O3Si
B1960-112380

CALCIFEDIOL MONOHYDRATE
CAS:63283-36-3
Formula: C27H46O3
>98%
B2694-073954
25-Hydroxycholecalciferol monohydrate; 25-hydroxy Vitamin D3 monohydrate

Calcifediol Monohydrate EP Impurity A
CAS:61585-29-3
Formula: C27H44O2
B1960-054082
Calcifediol EP Impurity A; 9+¦,10+¦-cholesta-5,7-diene-3+¦,25-diol; 25-Hydroxylumisterol; 25-Hydroxyprovitamin D3

Calcifediol Monohydrate EP Impurity B
CAS:22145-68-2
Formula: C27H44O2
B1960-054084
Calcifediol EP Impurity B; 25-Hydroxyprovitamin D3; 25-Hydroxy-7-dehydrocholesterol; cholesta-5,7-diene-3+¦,25-diol; 7-Dehydro-25-hydroxycholesterol

Calcifediol Monohydrate EP Impurity C
CAS:39932-44-0
Formula: C27H44O2
B1960-054085
Calcifediol EP Impurity C; 25-Hydroxytachysterol 3; (6E)-9,10-secocholesta-5(10),6,8-triene-3+¦,25-diol; (3S,6E)-9,10-secocholesta-5(10),6,8-triene-3,25-diol

Calcifediol Monohydrate EP Impurity D
CAS:1233749-00-2
Formula: C27H44O2
B1960-054091
Calcifediol EP Impurity D; 25-Hydroxycholecalciferol, 5-trans-; 5,6-trans-25-Hydroxy vitamin D3; 9,10-Secocholesta-5,7,10(19)-triene-3beta,25-diol; (3S,5E,7E)-9,10-secocholesta-5,7,10(19)-triene-3,25-diol

CALCIMYCIN
CAS:52665-69-7
Formula: C29H37N3O6
>99% by HPLC
BBF-00596
A-23187

CALCIMYCIN HEMICALCIUM SALT
CAS:59450-89-4
Formula: C58H72CaN6O12
59450-89-4
A-23187 hemicalcium salt; Antibiotic A-23187 hemicalcium salt

CALCIMYCIN HEMIMAGNESIUM
CAS:72124-77-7
Formula: C58H72MgN6O12
72124-77-7
A-23187 hemimagnesium; Antibiotic A-23187 hemimagnesium

CALCINEURIN AUTOINHIBITORY PEPTIDE
CAS:148067-21-4
Formula: C124H205N39O39S2
>98%
BAT-010300

CALCINEURIN SUBSTRATE
CAS:113873-67-9
Formula: C92H150N28O29
98%
BAT-006181
H-Asp-Leu-Asp-Val-Pro-Ile-Pro-Gly-Arg-Phe-Asp-Arg-Arg-Val-Ser-Val-Ala-Ala-Glu-OH; L-alpha-aspartyl-L-leucyl-L-alpha-aspartyl-L-valyl-L-prolyl-L-isoleucyl-L-prolyl-glycyl-L-arginyl-L-phenylalanyl-L-alpha-aspartyl-L-arginyl-L-arginyl-L-valyl-

Calcineurin substrate acetate
Formula: C94H154N28O31
GëÑ95%
BAT-016182
H-Asp-Leu-Asp-Val-Pro-Ile-Pro-Gly-Arg-Phe-Asp-Arg-Arg-Val-Ser-Val-Ala-Ala-Glu-OH.CH3CO2H; L-+¦-Aspartyl-L-leucyl-L-+¦-aspartyl-L-valyl-L-prolyl-L-isoleucyl-L-prolylglycyl-L-arginyl-L-phenylalanyl-L-+¦-aspartyl-L-arginyl-L-arginyl-L-valyl-L-ser

Calcipotriene +¦-Isomer
Formula: C27H40O3

CALCIPOTRIOL
CAS:112965-21-6
Formula: C27H40O3
95%
B0084-180330
(1R,3S,5Z)-5-[(2E)-2-[(1R,3aS,7aR)-1-[(1R,2E,4S)-4-Cyclopropyl-4-hydroxy-1-methyl-2-buten-1-yl]octahydro-7a-methyl-4H-inden-4-ylidene]ethylidene]-4-methylene-1,3-cyclohexanediol; Calcipotriol; MC-903; Daivonex; Dovonex; Psorcutan; Calcipotr

CALCIPOTRIOL EP IMPURITY A
CAS:126860-83-1
Formula: C27H38O3
>98%
B0503-467974
Impurity A of Calcipotriol; MC 1046; MC1046; MC-1046

CALCIPOTRIOL EP IMPURITY B
CAS:2948288-30-8
Formula: C27H40O3
GëÑ90%
2948288-30-8
(5Z,7Z,22E,24S)-24-Cyclopropyl-9,10-secochola-5,7,10(19),22-tetraene-1+¦,3+¦,24-triol; (7Z)-Calcipotriene; (7Z)-calcipotriol; (5Z,7Z)-Calcipotriene; (1R,3S,Z)-5-(2-((1R,3aS,7aR,Z)-1-((2R,5S,E)-5-cyclopropyl-5-hydroxypent-3-en-2-yl)-7a-methylo

CALCIPOTRIOL EP IMPURITY C
CAS:113082-99-8
Formula: C27H40O3
95%
B0503-467979
CS-M0059; CS M0059; CSM0059; (1a,3b,5E,7E,22E,24S)-24-Cyclopropyl-9,10-Secochola-5,7,10(19),22-tetraene-1,3,24-triol

CALCIPOTRIOL EP IMPURITY D
CAS:112827-99-3
Formula: C27H40O3
95%
B0503-467980
PRI 2202; PRI2202; PRI-2202; 24R-Calcipotriol; (24R)-Calcipotriene

CALCIPOTRIOL EP IMPURITY E
Formula: C27H42O3
95%
B1370-120726
rac-(5Z,7E,24S)-24-cyclopropyl-9,10-secochola-5,7,10(19)-triene-1+¦,3+¦,24-triol

CALCIPOTRIOL EP IMPURITY F
CAS:112875-61-3
Formula: C39H68O3Si2
>98%
B0503-467982
(1+¦,3+¦,5Z,7E,22E,24S)-24-cyclopropyl-1,3-bis[[(1,1-dimethylethyl)dimethylsilyl]oxy]-9,10-Secochola-5,7,10(19),22-tetraen-24-ol; (+¦S)-+¦-[(1E,3R)-3-[(1R,3aS,4E,7aR)-4-[(2Z)-2-[(3S,5R)-3,5-bis[[(1,1-dimethylethyl)dimethylsilyl]oxy]-2-methylene

CALCIPOTRIOL EP IMPURITY G
Formula: C54H78O5
B0503-054075
24,24'-oxybis[(5Z,7E,22E,24S)-24-cyclopropyl-9,10-secochola-5,7,10(19),22-tetraene-1+¦,3+¦-diol]

CALCIPOTRIOL EP IMPURITY H
Formula: C54H78O5
B0503-054078
(5Z,7E,22E,24R)-24-cyclopropyl-24-[[(5Z,7E,22E,24S)-24-cyclopropyl-1+¦,3+¦-dihydroxy-9,10-secochola-5,7,10(19),22-tetraen-24-yl]oxy]-9,10-secochola-5,7,10(19),22-tetraene-1+¦,3+¦-diol

CALCIPOTRIOL EP IMPURITY I
Formula: C27H40O3
B0503-054081
(6S,7R,8R,22E,24S)-24-cyclopropyl-6,8:7,19-dicyclo-9,10-secochola-5(10),22-diene-1+¦,3+¦,24-triol; suprasterol of calcipotriol

CALCIPOTRIOL IMPURITY 1
CAS:112849-47-5
Formula: C27H40O3
> 95%
B0503-467984
(1+¦,3+¦,5E,7E,22E,24R)-24-Cyclopropyl-9,10-secochola-5,7,10(19),22-tetraene-1,3,24-triol; (1R,3S,E)-5-((E)-2-((1R,3aS,7aR)-1-((2R,5R,E)-5-Cyclopropyl-5-hydroxypent-3-en-2-yl)-7a-methylhexahydro-1H-inden-4(2H)-ylidene)ethylidene)-4-methylenec

CALCIPOTRIOL IMPURITY 2
Formula: C27H40O3

CALCIPOTRIOL INTERMEDIATE 9
CAS:112849-17-9
Formula: C39H66O3Si2
B0503-081828
(2E,4R)-4-[(1R,3aS,4E,7aR)-4-[(2E)-2-[(3S,5R)-3,5-Bis[[(tert-butyl)dimethylsilyl]oxy]-2-methylenecyclohexylidene]ethylidene]octahydro-7a-methyl-1H-inden-1-yl]-1-cyclopropyl-2-penten-1-one; (5E)-1,3-Bis-O-(tert-Butyldimethylsilyl)-24-oxo-cal

CALCIPOTRIOL MC-1080-[D4]
Formula: C27H36D4O3
BLP-002130
Calcipotriol MC-1080 D4

CALCIPOTRIOL MONOHYDRATE
CAS:147657-22-5
Formula: C27H42O4
>98%
147657-22-5
Calcipotriene monohydrate; Dovonex (TN)

CALCIPOTRIOL-[D4]
Formula: C27H36D4O3
95% by HPLC; 98% atom D
BLP-003495
Calcipotriol D4

Calcitermin
BAT-013602

CALCITETROL
CAS:72203-93-1
Formula: C27H44O4
>98%
72203-93-1
1+¦, 24, 25-Trihydroxy VD3

CALCITONIN
CAS:9007-12-9
95%
9007-12-9
Calcitrin; TCA; TCT; Thyrocalcitonin; Thyrocalcitonins

Calcitonin (20-32), salmon
Formula: C57H91N19O21
BAT-017048
Gln-Thr-Tyr-Pro-Arg-Thr-Asn-Thr-Gly-Ser-Gly-Thr-Pro-NH2

CALCITONIN (8-32), SALMON
CAS:155069-90-2
Formula: C119H198N36O37
GëÑ95%
BAT-010552
H-Val-Leu-Gly-Lys-Leu-Ser-Gln-Glu-Leu-His-Lys-Leu-Gln-Thr-Tyr-Pro-Arg-Thr-Asn-Thr-Gly-Ser-Gly-Thr-Pro-NH2; L-valyl-L-leucyl-glycyl-L-lysyl-L-leucyl-L-seryl-L-glutaminyl-L-alpha-glutamyl-L-leucyl-L-histidyl-L-lysyl-L-leucyl-L-glutaminyl-L-th

CALCITONIN (CHICKEN)
CAS:100016-62-4
Formula: C145H240N42O46S2
95%
100016-62-4
L-Prolinamide, L-cysteinyl-L-alanyl-L-seryl-L-leucyl-L-seryl-L-threonyl-L-cysteinyl-L-valyl-L-leucylglycyl-L-lysyl-L-leucyl-L-seryl-L-glutaminyl-L-+¦-glutamyl-L-leucyl-L-histidyl-L-lysyl-L-leucyl-L-glutaminyl-L-threonyl-L-tyrosyl-L-prolyl-L-

CALCITONIN (RAT)
CAS:11118-25-5
Formula: C148H228N40O46S3
GëÑ95%
BAT-015132
H-Cys-Gly-Asn-Leu-Ser-Thr-Cys-Met-Leu-Gly-Thr-Tyr-Thr-Gln-Asp-Leu-Asn-Lys-Phe-His-Thr-Phe-Pro-Gln-Thr-Ser-Ile-Gly-Val-Gly-Ala-Pro-NH2 (Disulfide bridge: Cys1-Cys7); L-cysteinyl-glycyl-L-asparagyl-L-leucyl-L-seryl-L-threonyl-L-cysteinyl-L-me

CALCITONIN (SALMON) TRIFLUOROACETATE SALT
CAS:171052-37-2
Formula: C145H240N44O48S2.xC2HF3O2
GëÑ95%
171052-37-2
H-Cys-Ser-Asn-Leu-Ser-Thr-Cys-Val-Leu-Gly-Lys-Leu-Ser-Gln-Glu-Leu-His-Lys-Leu-Gln-Thr-Tyr-Pro-Arg-Thr-Asn-Thr-Gly-Ser-Gly-Thr-Pro-NH2.TFA (Disulfide bond between Cys1 and Cys7); L-cysteinyl-L-seryl-L-asparagyl-L-leucyl-L-seryl-L-threonyl-L-

Calcitonin (salmon), acetate (1:1)
CAS:1789726-86-8
Formula: C147H244N44O50S2
GëÑ95%
1789726-86-8
Calcitonin(salmon) Acetate; Salmon calcitonin-(1-32) Acetate; Salmon Thyrocalcitonin Acetate; H-Cys-Ser-Asn-Leu-Ser-Thr-Cys-Val-Leu-Gly-Lys-Leu-Ser-Gln-Glu-Leu-His-Lys-Leu-Gln-Thr-Tyr-Pro-Arg-Thr-Asn-Thr-Gly-Ser-Gly-Thr-Pro-NH2.CH3CO2H (Dis

CALCITONIN (SWINE)
CAS:12321-44-7
Formula: C159H232N46O45S3
95%
12321-44-7
L-Prolinamide, L-cysteinyl-L-seryl-L-asparaginyl-L-leucyl-L-seryl-L-threonyl-L-cysteinyl-L-valyl-L-leucyl-L-seryl-L-alanyl-L-tyrosyl-L-tryptophyl-L-arginyl-L-asparaginyl-L-leucyl-L-asparaginyl-L-asparaginyl-L-phenylalanyl-L-histidyl-L-argin

CALCITONIN EEL
CAS:57014-02-5
Formula: C146H241N43O47S2
98%
BAT-006141
Eel calcitonin; Calcitonin (eel); Calcitonin, Eel; Cys-Ser-Asn-Leu-Ser-Thr-Cys-Val-Leu-Gly-Lys-Leu-Ser-Gln-Glu-Leu-His-Lys-Leu-Gln-Thr-Tyr-Pro-Arg-Thr-Asp-Val-Gly-Ala-Gly-Thr-Pro-NH2 [Disulfide bridge: 1-7]; Thyrocalcitonin Eel; L-Cysteinyl

CALCITONIN GENE RELATED PEPTIDE (CGRP) (83-119), RAT TFA
Formula: C162H262N50O52S2.C2HF3O2
>98%
BAT-009297
Ser-Cys-Asn-Thr-Ala-Thr-Cys-Val-Thr-His-Arg-Leu-Ala-Gly-Leu-Leu-Ser-Arg-Ser-Gly-Gly-Val-Val-Lys-Asp-Asn-Phe-Val-Pro-Thr-Asn-Val-Gly-Ser-Glu-Ala-Phe-NH2.TFA (Disulfide bridge: Cys2-Cys7); CGRP-1 (rat) TFA; L-seryl-L-cysteinyl-L-asparagyl-L-t

CALCITONIN GENE-RELATED PEPTIDE
CAS:83652-28-2
Formula: C163H266N50O50S2
BAT-013603
Calcitonin, pro-; CALCA protein, human; CALC1 protein, human; CGRP1 protein, human

CALCITONIN GENE-RELATED PEPTIDE 1 (16-25)
BAT-009638
Alpha-type CGRP (16-25)

CALCITONIN HUMAN
CAS:21215-62-3
Formula: C151H226N40O45S3
GëÑ95%
BAT-010826
Calcitonin (human); Calcitonin M (human C carcinoma); L-Prolinamide, L-cysteinylglycyl-L-asparaginyl-L-leucyl-L-seryl-L-threonyl-L-cysteinyl-L-methionyl-L-leucylglycyl-L-threonyl-L-tyrosyl-L-threonyl-L-glutaminyl-L-+¦-aspartyl-L-phenylalanyl

CALCITONIN N-TERMINAL FLANKING PEPTIDE (HUMAN)
CAS:118277-01-3
Formula: C264H426N74O97S
95%
BAT-015133
N-PCT (human); H-Ala-Pro-Phe-Arg-Ser-Ala-Leu-Glu-Ser-Ser-Pro-Ala-Asp-Pro-Ala-Thr-Leu-Ser-Glu-Asp-Glu-Ala-Arg-Leu-Leu-Leu-Ala-Ala-Leu-Val-Gln-Asp-Tyr-Val-Gln-Met-Lys-Ala-Ser-Glu-Leu-Glu-Gln-Glu-Gln-Glu-Arg-Glu-Gly-Ser-Ser-Leu-Asp-Ser-Pro-Arg

Calcitonin Paralle Dimer
Formula: C290H480N88O96S4
2[H-Cys-Ser-Asn-Leu-Ser-Thr-Cys-Val-Leu-Gly-Lys-Leu-Ser-Gln-Glu-Leu-His-Lys-Leu-Gln-Thr-Tyr-Pro-Arg-Thr-Asn-Thr-Gly-Ser-Gly-Thr-Pro-NH2] (inter-disulfide bridges between 1,1' and 7,7' cysteines)

CALCITONIN SALMON
CAS:47931-85-1
Formula: C145H240N44O48S2
98%
BAT-006117
Salmon calcitonin; H-Cys-Ser-Asn-Leu-Ser-Thr-Cys-Val-Leu-Gly-Lys-Leu-Ser-Gln-Glu-Leu-His-Lys-Leu-Gln-Thr-Tyr-Pro-Arg-Thr-Asn-Thr-Gly-Ser-Gly-Thr-Pro-NH2 (Disulfide bridge: Cys1-Cys7); L-cysteinyl-L-seryl-L-asparagyl-L-leucyl-L-seryl-L-threo

Calcitonin Salmon-[d10]
Formula: C145H230D10N44O48S2
H-Cys-Ser-Asn-Leu(D10)-Ser-Thr-Cys-Val-Leu-Gly-Lys-Leu-Ser-Gln-Glu-Leu-His-Lys-Leu-Gln-Thr-Tyr-Pro-Arg-Thr-Asn-Thr-Gly-Ser-Gly-Thr-Pro-NH2 (Disulfide bond between Cys1 and Cys7); Calcitonin Salmon D10 Impurity

CALCITONIN, EEL TFA
Formula: C146H241N43O47S2.C2HF3O2
>98%
BAT-009344
Thyrocalcitonin eel (TFA); Cys-Ser-Asn-Leu-Ser-Thr-Cys-Val-Leu-Gly-Lys-Leu-Ser-Gln-Glu-Leu-His-Lys-Leu-Gln-Thr-Tyr-Pro-Arg-Thr-Asp-Val-Gly-Ala-Gly-Thr-Pro-NH2.TFA (Disulfide bridge: Cys1-Cys7); L-cysteinyl-L-seryl-L-asparagyl-L-leucyl-L-ser

CALCITRIOL
CAS:32222-06-3
Formula: C27H44O3
>98%
B1960-485217
Rocaltrol; 1alpha,25-Dihydroxyvitamin D3; Topitriol; Soltriol; Vectical; 1,25-DHCC; 1,25-Dihydroxyvitamin D3

Calcitriol Derivatives
CAS:2070009-24-2
Formula: C30H47NO3
2070009-24-2
3-{[(1S,3R,5Z,7E)-1,25-Dihydroxy-9,10-secocholesta-5,7,10-trien-3-yl]oxy}propanenitrile; Propanenitrile, 3-[[(1R,3S,5Z)-3-hydroxy-4-methylene-5-[(2E)-2-[(1R,3aS,7aR)-octahydro-1-[(1R)-5-hydroxy-1,5-dimethylhexyl]-7a-methyl-4H-inden-4-yliden

CALCITRIOL EP IMPURITY A
CAS:73837-24-8
Formula: C27H44O3
98%
B0504-485047
trans-Calcitriol; 5,6-trans-Calcitriol; 1,25-Dihydroxy-5,6-trans-vitamin D3; (5E,7E)-9,10-secocholesta-5,7,10(19)-triene-1+¦,3+¦,25-triol; (1+¦,3+¦,5E,7E)-9,10-Secocholesta-5,7,10(19)-triene-1,3,25-triol; 1+¦,25-Dihydroxy-5,6-trans-vitamin D3

CALCITRIOL EP IMPURITY B
CAS:66791-71-7
Formula: C27H44O3
>98%
B0504-467988
Epi-Calcitriol; 1+¦,25-Dihydroxyvitamin-D3; 1-Epicalcitriol; Impurity B of Calcitriol; 1+¦-Calcitriol; 1-epi-Calcitriol; (5Z,7E)-9,10-secocholesta-5,7,10(19)-triene-1+¦,3+¦,25-triol

CALCITRIOL EP IMPURITY C
CAS:86307-44-0
Formula: C35H49N3O5
>98%
B0504-485045
Triazoline Adduct of pre-Calcitriol; pre-Calcitriol PTAD Adduct (Mixture of Diastereomers); Impurity C of Calcitriol (6aR,7R,9aR)-11-[(3S,5R)-3,5-dihydroxy-2-methylcyclohex-1-enyl]-7-[(1R)-5-hydroxy-1,5-dimethylhexyl]-6a-methyl-2-phenyl-5,6

CALCITRIOL IMPURITY 1
Formula: C27H44O3

CALCITRIOL INTERMEDIATE
CAS:169900-32-7
Formula: C39H70O4Si2
B0504-352715
(5R)-ethyl-5-((1R,3aS,7aR)-4-((E)-2-((3S,5R)-3,5-bis(tert-butyldimethylsilyloxy)-2-methylenecyclohexylidene)ethyl)-7a-Methyloctahydro-1H-inden-1-yl)hexanoate

CALCITROIC ACID
CAS:71204-89-2
Formula: C23H34O4
>95%
71204-89-2
1H-Indene-1-propanoic acid, 4-[(2Z)-2-[(3S,5R)-3,5-dihydroxy-2-methylenecyclohexylidene]ethylidene]octahydro-+¦,7a-dimethyl-, (+¦R,1R,3aS,4E,7aR)-; (+¦R,1R,3aS,4E,7aR)-4-[(2Z)-2-[(3S,5R)-3,5-Dihydroxy-2-methylenecyclohexylidene]ethylidene]octa

Calcium 2-glycerophosphate
CAS:58409-70-4
Formula: C3H7CaO6P
GëÑ95%
58409-70-4
1,2,3-Propanetriol, 2-(dihydrogen phosphate), calcium salt (1:1); 1,3-Dihydroxypropan-2-yl dihydrogen phosphate calcium salt; Calcium beta-glycerophosphate; Calcium 1,3-hydroxypropyl phosphate; beta-glycerophosphoric acid calcium salt; 1,3-

CALCIUM 2-OXOGLUTARATE
CAS:71686-01-6
Formula: C5H4CaO5
B2699-179986
Calcium oxoglurate; calcium 2-oxopentanedioate

CALCIUM 3-HYDROXYBUTYRATE
CAS:51899-07-1
Formula: C8H14CaO6
98%
B1370-071151
Calcium beta-hydroxybutyrate; Calcium BHB

CALCIUM 5-METHYLTETRAHYDROFOLATE-[13C5]
Formula: C15[13C]5H23CaN7O6
BLP-002131
Calcium 5-methyltetrahydrofolate 13C5

CALCIUM ASCORBATE DIHYDRATE
CAS:5743-28-2
Formula: C12H14O12Ca.2H2O
98%
5743-28-2
L-Ascorbic Acid Calcium Salt Hydrate; L-Ascorbic Acid Calcium Salt Dihydrate; Calcium L-ascorbate dihydrate; L-Ascorbic acid, calcium salt, hydrate (2:1:2); L-Ascorbic acid, calcium salt (2:1), dihydrate

CALCIUM BIPHOSPHATE
CAS:7758-23-8
Formula: Ca.2H3O4P
GëÑ95%
7758-23-8
Phosphoric acid, calcium salt (2:1); Acid calcium phosphate; C 38; C 38 (phosphate); Calcium bis(dihydrogen phosphate); Calcium bis(orthophosphate); Calcium dihydrogen orthophosphate; Calcium dihydrogen phosphate; Calcium diorthophosphate;

CALCIUM BIS[MONOETHYL(3,5-DI-TERT-BUTYL-4-HYDROXYLBENZYL)PHOSPHONATE]
CAS:65140-91-2
Formula: C34H56CaO8P2
B1370-013107
Irganox 1425; calcium bis(ethyl 3,5-di-tert-butyl-4-hydroxybenzylphosphonate); Phosphonic acid, ((3,5-bis(1,1-dimethylethyl)-4-hydroxyphenyl)methyl)-, monoethyl ester, calcium salt (2:1)

CALCIUM CARBONATE
CAS:471-34-1
Formula: CaCO3
95%
471-34-1
Aeromatt; Akadama; Albacar; Baracarb; Bealite 30; Beatite; Brilliant 15; Calcium Factor; Calcium Carbonate (1:1); Calcium Monocarbonate; Carbonic acid, calcium salt (1:1)

CALCIUM CARBONATE-[13C]
CAS:287389-46-2
Formula: [13C]CaO3
99% atom 13C
BLP-009192
Carbonic-13C acid, calcium salt

CALCIUM CHANNEL-MODULATOR-1
CAS:136941-70-3
Formula: C26H24Cl2N2O7S
136941-70-3
3-O-methyl 5-O-[3-(1,1,3-trioxo-1,2-benzothiazol-2-yl)propyl] 4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate; 3,5-Pyridinedicarboxylic acid, 4-(2,3-dichlorophenyl)-1,4-dihydro-2,6-dimethyl-, methyl 3-(3-oxo-1,2-be

CALCIUM CHLORIDE
CAS:10043-52-4
Formula: CaCl2
GëÑ95%
10043-52-4
Bovikalc; CalPlus; Calcium dichloride; Calcium(2+) chloride; Calcosan; Calmate R; Calol; Calzina oral; Chrysoxel C 4; Daraccel; Dowflake; Kalgan; Liquidow; Peladow; Stopitl; U-Ramin MC

CALCIUM CHLORIDE DIHYDRATE
CAS:10035-04-8
Formula: CaCl2H4O2
10035-04-8
Calcium dichloride

CALCIUM CHLORIDE HEXAHYDRATE
CAS:7774-34-7
Formula: CaCl2.6H2O
GëÑ95%
7774-34-7
Calcium dichloride hexahydrate

CALCIUM D-PANTOTHENATE
CAS:137-08-6
Formula: C18H32CaN2O10
98%
B0005-464900
Calcium pantothenate; D-Calcium pantothenate; Calpanate; Pantholin

CALCIUM D-SACCHARATE TETRAHYDRATE
CAS:5793-89-5
Formula: C6H8CaO8.4H2O
98%
5793-89-5
D-Glucaric acid, calcium salt, hydrate (1:1:4); D-Saccharic acid calcium salt tetrahydrate; Glucaric acid calcium salt tetrahydrate; Calcium D-glucarate tetrahydrate; Glucosaccharic acid calcium salt tetrahydrate; D-Glucaric acid, calcium s

CALCIUM DODECYLBENZENE SULFONATE
CAS:26264-06-2
Formula: C36H58O6S2Ca
26264-06-2
EMULSIFIER 1371 A; CALCIUM N-DODECYLBENZENESULFONATE; CALCIUM DODECYLBENZENE SULFONATE; 1371a; calciumalkylaromaticsulfonate; calciumalkylbenzenesulfonate; calciumbis(dodecylbenzenesulfonate); calciumdodecylbenzensulfonate

CALCIUM FOLINATE-[13C5]
Formula: C15[13C]5H23CaN7O8
97% (CP); 99% atom 13C
BLP-000127
Calcium folinate-(glutamyl-13C5)

CALCIUM FORMATE
CAS:544-17-2
98%
544-17-2
Calcium diformate; Calcoform

CALCIUM GLUCOHEPTONATE
CAS:29039-00-7
Formula: C14H26O16Ca
B1370-069770
D-gluco-Heptonic acid, calcium salt (2:1), (2++)-; Glucoheptonic acid, calcium salt (2:1); Calcihept; Calcium gluceptate; Calcium heptagluconate; Glucoheptonic acid calcium salt

CALCIUM GLUCONATE
CAS:299-28-5
Formula: C12H22CaO14
GëÑ95%
299-28-5
Calcium D-gluconate; 2,3,4,5,6-Pentahydroxycaproic acid hemicalcium salt; D-Gluconic acid, calcium salt (2:1); Gluconic acid, calcium salt (2:1), D-; Biocal; Calcicol; Calciofon; Calcipur; Calcium D-gluconate; Calcium hexagluconate; Calgluc

CALCIUM GLYCEROPHOSPHATE
CAS:27214-00-2
Formula: C3H7CaO6P
GëÑ95%
B1370-064790
Calcium 1-glycerophosphate; Calcium glycerol phosphate; 1,2,3-Propanetriol, 1-(dihydrogen phosphate), calcium salt (1:1)

CALCIUM GREEN 1 AM
CAS:186501-28-0
Formula: C59H53Cl2N3O26
GëÑ90%
186501-28-0
N-[2-[(acetyloxy)methoxy]-2-oxoethyl]-N-[2-[2-[5-[[[3',6'-bis(acetyloxy)-2',7'-dichloro-3-oxospiro[isobenzofuran-1(3H),9'-[9H]xanthen]-5-yl]carbonyl]amino]-2-[bis[2-[(acetyloxy)methoxy]-2-oxoethyl]amino]phenoxy]ethoxy]phenyl]-glycine, (acet

CALCIUM GREEN 1 POTASSIUM SALT
Formula: C43H27Cl2K6N3O16
GëÑ90%
2,2'-((2-(2-(2-(bis(carboxylatomethyl)amino)-5-(3-carboxylato-4-(2,7-dichloro-6-oxido-3-oxo-3H-xanthen-9-yl)benzamido)phenoxy)ethoxy)phenyl)azanediyl)diacetate, hexapotassium salt

CALCIUM GREEN BAPTA-2 AM
Formula: C84H66Cl4N4O34

CALCIUM GREEN-5N AM
CAS:216699-33-1
Formula: C59H52Cl2N4O28
216699-33-1

CALCIUM HYDROGEN PHOSPHATE
CAS:7757-93-9
Formula: CaHPO4
GëÑ95%
7757-93-9
Calcium phosphate dibasic; Phosphoric acid, calcium salt (1:1); A-Tab; Anhydrous Emcompress; Bekapress; Biofos; Calcium acid phosphate; Calcium dibasic phosphate; Calcium hydrogen orthophosphate; Calcium hydrogen phosphate (CaHPO4); Calcium

CALCIUM HYDROXIDE
CAS:1305-62-0
Formula: Ca(OH)2
95%
1305-62-0
BTTE; Biocalc; Cal-Z; Calbit; Calbreed; Calcicure; Calcium dihydroxide; Calen; Calvit; Carboxide; Ecolomaster; Kalic; Kalkhydrate; Slaked Lime; Soprocal; Sorbacal SP; Super Microstar; Superia; Tamakalk-Spongiacal; Hydrated lime

CALCIUM IONOPHORE I
CAS:58801-34-6
Formula: C38H72N2O8
95%
58801-34-6
ETH 1001; (17R,18R)-diethyl 13,17,18,22-tetramethyl-14,21-dioxo-16,19-dioxa-13,22-diazatetratriacontane-1,34-dioate; diethyl [R-(R*,R*)]-13,17,18,22-tetramethyl-14,21-dioxo-16,19-dioxa-13,22-diazatetratriacontanedioate; (-)-(R,R)-N,N'-Bis-[

CALCIUM L-LACTATE
CAS:28305-25-1
Formula: 2(C3H5O3).Ca
95%
28305-25-1
Propanoic acid, 2-hydroxy-, calcium salt (2:1), (2S)-; Lactic acid, calcium salt (2:1), L-; Propanoic acid, 2-hydroxy-, calcium salt (2:1), (S)-; (S)-(+)-2-Hydroxypropanoic acid hemicalcium salt; L-Lactic acid hemicalcium salt

CALCIUM L-THREONATE
CAS:70753-61-6
Formula: C8H14CaO10
70753-61-6
L-Threonic acid calcium salt; (2R, 3S)-2,3,4-Trihydroxbutyric acid hemicalcium salt

CALCIUM LACTATE
CAS:5743-48-6
Formula: C3H6O3.xCa
95%
5743-48-6
Propanoic acid, 2-hydroxy-, calcium salt (1:x); Lactic acid, calcium salt; Propanoic acid, 2-hydroxy-, calcium salt

Calcium lactate (1:2)
CAS:814-80-2
Formula: 2(C3H5O3).Ca
GëÑ98%
814-80-2
Calcium dilactate; Hemicalcium L-lactate; Propanoic acid, 2-hydroxy-, calcium salt (2:1); Calcium 2-hydroxypropanoate (1:2); calcium DL-lactate; 2-Hydroxypropanoic acid calcium salt; Lactic acid, calcium salt (2:1); Calcium lactate; Calphos

CALCIUM LACTATE GLUCONATE
CAS:11116-97-5
Formula: (C3H5O3)2Ca (C6H11O7)2Ca
11116-97-5
(Gluconato)(lactato)calcium

CALCIUM LACTATE HYDRATE
CAS:41372-22-9
Formula: C3H6O3.(1/2Ca).xH2O
GëÑ85%
41372-22-9
2-Hydroxypropanoic acid calcium salt, hydrate; Calcium lactate,hydrate; calcium 2-hydroxypropanoate hydrate; Propanoic acid, 2-hydroxy-, calcium salt, hydrate (2:1:x)

CALCIUM LACTATE PENTAHYDRATE
CAS:5743-47-5
Formula: C6H20CaO11
GëÑ98%
5743-47-5
Lactic Acid Calcium Salt (2:1) Pentahydrate; Propanoic Acid 2-Hydroxycalcium Salt Pentahydrate; Puracal DC

CALCIUM LACTOBIONATE
CAS:5001-51-4
Formula: C24H42CaO24
5001-51-4
4-O-b-D-Galactopyranosyl-D-gluconic acid calcium salt; Calcium galactogluconate

CALCIUM LEVOFOLINATE
CAS:80433-71-2
Formula: C20H21CaN7O7
>98%
80433-71-2
Saponins

CALCIUM LEVOMEFOLATE
CAS:151533-22-1
Formula: C20H23N7O6.Ca
>98%
B0084-084644
Levomefolate calcium

CALCIUM N5-METHYLTETRAHYDROFOLATE
CAS:26560-38-3
Formula: C20H23CaN7O6
>98%
B0084-177400
Calcium methyltetrahydrofolate; NSC 173328; NSC-173328; NSC173328

CALCIUM NITRATE-[15N2] TETRAHYDRATE
Formula: CaH8[15N]2O10
10% atom 15N
BLP-000128
Calcium nitrate-15N2 tetrahydrate

CALCIUM ORANGE AM
CAS:172646-19-4
Formula: C59H62N6O21S
172646-19-4

CALCIUM OXIDE
CAS:73018-51-6
Formula: CaO
73018-51-6
Lime Oxide

Calcium pantothenate EP Impurity H
Formula: C10H17NO5
3-[(5+P)-5-(1-hydroxy-2-methylpropan-2-yl)-4-oxo-1,3-oxazolidin-3-yl]propanoic acid; Pantothenic Acid EP Impurity H; Calcium pantothenate Impurity H; Pantothenic Acid Impurity H

CALCIUM PHOSPHATE
CAS:10103-46-5
Formula: Ca.xH3O4P
95%
10103-46-5
Phosphoric acid, calcium salt (1:x); Phosphoric acid, calcium salt; Budal MW 500; Calcium phosphate; Crodax DP 30; Dikal 21; Dynafos; E 341; Halox 430; HAP 05NP; HAP 60NPG; KDV 15u; LF-CP-ZA; Man-Gill 51504; Mecahl P; Mekaru P; Osteon GBC03

Calcium phosphate (3:2)
CAS:7758-87-4
Formula: Ca3O8P2
GëÑ95%
B0001-308437
Phosphoric acid, calcium salt (2:3); Allogran-R; Bonarka; Calciresorb; Calcium orthophosphate (Ca3(PO4)2); Calcium phosphate; Calcium phosphate (Ca1.5(PO4)); Calcium phosphate (Ca10.5(PO4)7); Calcium tertiary phosphate; Cerasorb; Cerasorb C

CALCIUM PHOSPHATE DIBASIC DIHYDRATE
CAS:7789-77-7
Formula: H5CaO6P
GëÑ95%
7789-77-7
calcium hydrogenphosphate dihydrate; Calcium hydrogen phosphate dihydrate; Dicalcium phosphate dihydrate; Calcium monohydrogen phosphate dihydrate; Dibasic Calcium Phosphate Dihydrate; Phosphoric acid, calcium salt (1:1), dihydrate; Calcium

Calcium phosphate dihydrate
CAS:14567-92-1
Formula: CaHO4P.2H2O
GëÑ95%
14567-92-1
Brushite (Ca(HPO4).2H2O); Brushite; Calcium phosphate hydrate (1:1:2); Calcium hydrogenphosphate dihydrate; Calcium monohydrogen phosphate dihydrate; Calcium phosphate dibasic dihydrate

CALCIUM PHOSPHATE, TRIBASIC
CAS:12167-74-7
Formula: HCa5O13P3
12167-74-7
Hydroxyapatite; Tribasic calcium phosphate; Calcium hydroxyapatite; Calcium hydroxide phosphate; calcium hydroxide tris(phosphate)

CALCIUM POLYCARBOPHIL
CAS:126040-58-2
95%
126040-58-2
Calcium polycarbophil; Colonel

CALCIUM POLYSTYRENE SULFONATE
CAS:37286-92-3
Formula: (C8H8CaO3S)n
Calcium: 7.0-9.0%
B2699-019837
styrenesulfonic acid homopolymer, calcium salt; Calcium polystyrenesulfonate; Poly(styrenesulfonic acid) calcium salt; Benzenesulfonic acid, ethenyl-, homopolymer, calcium salt

CALCIUM PROPIONATE
CAS:4075-81-4
Formula: C6H10CaO4
> 95 %
4075-81-4
calcium;propanoate

CALCIUM SACCHARATE
CAS:5793-88-4
Formula: C6H8CaO8
5793-88-4
D-Saccharic acid calcium salt

CALCIUM SILICATE
CAS:1344-95-2
95%
1344-95-2
Silicic acid, calcium salt; Advacate; Calcium hydrosilicate; Calcium monosilicate; Calcium polysilicate; Calsil; Calsilite; Ecolux; Florite; Silasorb (celite); Taikalit; Taikalite; Zeodent 250

Calcium silicate (1:1)
CAS:10101-39-0
Formula: CaO3Si
99%
10101-39-0
Silicic acid (H2SiO3), calcium salt (1:1); Baysical K; C.I. 77230; C.I. Pigment White 28; Calcium metasilicate; Calcium silicate (Ca0.5(SiO3)0.5); Calcium silicate (Ca2(SiO3)2); Calcium silicate (CaSiO3); Calcium silicon oxide (CaSiO3); Cas

CALCIUM STEARATE
CAS:1592-23-0
Formula: C36H70CaO4
99%
1592-23-0
Octadecanoic acid, calcium salt (2:1); Stearic Acid Calcium Salt; 1097AH; 15F; 15F (stabilizer); AFCO-Chem CS; Adekafin; Efukodesupa C; Afco-Disper C; Aquacal; Aulabrite CA 65; BD 853; BS 3818; Baerlocher 5862; C 104HS; CP-S; CS 1; CS 1 (so

CALCIUM SULFATE
CAS:7778-18-9
Formula: CaO4S
GëÑ96%
7778-18-9
Basic Calcium Sulfate; Calcium Sulphate; Calmatrix; Capset; Crysalba; Drierite; E 541; Franklin Fiber H 45; Osteoset; Sulfuric acid Calcium Salt; SurgiPlaster; Thiolite

CALCIUM SULFATE DIHYDRATE
CAS:10101-41-4
Formula: CaSO4.2H2O
10101-41-4
Sulfuric Acid Calcium Salt (1:1) Dihydrate; Gypsum Dihydrate

CALCIUM THIOSULFATE
CAS:10124-41-1
Formula: CaS2O3
98%
10124-41-1
calcium thiosulphate; Thiosulfuric acid (H2S2O3), calcium salt (1:1); Calcium thiosulfate hexahydrate.; calcium hyposulfite; calcium thiosulfate [ca(s2o3)]; tecesal; thiosulfuric acid, calcium salt; Calcium thiosulfate, 50% solution

Calcium trinatrium diethylenetriaminepentaacetic acid hydrate
CAS:207226-35-5
Formula: C14H18CaN3Na3O10.xH2O
GëÑ95%
207226-35-5
Ca-DTPA trisodium salt hydrate; Diethylenetriamine-pentaacetic Acid Calcium Trisodium Salt hydrate; Calcium sodium 2,2',2'',2''',2''''-(1,2-ethanediylnitrilo)pentaacetate hydrate (1:3:1:x)

CALCIUM(II) ACETYLACETONATE
CAS:19372-44-2
Formula: C10H14O4Ca
BB015013
calcium;(Z)-4-oxo-2-penten-2-olate; calcium;(Z)-4-oxopent-2-en-2-olate

CALCIUM(II) BIS(TRIFLUOROMETHANESULFONIMIDE)
CAS:165324-09-4
Formula: C4CaF12N2O8S4
> 97.0 % (T)
BB012181
calcium;bis(trifluoromethylsulfonyl)azanide

CALCIUM-D-ARABONATE
CAS:22373-09-7
Formula: C10H18CaO12
22373-09-7
Calcium arabinoate; Arabinonic acid, Ca salt; D-Arabinonic acid, calcium salt (2:1)

CALCIUM-L(-)-ARABONATE TETRAHYDRATE
Formula: C10H26CaO16
L(-)-Arabonic acid calcium salt

CALCIUM-SENSING RECEPTOR ANTAGONISTS I
CAS:478963-79-0
Formula: C23H24N2O2
>98%
478963-79-0
2(1H)-Quinazolinone, 1-(1-methylethyl)-4-[4-(1-methylethyl)phenyl]-6-(2-propyn-1-yloxy)-

CALDARET
CAS:133804-44-1
Formula: C11H16N2O3S
95%
133804-44-1
Benzenesulfonic acid, 5-methyl-2-(1-piperazinyl)-; MCC 135; 2-(1-piperazinyl)-5-methylbenzenesulfonic acid

CALDARIOMYCIN
CAS:465-61-2
Formula: C5H8Cl2O2
BBF-00203

Calendoflavobioside 5-O-glucoside
CAS:1309795-36-5
Formula: C33H40O21
97.5%
NP2203
Quercetin 3-O-neohesperidoside 5-O-glucoside

CALENDULA EXTRACT
CAS:84776-23-8
Formula: C40H56O2
5%-20%; 10:1
84776-23-8
Calendula Officinalis Extract

CALENDULA OFFICINALIS OIL
CAS:70892-20-5
95%
70892-20-5
Calendula officinalis flower oil

CALENDULADIOL
CAS:10070-48-1
Formula: C30H50O2
98%
BBF-04866
Calendula

Calendulaglycoside C
CAS:26020-29-1
Formula: C48H76O19
26020-29-1
Calenduloside H; beta-D-Glucopyranosiduronic acid, (3beta)-28-(beta-D-glucopyranosyloxy)-28-oxoolean-12-en-3-yl 3-o-beta-D-galactopyranosyl-

CALENDULOSIDE E
CAS:26020-14-4
Formula: C36H56O9
>98%
NP7054
Silphioside F; Glycoside St-E; Polysciasaponin P7; Momordin Ib; (4bS,5R,10bS,11R)-5,6,11,12-Tetrahydro-13,18-dimethyl-5,10b:11,4b-Bis(iminoethano)dibenzo[c,h][2,6]naphthyridine; (+)-Calycanthine; 5,6,11,12-tetrahydro-13,18-dimethyl-, [4bS-(

CALEOCHROMENE A
CAS:24672-84-2
Formula: C13H14O3
BB062281
Desmethylisoencecalin;1-(5-Hydroxy-2,2-dimethyl-2H-1-benzopyran-6-yl)ethanone;1-(5-Hydroxy-2,2-dimethyl-2H-chromen-6-yl)ethan-1-one;6-Acetyl-5-hydroxy-2,2-dimethyl-2H-chromene;6-Acetyl-5-hydroxy-2,2-dimethylchromene

CalFluor 555 Azide
CAS:1798305-99-3
Formula: C41H60N7O11S2
95%
F04-0009

CALHEX 231
CAS:652973-93-8
Formula: C25H27ClN2O
GëÑ98% by HPLC
652973-93-8
Calhex231; Calhex-231; Benzamide, 4-chloro-N-[(1S,2S)-2-[[(1R)-1-(1-naphthalenyl)ethyl]amino]cyclohexyl]-

CALICHEAMICIN
CAS:108212-75-5
Formula: C55H74IN3O21S4
GëÑ95% by HPLC
BBF-00597
calicheamicin +¦1

CALINDOL AMIDE-[13C]
CAS:1217782-43-8
Formula: C20[13C]H18N2O
98% (CP); 98% atom 13C
BLP-002133
(R)-N-[1-(1-Naphthyl)ethyl]indole-2-carboxamide-13C; N-[(1R)-1-(1-Naphthalenyl)ethyl]-1H-Indole-2-carboxamide-13C; Calindol Amide 13C

CALINDOL HYDROCHLORIDE
CAS:729610-18-8
Formula: C21H20N2-+HCl
GëÑ98%
729610-18-8
Calindol

CALINDOL-[13C,D2] HYDROCHLORIDE
CAS:1217828-76-6
Formula: C20[13C]H19D2ClN2
> 98%
BLP-002132
N-[(1R)-1-(1-Naphthalenyl)ethyl]-1H-indole-2-(methan-13C,d2)amine Hydrochloride; (R)-2-[[[1-(1-Naphthyl)ethyl]amino]methyl-13C,d2]-1H-indole Hydrochloride; Calindol 13C,d2 Hydrochloride

Callinectin
BAT-013604

Callosin
CAS:166197-43-9
Formula: C16H16O4
98%
NP5381
Callosin; 166197-43-9; AKOS040763202

CALLOSOBRUCHUSIC ACID
CAS:87172-91-6
Formula: C10H16O4
>95% by HPLC
BBF-04676
R-(-)-Callosobruchusic Acid

CALMIDAZOLIUM CHLORIDE
CAS:57265-65-3
Formula: C31H23Cl7N2O
GëÑ98% by HPLC
57265-65-3
1-[Bis(4-chlorophenyl)methyl]-3-[2-(2,4-dichlorophenyl)-2-(2,4-dichlorobenzyloxy)ethyl]-1H-imidazolium chloride

CALMODULIN (58-70)
BAT-009496

Calmodulin antagonist-1
CAS:78957-84-3
Formula: C14H18Cl2N2O2S
GëÑ95%
78957-84-3
N-(4-Aminobutyl)-5-chloro-1-naphthalenesulfonamide Hydrochloride; W8 Hydrochloride; N-(4-Aminobutyl)-5-chloro-1-naphthalenesulfonamide Monohydrochloride

CALMODULIN BINDING PEPTIDE 1
CAS:104041-80-7
Formula: C231H373N69O70S2
GëÑ95%
BAT-009345
Gly-Val-Met-Pro-Arg-Glu-Glu-Thr-Asp-Ser-Lys-Thr-Ala-Ser-Pro-Trp-Lys-Ser-Ala-Arg-Leu-Met-Val-His-Thr-Val-Ala-Thr-Phe-Asn-Ser-Ile-Lys-Glu-Leu-Asn-Glu-Arg-Trp-Arg-Ser-Leu-Gln-Gln-Leu-Ala

CALMODULIN-DEPENDENT PROTEIN KINASE II (290-309) TRIFLUOROACETATE SALT
Formula: C103H185N31O24S-+xCF3COOH
GëÑ95%

CALMODULIN-DEPENDENT PROTEIN KINASE II 281-309
CAS:116826-37-0
Formula: C146H254N46O39S3
GëÑ95%
BAT-009346
Met-His-Arg-Gln-Glu-Thr-Val-Asp-Cys-Leu-Lys-Lys-Phe-Asn-Ala-Arg-Arg-Lys-Leu-Lys-Gly-Ala-Ile-Leu-Thr-Thr-Met-Leu-Ala; CAM-kinase II 281-309

CALMODULIN-DEPENDENT PROTEIN KINASE II 290-309
CAS:115044-69-4
Formula: C103H185N31O24S
GëÑ97% by HPLC
BAT-010622
Leu-Lys-Lys-Phe-Asn-Ala-Arg-Arg-Lys-Leu-Lys-Gly-Ala-Ile-Leu-Thr-Thr-Met-Leu-Ala; L-leucyl-L-lysyl-L-lysyl-L-phenylalanyl-L-asparagyl-L-alanyl-L-arginyl-L-arginyl-L-lysyl-L-leucyl-L-lysyl-glycyl-L-alanyl-L-isoleucyl-L-leucyl-L-threonyl-L-thr

Calophyllic acid
CAS:36626-19-4
Formula: C25H24O6
97%
NP5102

CALOPOROSIDE
CAS:160471-36-3
Formula: C40H64O17
BBF-02001
2-O-Acetyl-5-O-(2-O-acetylhexopyranosyl)-2-C-[17-(2-carboxy-3-hydroxyphenyl)heptadecan-2-yl]hexonic acid; D-Mannonic acid, 5-O-(2-O-acetyl-beta-D-mannopyranosyl)-, 16-(2-carboxy-3-hydroxyphenyl)-1-methylhexadecyl ester, 2-acetate, (R)-

Caloxanthone B
CAS:155233-17-3
Formula: C24H26O6
98%
NP7294
Caloxanthone B; 155233-17-3

CALOXIN 2A1
CAS:350670-85-8
Formula: C64H91N19O22
GëÑ95%
BAT-014688
H-Val-Ser-Asn-Ser-Asn-Trp-Pro-Ser-Phe-Pro-Ser-Ser-Gly-Gly-Gly-NH2; L-valyl-L-seryl-L-asparagyl-L-seryl-L-asparagyl-L-tryptophyl-L-prolyl-L-seryl-L-phenylalanyl-L-prolyl-L-seryl-L-seryl-glycyl-glycyl-glycinamide; Glycinamide, L-valyl-L-seryl

Caloxin 2A1 TFA
Formula: C66H92F3N19O24

CALP1
CAS:145224-99-3
Formula: C40H75N9O10
145224-99-3
Calcium-like peptide 1

CALP1 acetate
Formula: C42H79N9O12
Calcium-like peptide 1 acetate

CALP1 TFA
Formula: C42H76F3N9O12
L-valyl-L-alanyl-L-isoleucyl-L-threonyl-L-valyl-L-leucyl-L-valyl-L-lysine,trifluoroacetatesalt

CALP1 TRIFLUOROACETATE SALT
Formula: C40H75N9O10-+xCF3COOH
GëÑ95%
Calcium-like peptide 1

CALP2
CAS:261969-04-4
Formula: C68H104N14O13S
BAT-010725
Calcium-like peptide 2

CALP3
CAS:261969-05-5
Formula: C44H68N10O9
BAT-010124
Calcium-Like Peptide 3

CALP3 acetate
Formula: C46H72N10O11
GëÑ95%
BAT-016421
H-Val-Lys-Phe-Gly-Val-Gly-Phe-Lys-OH.CH3CO2H; L-valyl-L-lysyl-L-phenylalanyl-glycyl-L-valyl-glycyl-L-phenylalanyl-L-lysine acetic acid; CALP 3 acetate; CALP-3 acetate; Calcium-like peptide 3 acetate

CALP3 TRIFLUOROACETATE SALT
Formula: C46H69F3N10O11
GëÑ98%
BAT-016422
H-Val-Lys-Phe-Gly-Val-Gly-Phe-Lys-OH.TFA; L-valyl-L-lysyl-L-phenylalanyl-glycyl-L-valyl-glycyl-L-phenylalanyl-L-lysine trifluoroacetate; CALP 3 trifluoroacetate; CALP-3 trifluoroacetate; CALP3 TFA; CALP 3 TFA; CALP-3 TFA; Calcium-like pepti

CALPAIN INHIBITOR I
CAS:110044-82-1
Formula: C20H37N3O4
98 %
110044-82-1
(S)-N-Acetyl-L-leucyl-N-(1-formylpentyl)-L-leucinamide; ALLN; ALLnL; CI-1 (peptide); Calp I; Calpain inhibitor I; MG 101; (S)-N-Acetyl-L-leucinyl-L-leucinyl-L-norleucinal; MG-101

CALPAIN INHIBITOR II
CAS:110115-07-6
Formula: C19H35N3O4S
GëÑ98%
110115-07-6
L-Leucinamide, N-acetyl-L-leucyl-N-[(1S)-1-formyl-3-(methylthio)propyl]-; L-Leucinamide, N-acetyl-L-leucyl-N-[1-formyl-3-(methylthio)propyl]-, (S)-; N-Acetyl-L-leucyl-N-[(1S)-1-formyl-3-(methylthio)propyl]-L-leucinamide; ALLM; Calp II; CI 2

CALPAIN INHIBITOR VI
CAS:190274-53-4
Formula: C17H25FN2O4S
GëÑ95%
190274-53-4
SJA 6017

CALPAIN INHIBITOR XII
CAS:181769-57-3
Formula: C26H34N4O5
GëÑ90%
181769-57-3
Z-L-Nva-CONH-CH2-2-Py

CALPEPTIN
CAS:117591-20-5
Formula: C20H30N2O4
>98%
B2693-161534
Benzylcarbonyl-leu-nleu-H; Cbz-Leu-Nle-al

CALPHOSTIN A
CAS:120461-92-9
Formula: C44H38O12
BBF-00204

CALPHOSTIN B
CAS:124824-06-2
Formula: C37H34O11
BBF-00205

CALPHOSTIN C
CAS:121263-19-2
Formula: C44H38O14
>95% by HPLC
BBF-00598
UCN 1028 C, PKF 115-384

CALPHOSTIN D
CAS:124986-26-1
Formula: C30H30O10
BBF-00206
Phleichrome

CALTERIDOL
CAS:120041-08-9
Formula: C17H32N4O7
95%
120041-08-9
calteridol; CHEBI:37387; 1,4,7,10-Tetraazacyclododecane-1,4,7-triaceticacid,10-(2-hydroxypropyl)-; 2,2',2'-[10-(2-hydroxypropyl)-1,4,7,10-tetraazacyclododecane-1,4,7-triyl]triacetic acid; ACMC-20mop4

CALVATIC ACID
CAS:54723-08-9
Formula: C8H5N3O3
BBF-00599
p-Carboxyphenylazoxycyanide; Benzoic acid, 4-(cyano-NNO-azoxy)-

CALYCANTHINE
CAS:595-05-1
Formula: C22H26N4
>98%
NP0083
(1S,2R,10S,11R)-21,24-dimethyl-3,12,21,24-tetraazahexacyclo[9.7.3.3(2,10).0(1,10).0(4,9).0(13,18)]tetracosa-4,6,8,13,15,17-hexaene; (4bS,5R,10bS,11R)-13,18-dimethyl-5,6,11,12-tetrahydro-5,10b:11,4b-di(epiminoethano)dibenzo[c,h]-2,6-naphthyr

CALYCANTHOSIDE
CAS:483-91-0
Formula: C17H20O10
98.5%
NP1082
Isofraxidin 7-O-+¦-D-glucopyranoside; 6,8-Dimethoxy-7-(beta-D-glucopyranosyloxy)coumarin; 7-(beta-D-Glucopyranosyloxy)-6,8-dimethoxy-2H-1-benzopyran-2-one

CALYCIN
CAS:10091-92-6
Formula: C18H10O5
BBF-04867
Calycine; Oxypulvic acid lactone; 3-(3-Hydroxy-5-oxo-4-phenyl-2(5H)-furylidene)-2(3H)-benzofuranone

CALYCIPHYLLINE A
CAS:596799-30-3
Formula: C23H31NO4
98.5%
NP0367
Methyl (1R,2S,3R,5R,6S,8R,10S,16R,17R)-2,6-dimethyl-20-oxo-8-azahexacyclo[11.5.1.11,5.02,10.03,8.016,19]icos-13(19)-ene-17-carboxylate 8-oxide

CALYCOSIN
CAS:20575-57-9
Formula: C16H12O5
0.99
NP1831
7,3'-DIHYDROXY-4'-METHOXYISOFLAVONE;3'-HYDROXYFORMONONETIN;3',7-DIHYDROXY-4'-METHOXYISOFLAVONE;3-(3-Hydroxy-4-methoxyphenyl)-7-hydroxy-4H-1-benzopyran-4-one;7-Hydroxy-3-(3-hydroxy-4-methoxyphenyl)-4H-1-benzopyran-4-one;

Calycosin 7-O-+¦-D-glucopyranoside
CAS:20633-67-4
Formula: C22H22O10
>98%
NP1930
calycosin-7-O-beta-D-glucopyranoside; Calycosin 7-o-beta-D-glucoside; Calycosin-7-O-beta-D-glucoside; Calycosin 7-O-gluc

Calycosin 7-O-xylosylglucoside
CAS:224957-12-4
Formula: C27H30O14
98.0%
NP2432

CALYCULIN A
CAS:101932-71-2
Formula: C50H81N4O15P
>98 %
101932-71-2
CALYCULIN A;CALYCULIN A, DISCODERMIA CALYX;calyculin A from discodermia calyx;CALYCULIN A FROM DISCODERMIA CALYX, 10 U G;N-[(3S)-[4-(1E)-3-[(2R,3R,4R,7S,8S,9R)-2-[(1S,3S,4S,5R,7E,9E,11E,13Z)-14-Cyano-3,5-dihydroxy-1-methoxy-4,6,8,9,13-penta

CALYSTEGINE A3
CAS:131580-36-4
Formula: C7H13NO3
GëÑ95%
131580-36-4
[1R-(2-endo,3-exo)]-8-Azabicyclo[3.2.1]octane-1,2,3-triol; (+)-Calystegine A3; 8-Azabicyclo[3.2.1]octane-1,2,3-triol, (1R,2S,3R,5R)-

CALYSTEGINE A5
CAS:165905-26-0
Formula: C7H13NO3
165905-26-0
Calystegin A5; 8-Azabicyclo(3.2.1)octane-1,3,4-triol, (1R,3S,4S,5R)-

CALYSTEGINE B1
CAS:127414-86-2
Formula: C7H13NO4
127414-86-2
Calystegine B(1); 8-azabicyclo[3.2.1]octane-1,2,3,6-tetrol; 8-Azabicyclo(3.2.1)octane-1,2,3,6-tetrol, (1R,2S,3R,5S,6R)-rel-

CALYSTEGINE B2
CAS:127414-85-1
Formula: C7H13NO4
127414-85-1
Nortropanoline; 8-Aza-bicyclo[3.2.1]octane-1,2,3,4-tetraol

CALYSTEGINE B3
CAS:178231-95-3
Formula: C7H13NO4
>98%
178231-95-3
8-Azabicyclo(3.2.1)octane-1,2,3,4-tetrol, (1R,2R,3R,4S,5R)-; 2-Epicalystegine B2; (+)-Calystegine B3; (1R,5R)-8-Azabicyclo[3.2.1]octane-1,2alpha,3alpha,4beta-tetrol; Calystegin B3; 8-Azabicyclo(3.2.1)octane-1,2,3,4-tetrol, (2-exo,3-exo,4-en

CALYSTEGINE B4
CAS:184046-85-3
Formula: C7H13NO4
184046-85-3
8-Azabicyclo(3.2.1)octane-1,2,3,4-tetrol, (1R,2S,3R,4R,5R)-; 8-Azabicyclo[3.2.1]octane-1,2,3,4-tetrol, (1R,2S,3R,4R,5R)-; (-)-Calystegine B4; 8-Azabicyclo[3.2.1]octane-1,2,3,4-tetrol, (2-endo,3-exo,4-exo)-(-)-

CALYSTEGINE N1
CAS:177794-03-5
Formula: C7H14N2O3
177794-03-5

CALYXAMINE B
CAS:150710-72-8
Formula: C12H21NO
>98%
NP0410
1-(2,2,6,6-Tetramethyl-4-piperidinylidene)acetone

CALYXIN B
CAS:164991-53-1
Formula: C35H34O8
9%
NP0944
2-Propen-1-one, 1-[2,4-dihydroxy-3-[(1S,2E,5S)-5-hydroxy-1,7-bis(4-hydroxyphenyl)-2-hepten-1-yl]-6-methoxyphenyl]-3-(4-hydroxyphenyl)-, (2E)-

CALYXIN H
CAS:202596-22-3
Formula: C35H34O7
0.99
NP0951
(E)-1-[2,4-dihydroxy-3-[(E,1S,5S)-5-hydroxy-1-(4-hydroxyphenyl)-7-phenylhept-2-enyl]-6-methoxyphenyl]-3-(4-hydroxyphenyl)prop-2-en-1-one

CAM KINASE II INHIBITOR TFA SALT
Formula: C66H117F3N22O21

CAM-IN-1
CAS:251994-14-6
Formula: C15H11BrN2O2S
251994-14-6
Thieno[2,3-c]pyridine-2-carboxamide, 4-(4-bromophenoxy)-N-methyl-

CAMALDULENIC ACID
CAS:71850-15-2
Formula: C30H46O4
98.0%
NP6535
Camaldulenic acid;Dehydromaslinic acid;Oleana-11,13(18)-dien-28-oic acid, 2,3-dihydroxy-, (2+¦,3+¦)-

CAMALEXIN
CAS:135531-86-1
Formula: C11H8N2S
98%
B2703-383248
3-(1,3-thiazol-2-yl)-1H-indole; 3-(thiazol-2-yl)indole

CAMARIC ACID
CAS:146450-83-1
Formula: C35H52O6
>95%
NP6680
(+)-22beta-(Angeloyloxy)lantanolic acid

CAMBENDAZOLE
CAS:26097-80-3
Formula: C14H14N4O2S
26097-80-3
(2-Thiazol-4-yl-1H-benzimidazol-5-yl)-carbamic acid isopropyl ester

Cambendazole-[d7]
CAS:1228182-48-6
Formula: C14H7D7N4O2S
95% by HPLC; 98% atom D
BLP-011725
Cambendazole-D7; (2-Thiazol-4-yl-1H-benzimidazol-5-yl)-carbamic acid isopropyl-D7 ester; 2-(4-Thiazolyl)-5-benzimidazolecarbamic Acid-d7 Isopropyl Ester; [2-(4-Thiazolyl)-1H-benzimidazol-5-yl]carbamic Acid-d7 1-Methylethyl Ester; 2-(4-Thiaz

CAMBINOL
CAS:14513-15-6
Formula: C21H16N2O2S
14513-15-6
2,3-dihydro-5-[(2-hydroxy-1-naphthalenyl)methyl]-6-phenyl-2-thioxo-4(1H)-pyrimidinone; Cambinol; NSC 112546; SIRT1 Inhibitor II; SIRT2 Inhibitor VI; SIRT 1/2 inhibitor IV; NSC112546; NSC-112546; NSC 112546

CAMELLIANIN A
CAS:109232-77-1
Formula: C29H32O15
GëÑ95%
109232-77-1
4H-1-Benzopyran-4-one, 5-[[6-O-acetyl-4-O-(6-deoxy-+¦-L-mannopyranosyl)-+¦-D-glucopyranosyl]oxy]-7-hydroxy-2-(4-hydroxyphenyl)-; 5-[[6-O-Acetyl-4-O-(6-deoxy-+¦-L-mannopyranosyl)-+¦-D-glucopyranosyl]oxy]-7-hydroxy-2-(4-hydroxyphenyl)-4H-1-benzop

CAMELLIANIN B
CAS:109232-76-0
Formula: C27H30O14
98%
109232-76-0
Camellianin B; 109232-76-0; 5-[(2S,3R,4R,5S,6R)-3,4-dihydroxy-6-(hydroxymethyl)-5-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-7-hydroxy-2-(4-hydroxyphenyl)chromen-4-one; DTXSID00148850; HY-N9314; AKOS032945742; CS-

CAMELLIASIDE A
CAS:135095-52-2
Formula: C33H40O20
98%
135095-52-2
4H-1-Benzopyran-4-one, 3-[(O-6-deoxy-+¦-L-mannopyranosyl-(1GåÆ6)-O-[+¦-D-galactopyranosyl-(1GåÆ2)]-+¦-D-glucopyranosyl)oxy]-5,7-dihydroxy-2-(4-hydroxyphenyl)-; 3-[(O-6-Deoxy-+¦-L-mannopyranosyl-(1GåÆ6)-O-[+¦-D-galactopyranosyl-(1GåÆ2)]-+¦-D-glucopyranosy

CAMELLIASIDE B
CAS:131573-90-5
Formula: C32H38O19
B2703-002880
3-(((2S,3R,4S,5S,6R)-4,5-Dihydroxy-6-((((2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)methyl)-3-(((2S,3R,4S,5R)-3,4,5-trihydroxytetrahydro-2H-pyran-2-yl)oxy)tetrahydro-2H-pyran-2-yl)oxy)-5,7-dihydroxy-2-(4-hydroxyph

CAMIDANLUMAB
CAS:921618-45-3
921618-45-3
HuMax-TAC

Camizestrant
CAS:2222844-89-3
Formula: C24H28F4N6
GëÑ98%
2222844-89-3
N-[1-(3-fluoropropyl)azetidin-3-yl]-6-[(6S,8R)-8-methyl-7-(2,2,2-trifluoroethyl)-6,7,8,9-tetrahydro-3H-pyrazolo[4,3-f]isoquinolin-6-yl]pyridin-3-amine; Estrogen receptor antagonist 2; AZD-9833; AZD 9833; AZD9833; NSC-828717; N-[1-(3-Fluorop

CAMKII-IN-1
CAS:1208123-85-6
Formula: C29H30ClN5O2S
>98%
1208123-85-6
CaMKII-IN-1; CaMKII; CaMKII IN-1; CaMKII IN 1; CaMKII-IN 1.

CAMKP INHIBITOR
CAS:52789-62-5
Formula: C10H8NNaO7S2
GëÑ95%
52789-62-5
1,3-Naphthalenedisulfonic acid, 4-amino-5-hydroxy-, sodium salt (1:1); 1,3-Naphthalenedisulfonic acid, 4-amino-5-hydroxy-, monosodium salt; 8-Amino-1-naphthol-5,7-disulfonic acid monosodium salt

Camlipixant
CAS:1621164-74-6
1621164-74-6

CAMOSTAT MESYLATE
CAS:59721-29-8
Formula: C20H22N4O5.CH4O3S
>98%
B2693-072632
4-(2-(2-(dimethylamino)-2-oxoethoxy)-2-oxoethyl)phenyl 4-guanidinobenzoate methanesulfonate; Camostat Mesilate; Camostat Mesylate; FOY 305; FOY-305; FOY305

CAMP-AM
CAS:159764-93-9
Formula: C13H16O8N5P
GëÑ 97% by HPLC for mixture of isomers
159764-93-9
Adenosine- 3', 5'- monophosphate, acetoxymethyl ester

CAMP-BN
CAS:62742-71-6
Formula: C17H18N5O6P
GëÑ 95% by HPLC for mixture of isomers
62742-71-6
Adenosine- 3', 5'- monophosphate, benzyl ester

CAMPESTANOL
CAS:474-60-2
Formula: C28H50O
>99%
474-60-2
5alpha-campestan-3beta-ol; 5a-campestan-3b-ol; Ergostanol; 24beta-Ethylcholestanol; (24R)-5+¦-Ergostan-3+¦-ol

CAMPESTANOL O-(4-METHYLBENZOATE)
Formula: C36H56O2
BB070663

CAMPESTANOL-[D7]
Formula: C28H43D7O
98%; GëÑ98% atom D
BLP-007906
5+¦-Cholestan-24(RS)-methyl-3+¦-ol-25,26,26,26,27,27,27-d7; (3+¦,5+¦,24R)-Ergostan-3-ol-d7; 24+¦-Ethylcholestanol-d7; Campestanol-d7; 24+¦-Methylcholestanol-d7; 5+¦-Dihydrocampesterol-d7; Chalinastanol-d7; Dihydro-Neospongosterol-d7

CAMPESTEROL
CAS:474-62-4
Formula: C28H48O
>98%
B0005-118922
Campest-5-en-3beta-ol; Ergost-5-en-3beta-ol, (24R)-; Ergost-5-en-3-ol, (3beta,24R)-; 24+¦-Methyl-5-cholesten-3+¦-ol

CAMPESTEROL-[D3]
Formula: C28H45D3O
GëÑ98%
BLP-007907
5-Cholesten-24(RS)-methyl-d3-3+¦-ol; Campesterol-d3; (3+¦,24R)-Ergost-5-en-3-ol-d3; Campesterin-d3; (24alpha)-Methylcholest-5-en-3+¦-ol-d3; 24+¦-Methyl-5-cholesten-3+¦-ol-d3; 24+¦-Methylcholesterol-d3

Campesterol-[d6]
CAS:2260669-13-2
Formula: C28H42D6O
>99%
BLP-011256
campesterol-d6; 26,27-hexadeuteriocampest-5-en-3+¦-ol; Campest-5-en-3beta-ol-d6; Ergost-5-en-3-beta-ol-d6; (3+¦,24R)-Ergost-5-en-3-ol-d6; Campesterin-d6; (24R)-Methylcholest-5-en-3+¦-ol-d6; 24(R)-Methylcholesterol-d6; 24+¦-Methyl-5-cholesten-3+¦

CAMPESTEROL-[D7]
Formula: C28H41D7O
98% by CP; 98% atom D
BLP-007239
campesterol D7

CAMPHOR
CAS:76-22-2
Formula: C10H16O
GëÑ95%
NP4518
Bicyclo[2.2.1]heptan-2-one, 1,7,7-trimethyl-; (-¦)-Camphor; 1,7,7-Trimethylbicyclo[2.2.1]-2-heptanone; 1,7,7-Trimethylnorcamphor; 2-Bornanone; 2-Camphanone; DL-Camphor; Alphanon; Borneo camphor; dl-Camphor; HCXL 8899; MeSH ID: D002164; Racem

Camphor-d6
Formula: C10H16O
GëÑ98% (HPLC)
Camphor-d6|HY-N0808S|CS-0373670

CAMPNEOSIDE I
CAS:95519-12-3
Formula: C30H38O16
95519-12-3

CAMPNEOSIDE II
CAS:95587-86-3
Formula: C29H36O16
98%
95587-86-3
Beta-Hydroxyacteoside

CAMPSIKETALIN
CAS:93675-96-8
Formula: C10H20O4
95.0%
NP4353
Rengyoxide dimethyl ketal; 1-(2-Hydroxyethyl)-4,4-dimethoxycyclohexan-1-ol

CAMPTOTHECIN
CAS:7689-03-4
Formula: C6H14N2O2.ClH
>98%
7689-03-4
camptothecin;7689-03-4;Camptothecine;(S)-(+)-Camptothecin;Campathecin;(+)-Camptothecin;(+)-Camptothecine;d-Camptothecin;20(S)-Camptothecine;21,22-Secocamptothecin-21-oic acid lactone;NSC94600;Camptothecine (S,+);CHEMBL65;(S)-4-ethyl-4-hydro

CAMPTOTHECIN SODIUM
CAS:25387-67-1
Formula: C20H17N2NaO5
GëÑ95%
BBF-04594
20(S)-Camptothecin Sodium Salt; Camptothecine Sodium; NSC 100880; Sodium Camptothecin; (+¦S)-+¦-ethyl-9,11-Dihydro-+¦-hydroxy-8-(hydroxymethyl)-9-oxo-indolizino[1,2-b]quinoline-7-acetic Acid Monosodium Salt; 21,22-Secocamptothecin-21-oic Acid

CAMRELIZUMAB
CAS:1798286-48-2
GëÑ98%
1798286-48-2
Immunoglobulin G4, anti-(cell surface receptor) (human-Mus musculus monoclonal SHR-1210 heavy chain), disulfide with human-Mus musculus monoclonal SHR-1210 light chain, dimer; AiRuiKa; HR 301210; Immunoglobulin G4, anti-(human programmed ce

CAMSTATIN
CAS:1002295-95-5
Formula: C122H203N39O34
GëÑ95% by HPLC
BAT-010314
Camstatin; 1002295-95-5; AKOS024458712; PD078973; S-1002295-95-5

CAMYLOFINE
CAS:54-30-8
Formula: C19H32N2O2
54-30-8
Camylofine; Acamylophenine; Adopon; Avacan; Novospasmin; 3-methylbutyl 2-[2-(diethylamino)ethylamino]-2-phenylacetate

CAMYLOFINE DIHYDROCHLORIDE
CAS:5892-41-1
Formula: C19H34Cl2N2O2
5892-41-1
3-Methylbutyl {[2-(diethylamino)ethyl]amino}(phenyl)acetate dihydrochloride

CANADENSOLIDE
CAS:20421-31-2
Formula: C11H14O4
BBF-00207
(-)-Canadensolide; Furo(3,4-b)furan-2,4-dione, 6-butyltetrahydro-3-methylene-, (3aS,6R,6aR)-; (3aS,6R,6aR)-6-Butyl-3-methylenetetrahydrofuro[3,4-b]furan-2,4-dione

CANADINE
CAS:5096-57-1
Formula: C20H21NO4
98%
NP0142
6H-Benzo[g]-1,3-benzodioxolo[5,6-a]quinolizine, 5,8,13,13a-tetrahydro-9,10-dimethoxy-, (13aS)-; (13aS)-5,8,13,13a-Tetrahydro-9,10-dimethoxy-6H-benzo[g]-1,3-benzodioxolo[5,6-a]quinolizine; 13a+¦-Berbine, 9,10-dimethoxy-2,3-(methylenedioxy)-;

CANAGLIFLOZIN
CAS:842133-18-0
Formula: C24H25FO5S
>98%
NP3628
D-Glucitol, 1,5-anhydro-1-C-[3-[[5-(4-fluorophenyl)-2-thienyl]methyl]-4-methylphenyl]-, (1S)-; JNJ-24831754; TA-7284; JNJ 24831754; TA 7284; JNJ24831754; TA7284; (1S)-1,5-anhydro-1-C-[3-[[5-(4-fluorophenyl)-2-thienyl]methyl]-4-methylphenyl]

CANAGLIFLOZIN 2-GLUCURONIDE
CAS:2648415-15-8
Formula: C30H33FO11S
96%
2648415-15-8
Canagliflozin metabolite M5; (2S,3S,4S,5R,6R)-6-(((2S,3R,4S,5S,6R)-2-(3-((5-(4-Fluorophenyl)thiophen-2-yl)methyl)-4-methylphenyl)-4,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-3-yl)oxy)-3,4,5-trihydroxytetrahydro-2H-pyran-2-carboxylic

CANAGLIFLOZIN 3-GLUCURONIDE
CAS:2648415-13-6
Formula: C30H33FO11S
96%
2648415-13-6
Canagliflozin metabolite M7; (2S,3S,4S,5R,6R)-6-(((2S,3S,4R,5R,6R)-2-(3-((5-(4-Fluorophenyl)thiophen-2-yl)methyl)-4-methylphenyl)-3,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-4-yl)oxy)-3,4,5-trihydroxytetrahydro-2H-pyran-2-carboxylic

Canagliflozin 3-O-+¦-D-glucuronide
Formula: C30H33FO11S
(1S)-1,5-Anhydro-1-C-[3-[[5-(4-fluorophenyl)-2-thienyl]methyl]-4-methylphenyl]-3-O-+¦-D-glucopyranuronosyl-D-glucitol

CANAGLIFLOZIN ALPHA-ISOMER IMPURITY
CAS:1589590-87-3
Formula: C24H25FO5S
GëÑ95%
1589590-87-3
(1R)-1,5-Anhydro-1-[3-[[5-(4-fluorophenyl)thiophen-2-yl]methyl]-4-methylphenyl]-D-glucitol; epi-Canagliflozin; D-Glucitol, 1,5-anhydro-1-C-[3-[[5-(4-fluorophenyl)-2-thienyl]methyl]-4-methylphenyl]-, (1R)-; (1R)-1,5-Anhydro-1-C-[3-[[5-(4-flu

CANAGLIFLOZIN DEFLUORO IMPURITY
CAS:842133-16-8
Formula: C24H26O5S
GëÑ95%
842133-16-8
Canagliflozin Impurity A; Canagliflozin Desfluoro Impurity; D-GÇïGlucitol, 1,GÇï5-GÇïanhydro-GÇï1-GÇïC-GÇï[4-GÇïmethyl-GÇï3-GÇï[(5-GÇïphenyl-GÇï2-GÇïthienyl)GÇïmethyl]GÇïphenyl]GÇï-GÇï, (1S)GÇï-; (1S)-1,GÇï5-GÇïAnhydro-GÇï1-GÇïC-GÇï[4-GÇïmethyl-GÇï3-GÇï[(5-GÇïphenyl-GÇï2-GÇïthienyl)GÇïmethyl]GÇïphen

CANAGLIFLOZIN FURANOSE FORM (MIXTURE OF ANOMERS)
CAS:2161394-94-9
Formula: C24H25FO5S
2161394-94-9
D-Galactitol, 1,4-anhydro-1-C-[3-[[5-(4-fluorophenyl)-2-thienyl]methyl]-4-methylphenyl]-; Canagliflozin-10; Canagliflozin Impurity 17; (2R,3R,4R,5R)-2-((R)-1,2-dihydroxyethyl)-5-(3-((5-(4-fluorophenyl)thiophen-2-yl)methyl)-4-methylphenyl)te

CANAGLIFLOZIN HEMIHYDRATE
CAS:928672-86-0
Formula: C24H25FO5S.1/2H2O
>98%
B0084-463685
(3R,4R,5S,6R)-2-(3-((5-(4-fluorophenyl)thiophen-2-yl)methyl)-4-methylphenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol hemihydrate; JNJ 28431754 hemihydrate; TA 7284 hemihydrate; JNJ-24831754-ZAE hemihydrate; JNJ-28431754-AAA hemihyd

CANAGLIFLOZIN IMPURITY 14
CAS:842133-17-9
Formula: C24H25FO5S
842133-17-9
D-Glucitol, 1,5-anhydro-1-C-[3-[[5-(3-fluorophenyl)-2-thienyl]methyl]-4-methylphenyl]-, (1S)-; (2S,3R,4R,5S,6R)-2-(3-((5-(3-fluorophenyl)thiophen-2-yl)methyl)-4-methylphenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol

CANAGLIFLOZIN IMPURITY 17
CAS:1951467-28-9
Formula: C24H23FO6S
GëÑ95%
1951467-28-9
Methanone, [5-(4-fluorophenyl)-2-thienyl](5-+¦-D-glucopyranosyl-2-methylphenyl)-; Methanone, (5-(4-fluorophenyl)-2-thienyl)(5-beta-D-glucopyranosyl-2-methylphenyl)-; Canagliflozin impurity 12; (5-(4-Fluorophenyl)thiophen-2-yl)(2-methyl-5-((2

CANAGLIFLOZIN MONOACETYL IMPURITY
CAS:2146135-87-5
Formula: C26H27FO6S
2146135-87-5
((2R,3S,4R,5R,6S)-6-(3-((5-(4-fluorophenyl)thiophen-2-yl)methyl)-4-methylphenyl)-3,4,5-trihydroxytetrahydro-2H-pyran-2-yl)methyl acetate; Canagliflozin impurity 03

CANAGLIFLOZIN RELATED IMPURITY 10
CAS:1799552-91-2
Formula: C24H25FO6S
> 95%
1799552-91-2
+¦-GÇïD-GÇïGlucopyranose, 1-GÇïC-GÇï[3-GÇï[[5-GÇï(4-GÇïfluorophenyl)GÇï-GÇï2-GÇïthienyl]GÇïmethyl]GÇï-GÇï4-GÇïmethylphenyl]GÇï-

CANAGLIFLOZIN RELATED IMPURITY 14
CAS:58861-48-6
Formula: C10H7FS
> 95%
58861-48-6
Thiophene, 2-GÇï(4-GÇïfluorophenyl)GÇï-

CANAGLIFLOZIN RELATED IMPURITY 9
CAS:32384-65-9
Formula: C18H42O6Si4
> 95%
32384-65-9
(3R,4S,5R,6R)-3,4,5-tris((trimethylsilyl)oxy)-6-(((trimethylsilyl)oxy)methyl)tetrahydro-2H-pyran-2-one

CANAGLIFLOZIN RING OPENING IMPURITY
Formula: C24H27FO6S
(2S,3R,4R,5R)-1-(3-((5-(4-Fluorophenyl)thiophen-2-yl)methyl)-4-methylphenyl)hexane-1,2,3,4,5,6-hexaol; D-Glucitol, 1-C-[3-[[5-(4-fluorophenyl)-2-thienyl]methyl]-4-methylphenyl]-; 1-C-[3-[[5-(4-Fluorophenyl)-2-thienyl]methyl]-4-methylphenyl]

CANAGLIFLOZIN TETRAACETATE
CAS:866607-35-4
Formula: C32H33FO9S
98%
866607-35-4
(1S)-1,5-anhydro-1-C-[3-[[5-(4-fluorophenyl)-2-thienyl]methyl]-4-methylphenyl]-D-glucitol 2,3,4,6-Tetraacetate; Canagliflozin impurity 05; Tetra Acetyl Canagliflozin

CANAGLIFLOZIN-[13C6]
Formula: C18[13C]6H25FO5S
BLP-000996
[13C6]-Canagliflozin; (1S)-1,5-Anhydro-1-C-[3-[[5-(4-fluorophenyl-13C6)-2-thienyl]methyl]-4-methylphenyl]-D-glucitol; Canagliflozin-(fluorophenyl)-13C6

CANAGLIFLOZIN-[D4]
CAS:1997338-61-0
Formula: C24H21D4FO5S
98% HPLC
BLP-011203
(2S,3R,4R,5S,6R)-2-[3-({5-[4-fluoro(2,3,5,6-D4)phenyl]thiophen-2-yl}methyl)-4-methylphenyl]-6-(hydroxymethyl)oxane-3,4,5-triol

Canagliflozin-[d6]
CAS:1997338-60-9
Formula: C24H19D6FO5S
BLP-012762
Canagliflozin-D6; (1S)-1,5-Anhydro-1-C-[3-[[5-(4-fluorophenyl)-2-thienyl]methyl]-4-methylphenyl]-D-glucitol-D6; Canagliflozin-(Methylphenyl)-d6; (2S,3R,4R,5S,6R)-2-(3-((5-(4-fluorophenyl)thiophen-2-yl)methyl)-4-(methyl-d3)phenyl-2,5,6-d3)-6

CANAKINUMAB
CAS:914613-48-2
914613-48-2
Ilaris; ACZ 885; ACZ885

CANCER RELATED ANTIGENS BST-2 (126-134)
BAT-009812
Cancer related antigens Bone marrow stromal antigen 2 (126-134)

CANCER/TESTIS ANTIGEN 1 (119-138)
BAT-009783
NY-ESO-1 (119-138); Cancer/testis antigen 6.1 (119-138); L antigen family member 2 (119-138)

CANCER/TESTIS ANTIGEN 1 (119-143)
BAT-009779
NY-ESO-1 (119-143); Cancer/testis antigen 6.1 (119-143); L antigen family member 2 (119-143)

CANCER/TESTIS ANTIGEN 1 (121-130)
BAT-009787
NY-ESO-1 (121-130); Cancer/testis antigen 6.1 (121-130); L antigen family member 2 (121-130)

CANCER/TESTIS ANTIGEN 1 (123-137)
BAT-009789
NY-ESO-1 (123-137); Cancer/testis antigen 6.1 (123-137); L antigen family member 2 (123-137)

CANCER/TESTIS ANTIGEN 1 (124-134)
BAT-009790
NY-ESO-1 (124-134); Cancer/testis antigen 6.1 (124-134); L antigen family member 2 (124-134)

CANCER/TESTIS ANTIGEN 1 (124-135)
BAT-009776
NY-ESO-1 (124-135); Cancer/testis antigen 6.1 (124-135); L antigen family member 2 (124-135)

CANCER/TESTIS ANTIGEN 1 (127-136)
BAT-009763
NY-ESO-1 (127-136); Cancer/testis antigen 6.1 (127-136); L antigen family member 2 (127-136)

CANCER/TESTIS ANTIGEN 1 (139-156)
BAT-009788
NY-ESO-1 (139-156); Cancer/testis antigen 6.1 (139-156); L antigen family member 2 (139-156)

CANCER/TESTIS ANTIGEN 1 (53-62)
BAT-009772
NY-ESO-1 (53-62); Cancer/testis antigen 6.1 (53-62); L antigen family member 2 (53-62)

CANCER/TESTIS ANTIGEN 1 (60-72)
BAT-009774
NY-ESO-1 (60-72); Cancer/testis antigen 6.1 (60-72); L antigen family member 2 (60-72)

CANCER/TESTIS ANTIGEN 1 (80-88)
BAT-009775
NY-ESO-1 (80-88); Cancer/testis antigen 6.1 (80-88); L antigen family member 2 (80-88)

CANCER/TESTIS ANTIGEN 1 (86-97)
BAT-009780
NY-ESO-1 (86-97); Cancer/testis antigen 6.1 (86-97); L antigen family member 2 (86-97)

CANCER/TESTIS ANTIGEN 1 (87-100)
BAT-009791
NY-ESO-1 (87-100); Cancer/testis antigen 6.1(87-100); L antigen family member 2 (87-100)

CANCER/TESTIS ANTIGEN 1 (87-111)
BAT-009778
NY-ESO-1 (87-111); Cancer/testis antigen 6.1 (87-111); L antigen family member 2 (87-111)

CANCER/TESTIS ANTIGEN 1 (89-100)
BAT-009786
NY-ESO-1 (89-100); Cancer/testis antigen 6.1 (89-100); L antigen family member 2 (89-100)

CANCER/TESTIS ANTIGEN 1 (91-101)
BAT-009771
NY-ESO-1 (91-101); Cancer/testis antigen 6.1 (91-101); L antigen family member 2 (91-101)

CANCER/TESTIS ANTIGEN 1 (92-100)
BAT-009784
NY-ESO-1 (92-100); Cancer/testis antigen 6.1 (92-100); L antigen family member 2 (92-100)

CANCER/TESTIS ANTIGEN 1 (94-102)
BAT-009777
NY-ESO-1 (94-102); Cancer/testis antigen 6.1 (94-102); L antigen family member 2 (94-102)

CANCER/TESTIS ANTIGEN 1 (95-107)
BAT-009782
NY-ESO-1 (95-107); Cancer/testis antigen 6.1 (95-107); L antigen family member 2 (95-107)

CANCER/TESTIS ANTIGEN 1 (96-104)
BAT-009785
NY-ESO-1 (96-104); Cancer/testis antigen 6.1 (96-104); L antigen family member 2 (96-104)

CANCER/TESTIS ANTIGEN 1 (ORF2 (14-33))
BAT-009781
NY-ESO-1 (ORF2 (14-33)); Cancer/testis antigen 6.1 (ORF2 (14-33)); L antigen family member 2 (ORF2 (14-33))

CANCER/TESTIS ANTIGEN 1 (ORF2 (18-27))
BAT-009762
NY-ESO-1 (ORF2 (18-27)); Cancer/testis antigen 6.1 (ORF2 (18-27)); L antigen family member 2 (ORF2 (18-27))

CANCER/TESTIS ANTIGEN 2 (103-111)
BAT-009710
Autoimmunogenic cancer/testis antigen NY-ESO-2 (103-111); Cancer/testis antigen 6.2 (103-111); L antigen family member 1 (103-111)

CANCER/TESTIS ANTIGEN 2 (108-120)
BAT-009731
Autoimmunogenic cancer/testis antigen NY-ESO-2 (108-120); Cancer/testis antigen 6.2 (108-120); L antigen family member 1 (108-120)

CANCER/TESTIS ANTIGEN 2 (37-50)
BAT-009732
Autoimmunogenic cancer/testis antigen NY-ESO-2 (37-50); Cancer/testis antigen 6.2 (37-50); L antigen family member 1 (37-50)

CANCER/TESTIS ANTIGEN 2 (ORF2 (1-11))
BAT-009711
Autoimmunogenic cancer/testis antigen NY-ESO-2 (ORF2 (1-11)); Cancer/testis antigen 6.2 (ORF2 (1-11)); L antigen family member 1 (ORF2 (1-11))

CANDESARTAN
CAS:139481-59-7
Formula: C24H20N6O3
>98%
NP3027
Candesartan cilexetil EP Impurity G; Candesartan Cilexetil Related Compound G; CV11974; CV-1197; CV 11974

Candesartan Acetyloxy Impurity
CAS:253678-97-6

CANDESARTAN ACYL-GLUCURONIDE
CAS:180603-77-4
Formula: C30H28N6O9
96%
180603-77-4
1-[2-Ethoxy-1-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1H-benzimidazole-7-carboxylate+¦-D-Glucopyranuronic Acid

CANDESARTAN ACYL-GLUCURONIDE METHYL ESTER
Formula: C31H30N6O9
(2S,3R,4S,5S,6S)-3,4,5-Trihydroxy-6-(methoxycarbonyl)tetrahydro-2H-pyran-2-yl 1-((2'-(2H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-2-ethoxy-1H-benzo[d]imidazole-7-carboxylate

CANDESARTAN CILEXETIL
CAS:145040-37-5
Formula: C33H34N6O6
>98%
NP3201
TCV-116; TCV 116; TCV116; Candesartan cilexetil

CANDESARTAN CILEXETIL EP IMPURITY A
CAS:139481-58-6
Formula: C26H24N6O3
> 95%
NP3026
2-Ethoxy-1-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1H-benzimidazole-7-carboxylic Acid Ethyl Ester; Candesartan ethyl ester; Candesartan Cilexetil Related Compound A

CANDESARTAN CILEXETIL EP IMPURITY B
Formula: C31H30N6O6
(1RS)-1-[[(cyclohexyloxy)carbonyl]oxy]ethyl 2-oxo-3-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]-2,3-dihydro-1H-benzimidazole-4-carboxylate

CANDESARTAN CILEXETIL EP IMPURITY C
Formula: C33H34N6O6
(1RS)-1-[[(Cyclohexyloxy)carbonyl]oxy]ethyl 3-[[2'-(1-ethyl-1H-tetrazol-5-yl)biphenyl-4-yl]methyl]-2-oxo-2,3-dihydro-1H-benzimidazole-4-carboxylate

CANDESARTAN CILEXETIL EP IMPURITY D
Formula: C33H34N6O6
(1RS)-1-[[(Cyclohexyloxy)carbonyl]oxy]ethyl 3-[[2'-(2-ethyl-2H-tetrazol-5-yl)biphenyl-4-yl]methyl]-2-oxo-2,3-dihydro-1H-benzimidazole-4-carboxylate

CANDESARTAN CILEXETIL EP IMPURITY E
Formula: C35H38N6O6
(1RS)-1-[[(cyclohexyloxy)carbonyl]oxy]ethyl 2-ethoxy-1-[[2'-(1-ethyl-1H-tetrazol-5-yl)biphenyl-4-yl]methyl]-1H-benzimidazole-7-carboxylate

CANDESARTAN CILEXETIL EP IMPURITY F
Formula: C35H38N6O6
(1RS)-1-[[(cyclohexyloxy)carbonyl]oxy]ethyl 2-ethoxy-1-[[2'-(2-ethyl-2H-tetrazol-5-yl)biphenyl-4-yl]methyl]-1H-benzimidazole-7-carboxylate

CANDESARTAN CILEXETIL EP IMPURITY H
Formula: C52H48N6O6
(1RS)-1-[[(cyclohexyloxy)carbonyl]oxy]ethyl 2-ethoxy-1-[[2'-[1-(triphenylmethyl)-1H-tetrazol-5-yl]biphenyl-4-yl]methyl]-1H-benzimidazole-7-carboxylate; N-tritylcandesartan

CANDESARTAN CILEXETIL EP IMPURITY I
CAS:139481-69-9
Formula: C25H22N6O3
98.0%
NP3025
Candesartan methyl ester

CANDESARTAN CILEXETIL RELATED COMPOUND B
CAS:869631-11-8
Formula: C31H30N6O6
> 95%
869631-11-8
2,3-Dihydro-2-oxo-3-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1H-benzimidazole-4-carboxylic Acid 1-[[(Cyclohexyloxy)carbonyl]oxy]ethyl Ester; Desethyl Candesartan Cilexetil

CANDESARTAN CILEXETIL RELATED COMPOUND D
CAS:1185256-03-4
Formula: C33H34N6O6
> 95%
1185256-03-4
2-Desethoxy-2-hydroxy-2H-2-ethyl Candesartan Cilexetil; 2-Desethoxy-2-oxo-2H-2-ethyl candesartan cilexetil

CANDESARTAN CILEXETIL RELATED COMPOUND F
CAS:914613-36-8
Formula: C35H38N6O6
> 95%
914613-36-8
2-Ethoxy-1-[[2'-(2-ethyl-2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1H-benzimidazole-7-carboxylic Acid 1-[[(Cyclohexyloxy)carbonyl]oxy]ethyl Ester; 2-Ethyl-Candesartan Cilexetil

CANDESARTAN CILEXETIL-[D11]
CAS:1261393-19-4
Formula: C33H23D11N6O6
95% (CP); 98% atom D
BLP-002134
2-Ethoxy-1-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1H-benzimidazole-7-carboxylic Acid 1-[[(Cyclohexyl-d11-oxy)carbonyl]oxy]ethyl Ester; Atacand-d11; Blopress-d11; TCV 116-d11; Candesartan Cilexetil D11

CANDESARTAN METHYL ESTER-[D5]
CAS:1216502-48-5
Formula: C25H17D5N6O3
BLP-002136
Candesartan-d5 Methyl Ester; Candesartan Methyl Ester-d5

CANDESARTAN N-TRITYL O-TRI-ACETYL ACYL-GLUCURONIDE METHYL ESTER
Formula: C56H50N6O12
(2S,3R,4S,5S,6S)-2-((2-Ethoxy-1-((2'-(2-trityl-2H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-1H-benzo[d]imidazole-7-carbonyl)oxy)-6-(methoxycarbonyl)tetrahydro-2H-pyran-3,4,5-triyl Triacetate

CANDESARTAN N2-GLUCURONIDE
CAS:180603-76-3
Formula: C30H28N6O9
>95%
180603-76-3
1-[5-[4'-[(7-Carboxy-2-ethoxy-1H-benzimidazol-1-yl)methyl][1,1'-biphenyl]-2-yl]-2H-tetrazol-2-yl]-1-deoxy-+¦-D-glucopyranuronic acid; +¦-D-Glucopyranuronic acid, 1-[5-[4'-[(7-carboxy-2-ethoxy-1H-benzimidazol-1-yl)methyl][1,1'-biphenyl]-2-yl]-

Candesartan PGI-5 Impurity
CAS:136285-67-1
Formula: C23H19N3O4
95%
NP3023
2-[[(2'-Cyano[1,1'-biphenyl]-4-yl)methyl]amino]-3-nitro-benzoic acid ethyl ester; Ethyl-2-[[(2'-cyanobiphenyl-4-yl)methyl]amino]-3-nitrobenzoate; Ethyl(2-ethoxy-1-benzimidazole)-7-carboxylate

CANDESARTAN-[D4]
CAS:1346604-70-3
Formula: C24H16D4N6O3
GëÑ95% by HPLC; GëÑ98% atom D
BLP-011202
2-Ethoxy-1-[[2'-(1H-tetrazol-5-yl)[1-(phenyl-d4)-1'-phenyl]-4-yl]methyl]-1H-benzimidazole-7-carboxylic Acid; CV-11974-d4; Candesartan M1-d4; 3-[[2'-(1H-Tetrazol-5-yl)[1-(phenyl-d4)-1'-phenyl]-4-yl]methyl]-2-ethoxy-3H-benzimidazole-4-carboxy

CANDESARTAN-[D5]
CAS:1189650-58-5
Formula: C24H15D5N6O3
98% (CP); 98% atom D
BLP-002135
2-Ethoxy-1-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1H-benzimidazole-7-carboxylic Acid-d5; Candesartan D5

CANDICIDIN COMPLEX
CAS:1403-17-4
Formula: C59H84N2O18 (for Candicidin D)
>95% by HPLC
BBF-03825
Levorin

CANDICIDIN D
CAS:39372-30-0
Formula: C59H84N2O18
BBF-00600
Candizidin; Candicidin D1; Levorin A2

CANDICINE
CAS:6656-13-9
Formula: C11H18NO
6656-13-9

Candida Albicans alpha factor
Formula: C72H97N17O19
BAT-017023
Gly-Phe-Arg-Leu-Thr-Asn-Phe-Gly-Tyr-Phe-Glu-Pro-Gly

CANDIDIN
CAS:1405-90-9
Formula: C47H71NO17
95%
BBF-00601
Amphotericin B, 8,9-dideoxy-10-hydroxy-7-oxo-; Candidin

CANDIDOIN
CAS:65776-69-4
Formula: C54H81NO19
BBF-00208

CANDIDUSIN A
CAS:81474-59-1
BBF-06233

Candidusin B
CAS:81474-60-4
BBF-06272

CANERTINIB
CAS:267243-28-7
Formula: C24H25ClFN5O3
>98%
267243-28-7
CI-1033; PD-183805; N-[4-[(3-Chloro-4-fluorophenyl)amino]-7-[3-(4-morpholinyl)propoxy]-6-quinazolinyl]-2-propenamide; N-[4-(3-Chloro-4-fluorophenylamino)-7-(3-morpholin-4-ylpropoxy)quinazolin-6-yl]acrylamide; 2-propenamide, N-[4-[(3-chloro-

CANERTINIB DIHYDROCHLORIDE
CAS:289499-45-2
Formula: C24H27Cl3FN5O3
GëÑ98% (HPLC)
B0084-065207
N-(4-((3-Chloro-4-fluorophenyl)amino)-7-(3-(morpholin-4-yl)propoxy)quinazolin-6-yl)prop-2-enamide; CI1033PD183805

CANESCIN A
CAS:24219-64-5
Formula: C15H14O7
BBF-00209

CANESCIN B
CAS:24319-86-6
Formula: C15H14O7
BBF-00210

CANESOLIDE
CAS:69799-34-4
Formula: C18H14Cl4O6
BBF-05542
4,6-Dichloro-7-(2,4-dichloro-3,6-dimethoxy-5-methylphenoxy)-5-methoxyisobenzofuran-1(3H)-one; 1(3H)-Isobenzofuranone, 4,6-dichloro-7-(2,4-dichloro-3,6-dimethoxy-5-methylphenoxy)-5-methoxy-

CANFOSFAMIDE
CAS:158382-37-7
Formula: C26H40Cl4N5O10PS
158382-37-7
TELCYTA; TLK286; TLK 286; TLK-286

CANFOSFAMIDE HYDROCHLORIDE
CAS:439943-59-6
Formula: C26H41Cl5N5O10PS
GëÑ98%
439943-59-6
Telcyta; TER 286; TLK 286; TER286; TLK286; TER-286; TLK-286;N5-(((2-((bis(bis(2-chloroethyl)amino)phosphoryl)oxy)ethyl)sulfonyl)-D-alanyl)-N5-((R)-carboxy(phenyl)methyl)-L-glutamine hydrochloride;

Cangorinine E-1
CAS:155944-24-4
Formula: C43H49NO18
98%
155944-24-4
Cangorinine-E-I;Cangorinine- E-I;155944-24-4;[(1R,3S,13R,14R,17R,18S,19S,20S,21R,22S,23S,24S,25R)-18,19,21,22-tetraacetyloxy-20-(acetyloxymethyl)-25-hydroxy-3,13,14,25-tetramethyl-6,15-dioxo-2,5,16-trioxa-11-azapentacyclo[15.7.1.01,20.03,23

CANGRELOR
CAS:163706-06-7
Formula: C17H25Cl2F3N5O12P3S2
GëÑ98%
163706-06-7
Kengreal; UNII-6AQ1Y404U7; AR-C69931XX; AR-C69931MX; [dichloro-[[[(2R,3S,4R,5R)-3,4-dihydroxy-5-[6-(2-methylsulfanylethylamino)-2-(3,3,3-trifluoropropylsulfanyl)purin-9-yl]oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]methyl]p

CANGRELOR IMPURITY 1
CAS:1054332-15-8
Formula: C19H25F3N7O5PS2
> 95%
1054332-15-8
Adenosine, N-GÇï[2-GÇï(methylthio)GÇïethyl]GÇï-GÇï2-GÇï[(3,GÇï3,GÇï3-GÇïtrifluoropropyl)GÇïthio]GÇï-GÇï, 5'-GÇï(hydrogen P-GÇï1H-GÇïimidazol-GÇï1-GÇïylphosphonate)

CANGRELOR IMPURITY 2
CAS:847460-53-1
Formula: C16H23F3N5O6PS2
> 95%
847460-53-1
5'-GÇïAdenylic acid, N-GÇï[2-GÇï(methylthio)GÇïethyl]GÇï-GÇï2-GÇï[(3,GÇï3,GÇï3-GÇïtrifluoropropyl)GÇïthio]GÇï- (9CI)

CANGRELOR IMPURITY 4
CAS:1830294-26-2
Formula: C22H28F3N5O7S2
> 95%
1830294-26-2
Adenosine, N-GÇï[2-GÇï(methylthio)GÇïethyl]GÇï-GÇï2-GÇï[(3,GÇï3,GÇï3-GÇïtrifluoropropyl)GÇïthio]GÇï-GÇï, 2',GÇï3',GÇï5'-GÇïtriacetate

CANGRELOR IMPURITY 5
CAS:163706-51-2
Formula: C13H16F3N5O4S
> 95%
163706-51-2
Adenosine, 2-GÇï[(3,GÇï3,GÇï3-GÇïtrifluoropropyl)GÇïthio]GÇï-

CANGRELOR IMPURITY 8
CAS:1830294-25-1
Formula: C11H14F3N5S2
> 95%
1830294-25-1
9H-GÇïPurin-GÇï6-GÇïamine, N-GÇï[2-GÇï(methylthio)GÇïethyl]GÇï-GÇï2-GÇï[(3,GÇï3,GÇï3-GÇïtrifluoropropyl)GÇïthio]GÇï-

CANGRELOR METABOLITE (CANGRELOR IMPURITY 3)
CAS:163706-58-9
Formula: C16H22F3N5O4S2
> 95%
163706-58-9
N6-(2-methylthioethyl)-2-(3,3,3-trifluoropropylthio)adenosine; Adenosine, N-GÇï[2-GÇï(methylthio)GÇïethyl]GÇï-GÇï2-GÇï[(3,GÇï3,GÇï3-GÇïtrifluoropropyl)GÇïthio]GÇï-(9CI); N-[2-(Methylthio)ethyl]-2-[(3,3,3-trifluoropropyl)thio]adenosine

CANGRELOR TETRASODIUM
CAS:163706-36-3
Formula: C17H21Cl2F3N5Na4O12P3S2
B0084-468043
Cangrelor Tetrasodium; AR-C69931MX; AR C69931MX; ARC69931MX; N6-(2-Methylthioethyl)-2-(3,3,3-trifluoropropylthio)-betagamma-dichloromethylene-ATP tetrasodium salt

CANGRELOR-[13C,D3]
Formula: C16[13C]H22D3Cl2F3N5O12P3S2
> 98%
BLP-002137
Cangrelor 13CD3

CANGRELOR-[13C,D7]
Formula: C16[13C]H18D7Cl2F3N5O12P3S2
> 98%
BLP-002138
Cangrelor 13CD7

Canine beta-defensin
BAT-013605

CANNABINOL-[D3]
Formula: C21H23D3O2
98% by CP; 98% atom D
BLP-007240
cannabinol D3

CANNABISPIRENONE A
CAS:63213-00-3
Formula: C15H16O3
97.0%
NP4871
(3R)-4-hydroxy-6-methoxyspiro[1,2-dihydroindene-3,4'-cyclohex-2-ene]-1'-one

CANNABIVARIN
CAS:33745-21-0
Formula: C19H22O2
97.5%
NP4966
Cannabivarol; CBV

CANNIPRENE
CAS:70677-47-3
Formula: C21H26O4
>98%
NP4863
3-[2-(3-Hydroxy-5-methoxyphenyl)ethyl]-6-methoxy-2-(3-methyl-2-butenyl)phenol

Cannogenol 3-O-+¦-gentiobiosyl-(1GåÆ4)-+¦-L-thevetoside
CAS:1841524-78-4
Formula: C42H66O19
1841524-78-4
Cannogenol 3-O-beta-gentiobiosyl-(1GåÆ4)-alpha-L-thevetoside; Cannogenol 3-O-b-gentiobiosyl-(1GåÆ4)-a-L-thevetoside

CANOLA OIL
CAS:120962-03-0
120962-03-0
Rapeseed Oil, Refined; Canbra oil; Colzao CT; Lipex 108; Lipex 204; Lipovol CAN; low erucic acid colza oil; low erucic acid rapeseed oil; rapae oleum raffinatum; tower rapeseed oil

CANOPHYLLAL
CAS:14440-40-5
Formula: C30H48O2
98.5%
NP7195
24,25,26-Trinoroleanan-28-al, 5,9,13-trimethyl-3-oxo-, (4+¦,5+¦,8+¦,9+¦,10+¦,13+¦,14+¦)-; (4+¦,5+¦,8+¦,9+¦,10+¦,13+¦,14+¦)-5,9,13-Trimethyl-3-oxo-24,25,26-trinoroleanan-28-al; D:A-Friedooleanan-28-al, 3-oxo-; 3-Oxo-D:A-friedooleanan-28-al; 3-Oxofriedelan

Canrenone-2,2,21,21-[d4]
Formula: C22H24D4O3
>95%; 98% atom D
BLP-013448
Aldadiene-d4; Canrenone-d4; (17+¦)-17-Hydroxy-3-oxo-pregna-4,6-diene-21-carboxylic acid-2,2,21,21-d4 +¦-lactone

CANRENONE-D7 (MAJOR)
Formula: C22H21D7O3
99.1% HPLC; 99% atom D
(2'R)-3',4'-dihydro-5'H-spiro[androst-4,6-diene-17,2'-furan]-3,5'-dione-2,2,4,4',4',7,8-D7

CANTHARIDIC ACID SODIUM SALT
CAS:1465-77-6
Formula: C10H12O5-+2Na
GëÑ95%
1465-77-6
Disodium cantharidin; Cantharidin disodium; 1465-77-6; Disodium cantharidate; 8OIF7X5MK8; Cantharidic Acid (sodium salt); disodium (1R,2S,3R,4S)-2,3-dimethyl-7-oxabicyclo[2.2.1]heptane-2,3-dicarboxylate; disodium; (1R,2S,3R,4S)-2,3-dimethyl

CANTHARIDIN
CAS:514-78-3
Formula: C40H52O2
95%
514-78-3
all-trans-Canthaxanthin; 4,4'-Diketo-+¦-carotene; 4,4'-Dioxo-+¦-carotene; Canthaxanthin; Canthaxanthine; all-trans-+¦-Carotene-4,4'-dione; NSC 374110; Orobronze; beta,beta-Carotene-4,4'-dione; Carophyll Red; Food orange 8

CANTHIN-6-ONE
CAS:479-43-6
Formula: C14H8N2O
>98%
NP0101
6H-Indolo(3,2,1-de)(1,5)naphthyridin-6-one

Canthoside A
CAS:491613-70-8
Formula: C19H26O12
98%
491613-70-8

CANTLEYOSIDE
CAS:32455-46-2
Formula: C33H46O19
>98%
32455-46-2
Cantleyoside; (1S,4aS,6S,7R,7aS)-6-[[[(2S,3R,4S)-3-Ethenyl-2-(beta-D-glucopyranosyloxy)-3,4-dihydro-4-(2-oxoethyl)-2H-pyran-5-yl]carbonyl]oxy]-1-(beta-D-glucopyranosyloxy)-1,4a,5,6,7,7a-hexahydro-7-methyl-cyclopenta[c]pyran-4-carboxylic aci

Cantrixil
CAS:2135511-22-5
Formula: C24H24O6
2135511-22-5
cis-4-(p-hydroxyphenyl)-7,4'-dihydroxy-3',5'-dimethoxy-8-methylisoflavan; TRX-E-002-1; TRXE-0021; TRXE0021

Cantuzumab
CAS:1204740-23-7
1204740-23-7

CANTUZUMAB MERTANSINE
CAS:400010-39-1
BADC-01593
SB-408075; huC242-DM1

CANTUZUMAB RAVTANSINE
CAS:868747-45-9
BADC-01616
IMGN242; huC242-DM4

CANUSESNOL A
CAS:816456-90-3
Formula: C15H22O3
> 95%
NP5739
(4aS,7S)-7-Hydroxy-7-(2-hydroxy-2-propanyl)-1,4a-dimethyl-5,6,7,8 -tetrahydro-2(4aH)-naphthalenone

CAOHUOSIDE D
Formula: C28H34O12
> 95%

CAP 3
Formula: C52H82N6O11
GëÑ98%
CAP 3; CHEMBL5173640; benzyl (4R)-4-[(3R,5S,7R,8R,9S,10S,12S,13R,14S,17R)-3,7,12-tris[[2-[(2-amino-3-methylbutanoyl)amino]acetyl]oxy]-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoa

Cap-dependent endonuclease-IN-27
Formula: C23H19F2N3O4

Cap-dependent endonuclease-IN-28
Formula: C15H13NO5

Cap-dependent-endonuclease-IN-10
CAS:2663989-04-4
Formula: C25H18F2N4O5S
GëÑ98% (HPLC)
2663989-04-4
Cap-dependent endonuclease-IN-10|SCHEMBL23590814|HY-143757|CS-0375024

Cap-dependent-endonuclease-IN-11
CAS:2658472-51-4
Formula: C25H17F2N3O6S
GëÑ98% (HPLC)
2658472-51-4
Cap-dependent endonuclease-IN-11|SCHEMBL23604795|HY-143760|CS-0375025

Cap-dependent-endonuclease-IN-12
CAS:2460686-97-7
Formula: C55H46F4N6O14S2
GëÑ98% (HPLC)
2460686-97-7
Cap-dependent endonuclease-IN-12|HY-143762|CS-0375030

Cap-dependent-endonuclease-IN-13
CAS:2703046-60-8
Formula: C25H20F2N4O4S
GëÑ98% (HPLC)
2703046-60-8
Cap-dependent endonuclease-IN-13|HY-143766|CS-0375138

Cap-dependent-endonuclease-IN-14
CAS:2740486-73-9
Formula: C30H23FN2O6S
GëÑ98% (HPLC)
2740486-73-9
Cap-dependent endonuclease-IN-14|HY-143768|CS-0375142

Cap-dependent-endonuclease-IN-15
CAS:2581298-44-2
Formula: C27H23F2N3O7Se
GëÑ98% (HPLC)
2581298-44-2
Cap-dependent endonuclease-IN-15|HY-143769|CS-0375144

Cap-dependent-endonuclease-IN-16
CAS:2643370-92-5
Formula: C28H25F2N3O7S
GëÑ98% (HPLC)
2643370-92-5
Cap-dependent endonuclease-IN-16|HY-143770|CS-0375151

Cap-dependent-endonuclease-IN-17
CAS:2649362-71-8
Formula: C24H20F2N3O7PS
GëÑ98% (HPLC)
2649362-71-8
Cap-dependent endonuclease-IN-17|HY-143771|CS-0375159

Cap-dependent-endonuclease-IN-18
CAS:2649401-24-9
Formula: C32H29F2N3O7S
GëÑ98% (HPLC)
2649401-24-9
Cap-dependent endonuclease-IN-18|HY-143774S|CS-0375167

Cap-dependent-endonuclease-IN-19
CAS:2567929-06-8
Formula: C28H31N3O4
GëÑ98% (HPLC)
2567929-06-8
Cap-dependent endonuclease-IN-19|HY-144065|CS-0375168

Cap-dependent-endonuclease-IN-2
CAS:2741952-35-0
Formula: C30H24FN3O7S
GëÑ98% (HPLC)
2741952-35-0
Cap-dependent endonuclease-IN-2|SCHEMBL20829232|HY-143743|CS-0374992

Cap-dependent-endonuclease-IN-20
CAS:2656435-01-5
Formula: C24H19F2N3O7S2
GëÑ98% (HPLC)
2656435-01-5
Cap-dependent endonuclease-IN-20|HY-143775|CS-0375171

Cap-dependent-endonuclease-IN-22
CAS:2641942-32-5
Formula: C37H37ClF2N6O7S2
GëÑ98% (HPLC)
2641942-32-5
Cap-dependent endonuclease-IN-22|HY-143776|CS-0375176

Cap-dependent-endonuclease-IN-23
CAS:2741952-36-1
Formula: C26H23F2N3O7
GëÑ98% (HPLC)
2741952-36-1
Cap-dependent endonuclease-IN-23|HY-144067|CS-0375180

Cap-dependent-endonuclease-IN-24
CAS:2649000-32-6
Formula: C34H40F2N3O8PS
GëÑ98% (HPLC)
2649000-32-6
Cap-dependent endonuclease-IN-24|HY-143779|CS-0375181

Cap-dependent-endonuclease-IN-25
CAS:2415788-71-3
Formula: C25H25N3O3
GëÑ98% (HPLC)
2415788-71-3
Cap-dependent endonuclease-IN-25|US11312727, Compound 4|BDBM552069|US11312727, Compound 13|HY-144068|CS-0375183|Synthesis of 4-hydroxy-16-phenyl-7,8,9,10,11,16-hexahydro-6,17-methanobenzo[k]pyrido[1,2-b][1,2,5]triazacyclotridecine-3,5-dione

Cap-dependent-endonuclease-IN-26
CAS:1370238-26-8
Formula: C23H23N3O3
GëÑ98% (HPLC)
1370238-26-8
CHEMBL4465872|Cap-dependent endonuclease-IN-26|SCHEMBL10290014|TQR1119|BDBM50508964|HY-143781|CS-0375184

Cap-dependent-endonuclease-IN-3
CAS:2364589-86-4
Formula: C29H25F2N3O7S
GëÑ98% (HPLC)
2364589-86-4
Cap-dependent endonuclease-IN-3|SCHEMBL22636223|HY-143744|CS-0374994

Cap-dependent-endonuclease-IN-4
Formula: C27H23F2N3O7S
GëÑ98% (HPLC)
Cap-dependent endonuclease-IN-4|HY-109025BS|CS-0374998

Cap-dependent-endonuclease-IN-5
CAS:2416258-53-0
Formula: C27H21F2N3O4S2
GëÑ98% (HPLC)
2416258-53-0
Cap-dependent endonuclease-IN-5|HY-143747|CS-0375002

Cap-dependent-endonuclease-IN-6
CAS:2489248-15-7
Formula: C23H21N3O3S
GëÑ98% (HPLC)
2489248-15-7
Cap-dependent endonuclease-IN-6|HY-143749|CS-0375006

Cap-dependent-endonuclease-IN-7
CAS:2485715-97-5
Formula: C36H28FN3O7S
GëÑ98% (HPLC)
2485715-97-5
Cap-dependent endonuclease-IN-7|HY-143750|CS-0375009

Cap-dependent-endonuclease-IN-8
CAS:2454680-16-9
Formula: C29H23F2N3O6S
GëÑ98% (HPLC)
2454680-16-9
Cap-dependent endonuclease-IN-8|HY-143752|CS-0375015

Cap-dependent-endonuclease-IN-9
Formula: C29H26F2N4O7S
GëÑ98% (HPLC)
Cap-dependent endonuclease-IN-9|HY-143755|CS-0375020

CAPADENOSON
CAS:544417-40-5
Formula: C25H18ClN5O2S2
GëÑ95%
544417-40-5
BAY 68-4986; BAY-68-4986; BAY68-4986; Capadenoson2-Amino-6-[[[2-(4-chlorophenyl)-4-thiazolyl]methyl]thio]-4-[4-(2-hydroxyethoxy)phenyl]-3,5-pyridinedicarbonitrile;2-Amino-6-[[[2-(4-chlorophenyl)-4-thiazolyl]methyl]thio]-4-[4-(2-hydroxyethox

CAPECITABINE
CAS:154361-50-9
Formula: C15H22FN3O6
GëÑ98% by HPLC
BBF-05852
5'-Deoxy-5-fluoro-N-[(pentyloxy)carbonyl]cytidine; [1-(5-Deoxy-+¦-D-ribofuranosyl)-5-fluoro-1,2-dihydro-2-oxo-4-pyrimidinyl]carbamic Acid Pentyl Ester; Capecytabine; Capiibine; Captabin; Ro 09-1978; Xeloda; Pentyl 1-(5-deoxy-beta-D-ribofuran

CAPECITABINE 2',3'-DIACETATE
CAS:162204-20-8
Formula: C19H26FN3O8
> 95%
NP3684
5'-Deoxy-5-fluoro-N-[(pentyloxy)carbonyl]cytidine 2',3'-Diacetate; [1-(2,3-Di-O-acetyl-5-deoxy-+¦-D-ribofuranosyl)-5-fluoro-1,2-dihydro-2-oxo-4-pyrimidinyl]carbamic Acid Pentyl Ester

CAPECITABINE BENZOATE (MIXTURE OF 2'(3')-BENZOATE ISOMERS)
Formula: C22H26FN3O7
5'-Deoxy-5-fluoro-N-[(pentyloxy)carbonyl]cytidine Benozate

CAPECITABINE IMPURITY 3 (DEFLUORO CAPECITABINE)
CAS:216450-02-1
Formula: C15H23N3O6
> 95%
216450-02-1
5'-Deoxy-N-[(pentyloxy)carbonyl]cytidine

CAPECITABINE IMPURITY D
CAS:910129-15-6
Formula: C15H22FN3O6
GëÑ95%
B0246-468068
5'-Deoxy-5-fluoro-N4-[(2-methylbutoxy)carbonyl]cytidine; 5'-Deoxy-5-fluoro-N-[(2-methylbutoxy)carbonyl]cytidine; Capecitabine EP Impurity D; 2-Methylbutyl (1-((2R,3R,4S,5R)-3,4-dihydroxy-5-methyltetrahydrofuran-2-yl)-5-fluoro-2-oxo-1,2-dihy

CAPECITABINE IMPURITY F
CAS:162204-30-0
Formula: C15H22FN3O6
GëÑ95%
B0246-468069
5'-Deoxy-5-fluoro-N4-(isopentyloxycarbonyl)cytidine; [1-(5-Deoxy-+¦-D-ribofuranosyl)-5-fluoro-1,2-dihydro-2-oxo-4-pyrimidinyl]-carbamic Acid 3-Methylbutyl Ester; 5'-Deoxy-5-fluoro-N-[(3-methylbutoxy)carbonyl]cytidine; Isopentyl (1-((2R,3R,4S

CAPECITABINE IMPURITY M
CAS:296248-49-2
Formula: C11H14FN3O6
296248-49-2
Methyl [1-(5-Deoxy-+¦-D-ribofuranosyl)-5-fluoro-1,2-dihydro-2-ox-carbamic Acid Ester

Capecitabine-[d11]
CAS:1132662-08-8
Formula: C15H11D11FN3O6
96%; GëÑ98% atom D
BLP-011826
capecitabine D11; 5'-Deoxy-5-fluoro-N-[(pentyl-d11-oxy)carbonyl]cytidine; [1-(5-Deoxy-+¦-D-ribofuranosyl)-5-fluoro-1,2-dihydro-2-oxo-4-pyrimidinyl]carbamic Acid Pentyl Ester-d11; Capecitibine-d11; Capecytabine-d11; Capiibine-d11; Captabin-d1

CAPECITABINE-2',3'-CYCLIC CARBONATE
CAS:921769-65-5
Formula: C16H20FN3O7
> 95%
NP3711
5'-Deoxy-5-fluoro-N-[(pentyloxy)carbonyl]cytidine Cyclic 2',3'-Carbonate;

CAPERATIC ACID
CAS:29227-64-3
Formula: C21H38O7
BBF-05122
1,2,3-Heptadecanetricarboxylic acid, 2-hydroxy-, 1-methyl ester (8CI); 5-Methyl hydrogen 3-C-carboxy-2,4-dideoxy-2-tetradecylpentarate

CAPILLARISIN
CAS:56365-38-9
Formula: C16H12O7
95%
56365-38-9
Capillarisine; 5,7-dihydroxy-2-(4-hydroxyphenoxy)-6-methoxy-4H-chromen-4-one

Capistruin
BAT-013606

CAPLACIZUMAB
CAS:915810-67-2
915810-67-2
Cablivi; ALX-0681; ALX-0081

Capmatinib-[13C,d3]
Formula: C22[13C]H14D3FN6O
GëÑ99% atom 13C; GëÑ98% atom D
BLP-014042
[13C,d3]-INCB28060; [13C,d3]-UNII-TY34L4F9OZ; 2-fluoro-N-(methyl-13C-d3)-4-(7-(quinolin-6-ylmethyl)imidazo[1,2-b][1,2,4]triazin-2-yl)benzamide; 2-fluoro-4-[7-(quinolin-6-ylmethyl)imidazo[1,2-b][1,2,4]triazin-2-yl]-N-(trideuterio(113C)methyl

CAPOAMYCIN
CAS:97937-29-6
Formula: C35H38O10
BBF-00214
Capomycin; 2,4-Decadienoic acid, 4'-ester with 9-(2,6-dideoxy-beta-D-arabino-hexopyranosyl)-4a,12b-dihydro-4a,8,12b-trihydroxy-3-methylbenz(a)anthracene-1,7,12(4H)-trione

CAPRARIOSIDE
CAS:1151862-69-9
Formula: C22H28O11
98.0%
NP3843
8-O-Benzoylharpagide

CAPRAVIRINE-[D6]
Formula: C20H14D6Cl2N4O2S
> 98%
BLP-002139
Capravirine D6

Caprazamycin
CAS:327164-11-4
Formula: C53H87N5O22
BBF-00215

CAPREOMYCIN
CAS:11003-38-6
Formula: C50H88N28O15
>99% by HPLC
BBF-00602
Capromycin, Caprolin, Capastat, Capostatin, L 29275

CAPREOMYCIN IIA
CAS:62639-89-8
Formula: C19H32N12O7
> 95%
62639-89-8
Cyclo[3-amino-L-alanyl-(2Z)-3-[(aminocarbonyl)amino]-2,3-didehydroalanyl-(2S)-2-[(4R)-2-amino-1,4,5,6-tetrahydro-4-pyrimidinyl]glycyl-(2S)-2-amino-+¦-alanyl-L-seryl]; 1-De[(S)-3,6-diaminohexanoic acid]capreomycin IA ; 1,4,7,10,13-Pentaazacyc

CAPREOMYCIN IIB
CAS:754135-24-5
Formula: C19H32N12O6
> 95%
754135-24-5
Cyclo[(2S)-2-amino-+¦-alanyl-L-alanyl-3-amino-L-alanyl-(2Z)-3-[(aminocarbonyl)amino]-2,3-didehydroalanyl-(2S)-2-[(4R)-2-amino-1,4,5,6-tetrahydro-4-pyrimidinyl]glycyl]; 1-De[(S)-3,6-diaminohexanoic acid]-6-L-alaninecapreomycin IA; 1,4,7,10,13

CAPREOMYCIN SULFATE
CAS:1405-37-4
Formula: C24H42N14O8.H2SO4
GëÑ95%
BBF-04221
Kapreomycin; Capostatin; HSDB 3211; HSDB-3211; HSDB3211; Capastat sulfate; Caprocin sulfate; (2S)-2,5-diamino-N-(((2S,5R,11S,15R,Z)-15-amino-11-(2-amino-3,4,5,6-tetrahydropyrimidin-4-yl)-2-(hydroxymethyl)-3,6,9,12,16-pentaoxo-8-(ureidomethy

CAPRIC ACID
CAS:334-48-5
Formula: C10H20O2
98.0%
B1334-066368
CAPRIC ACID (NATURAL), Decanoic acid, Kortacid 1099

CAPROMAB PENDETIDE
CAS:145464-28-4
95%
145464-28-4
CYT 356; OncoScint Prostate; Immunoglobulin G1, anti-(human prostatic carcinoma cell) (mouse monoclonal 7E11-C5.3 +¦1-chain), disulfide with mouse monoclonal 7E11-C5.3 light chain, dimer, N6-[N-[2-[[2-[bis(carboxymethyl)amino]ethyl](carboxym

CAPROOYL TETRAPEPTIDE-3
CAS:1012317-70-2
Formula: C26H47N9O5
GëÑ95%
BAT-016686
L-Lysinamide, N2-(1-oxohexyl)-L-lysylglycyl-L-histidyl-; N2-(1-Oxohexyl)-L-lysylglycyl-L-histidyl-L-lysinamide; Caprooyl-Lys-Gly-His-Lys-NH2; L-Lysyl-N-hexanoylglycyl-L-histidyl-L-lysinamide; N-Hexanoyl-L-lysyl-glycyl-L-histidyl-L-lysinamid

Caprooyl Tetrapeptide-3 acetate
CAS:1012317-71-3
Formula: C26H47N9O5.xC2H4O2
GëÑ95%
BAT-016741
L-Lysinamide, N2-(1-oxohexyl)-L-lysylglycyl-L-histidyl-, acetate (1:x); N2-(1-Oxohexyl)-L-lysylglycyl-L-histidyl-L-lysinamide acetate; L-Lysyl-N-hexanoylglycyl-L-histidyl-L-lysinamide acetate; N-Hexanoyl-L-lysyl-glycyl-L-histidyl-L-lysinami

CAPROSPINOL
CAS:4952-56-1
Formula: C33H52O4
99%
4952-56-1
Diosgenin caproate; Diosgenin, hexanoate; Caprospinol; SP-233; SP 233; SP233

CAPRYLOCAPROYL POLYOXYLGLYCERIDES
CAS:223129-75-7
223129-75-7
Labrasol; macrogolglyceridorum caprylocaprates; PEG 400 caprylic/capric glycerides; Decanoic acid, mixed monoesters with glycerol and octanoic acid; poly(oxy-1,2-ethanediyl), +¦-hydro--ë-hydroxy-, mixed decanoate and octanoate

CAPRYLOYL GLYCINE
CAS:14246-53-8
Formula: C10H19NO3
> 95%
14246-53-8
N-Octanoylglycine; N-(1-Oxooctyl)glycine; Capryloylglycine; Lipacide C 8G; 2-Octanoylaminoacetic acid

Capsaicin-[d3] (E/Z-Mixture)
CAS:1185237-43-7
Formula: C18H24D3NO3
GëÑ98% by HPLC; GëÑ99% atom D
BLP-012820
Capsaicin-d3 (E/Z-Mixture); N-[(4-Hydroxy-3-(methoxy-d3)phenyl)methyl]-8-methyl-6-nonenamide; (E/Z)-8-Methyl-N-vanillyl-6-nonenamide-d3

CAPSAICIN-[D7]
Formula: C18H20D7NO3
BLP-002140
Capsaicin D7

CAPSAICIN-5,7-DENE
Formula: C18H25NO3
BB069226
(E)-N-(4-Hydroxy-3-methoxybenzyl)-8-methylnona-5,7-dienamide

CAPSAICIN-5,7-DIENOIC ACID
Formula: C10H16O2
BB069223
(E)-8-Methylnona-5,7-dienoic Acid

CAPSANTHIN
CAS:465-42-9
Formula: C40H56O3
95%
465-42-9
(3R,3'S,5'R)-3,3'-Dihydroxy-+¦,+¦-caroten-6'-one; (all-E)-9-(4-Hydroxy-2,6,6-trimethyl-1-cyclohexen-1-yl)-1-(4-hydroxy-1,2,2-trimethylcyclopentyl)-4,8,13,17-tetramethyl-2,4,6,8,10,12,14,16,18-Nonadecanonaen-1-one; all-trans-Capsanthin

CAPSAZEPINE
CAS:138977-28-3
Formula: C19H21ClN2O2S
> 95%
138977-28-3
N-[2-(4-Chlorophenyl)ethyl]-1,3,4,5-tetrahydro-7,8-dihydroxy-2H-2-benzazepine-2-carbothioamide

CAPSIAMIDE-[D3]
CAS:1795031-33-2
Formula: C17H32D3NO
> 98%
BLP-002141
N-(13-Methyltetradecyl)acetamide-d3; Cap-A-d3; Capsi-amide-d3; Capsiamide D3

CAPSIATE
CAS:205687-01-0
Formula: C18H26O4
95%
205687-01-0
(E)-4-Hydroxy-3-methoxybenzyl 8-methylnon-6-enoate; (4-hydroxy-3-methoxyphenyl)methyl (6E)-8-methylnon-6-enoate; 8-methyl-6E-nonenoic acid, (4-hydroxy-3-methoxyphenyl)methyl ester; vanillyl (6E)-8-methylnon-6-enoate; vanillyl trans-8-methyl

CAPSICONIATE
CAS:946572-73-2
Formula: C20H28O4
GëÑ98%
946572-73-2
Coniferyl (E)-8-methyl-6-nonenoate

CAPSICUM FRUIT EXTRACT
CAS:85940-30-3
85940-30-3
capsicum frutescens fruit extract

CAPSIMYCIN
CAS:70694-08-5
Formula: C30H40N2O6
BBF-00603

CAPSORUBIN
CAS:470-38-2
Formula: C40H56O4
GëÑ90%
470-38-2
(3S,3'S,5R,5'R)-3,3'-Dihydroxy-+¦,+¦-carotene-6,6'-dione; (1R,1R,4S,4S)-(all-E)-1,20-Bis(4-hydroxy-1,2,2-trimethylcyclopentyl)-4,8,13,17-tetramethyl-2,4,6,8,10,12,14,16,18-eicosanonaene-1,20-dione; Capsorubin; all-trans-Capsorubin

Capsular polysaccharide
B1370-099033
CPS

CAPTAN-[D6]
CAS:1330190-00-5
Formula: C9H2D6Cl3NO2S
>95%; >98% atom D
BLP-001583
Captan-3,3,4,5,6,6-d6; 2-Trichloromethylsulfanyl-3a,4,7,7a-tetrahydroisoindole-1,3-dione-D6; Trimegol-d6; Ugecap-d6

CAPTOPRIL
CAS:62571-86-2
Formula: C9H15NO3S
>98%
62571-86-2
ISF 2522; ISF2522; ISF-2522; Captopril, Capoten, SQ14225, SQ 14225, SQ-14225, SQ14,225, SQ 14,225, SQ-14,225

CAPTOPRIL DISULFIDE
CAS:64806-05-9
Formula: C18H28N2O6S2
> 95%
B1370-468095
1,1'-[Dithiobis[(2S)-2-methyl-1-oxo-3,1-propanediyl]]bis-L-proline CAPTOPRDS; SQ 14551; Captopril Imp. A (BP); Captopril EP Impurity A

CAPTOPRIL EP IMPURITY B
CAS:80629-35-2
Formula: C9H14BrNO3
GëÑ95%
80629-35-2
1-[(2S)-3-Bromo-2-methyl-1-oxopropyl]-L-proline; (S)-1-(3-bromo-2-methyl-1-oxopropyl)-L-proline; Captopril impurity B; (S)-1-((S)-3-bromo-2-methylpropanoyl)pyrrolidine-2-carboxylic acid; Captopril Impurity 2; L-Proline, 1-(3-bromo-2-methyl-

CAPTOPRIL EP IMPURITY C
CAS:26473-47-2
Formula: C4H8O2S
> 95%
26473-47-2
3-Mercaptoisobutyric Acid; 3-Mercapto-2-methyl-propionic Acid; +¦-Mercapto-isobutyric Acid;

CAPTOPRIL EP IMPURITY D
CAS:56970-78-6
Formula: C4H7BrO2
> 95%
56970-78-6
(-¦)-3-Bromo-2-methylpropionic acid; NSC 201472; +¦-Bromoisobutanoic Acid;

CAPTOPRIL EP IMPURITY E
CAS:23500-15-4
Formula: C9H15NO3
> 95%
23500-15-4
(2S)-1-(2-Methylpropanoyl)pyrrolidine-2-carboxylic acid, 1-Isobutyryl-L-proline

CAPTOPRIL IMPURITY F
CAS:63250-36-2
Formula: C9H15NO3S
> 95%
63250-36-2
1-[(2R)-3-Mercapto-2-methyl-1-oxopropyl]-L-proline; 2-D-Methyl-3-mercaptopropanoyl-L-proline; SQ 14534; Epicaptopril

CAPTOPRIL IMPURITY G
CAS:33325-40-5
Formula: C6H10O3S
> 95%
33325-40-5
3-(Acetylthio)-2-methylpropanoic Acid; 3-Mercapto-2-methylpropionic Acid Acetate (RS)-3-Acetylthio-2-methylpropionic Acid; (-¦)-3-Acetylthio-2-methylpropionic Acid; 2-(Acetylthiomethyl)propanoic Acid; 3-(Acetylthio)-2-methylpropanoic Acid; 3

CAPTOPRIL IMPURITY K
CAS:76497-39-7
Formula: C6H10O3S
98-100% (Assay by titration)
BAT-008046
(2S)-3-(Acetylthio)-2-methylpropanoic Acid; (S)-3-(Acetylthio)-2-methylpropanoic acid; (S)-3-Acetylsulfanyl-2-methylpropionic Acid; (S)-3-Acetylthio-2-methylpropionic acid; D-(-)-3-Acetylthio-2-methylpropionic Acid; D-3-Acetylthio-2-methylp

CAPTOPRIL IMPURITY N
CAS:65134-74-9
Formula: C8H14O4S2
> 95%
65134-74-9
3,GÇï3'-GÇïDisulfanediylbis[(2SGÇï)GÇï-GÇï2-GÇïmethylpropanoic] acid

CAPTOPRIL-[13C5,15N]
Formula: C4[13C]5H15[15N]O3S
98%
BLP-000896
[13C5,15N]-Captopril

Captopril-[d3]
CAS:1356383-38-4
Formula: C9H12D3NO3S
GëÑ95% by HPLC; GëÑ98% atom D
BLP-011827
Captopril-d3; (2S)-1-(3-Marcapto-2-methyl-1-oxopionyl]-L-proline-2,5,5-d3; SQ-14225-d3